In recent years, the cash generated from our operating activities has financed our operations as well as the repurchase of our ordinary shares and payment of dividends. Generally, we invest our excess cash in highly liquid investment grade securities. As of December 31, 217, we had $525.1 million of cash and cash equivalents and short-term and long-term investments, as compared to $286.0 million at December 31, 2016 and $828.4 million at December 31, 2015.
Cash provided by operating activities was $394.7 million, $228.2 million, and $252.3 million in 2017, 2016, and 2015, respectively. Net cash from operations in 2017 consisted primarily of net income of $143.3 million, adjusted for non-cash activities such as depreciation and amortization of $156.3 million, stock-based compensation of $57.0 million as well as working capital changes derived from an increase in deferred revenues of $41.6 million, increase in accrued expenses and other liabilities of $25.5 million, decrease in deferred taxes of $70.8 million and decrease in trade receivables of $37.7 million. Net cash from operations in 2016 consisted primarily of net income of $126.1 million (excluding non-cash gain on disposal of discontinued operations of $9.1 million), adjusted for non-cash activities such as depreciation and amortization of $77.8 million, stock-based compensation of $40.5 million as well as working capital changes derived from an increase in accrued expenses and other liabilities of $18.0 million, decrease in deferred taxes of $25.9 million and increase in trade receivables of $31.7 million. Net cash from operations in 2015 consisted primarily of net income of $111.5 million (excluding non-cash gain on disposal of discontinued operations of $147.3 million), adjusted for non-cash activities such as depreciation and amortization of $57.9 million, stock-based compensation of $28.4 million as well as working capital changes derived from an increase in accrued expenses and other liabilities of $38.5 million and increase in deferred revenues of $54.9 million, which were partially offset by an increase in trade receivables of $56.3 million.
Net cash used in investing activities was $213.0 million, $800.0 million and $28.4 million in 2017, 2016 and 2015, respectively. In 2017, net cash used in investing activities consisted primarily of payment for acquisitions in an aggregate amount of $76.0 million, net investment in marketable securities and short term bank deposits of $69.1 million and purchase of property, equipment of $39.9 million and capitalization of internal use software costs of $27.9 million. In 2016, net cash used in investing activities consisted primarily of payment for the acquisition of inContact, Nexidia and other acquisitions in an aggregate amount of $1,157 million, which were partially offset by net proceeds received from the sale of marketable securities of $402.7 million. In 2015, net cash used in investing activities consisted primarily of net investment in marketable securities and short term bank deposits of $195.0 million and purchase of property and equipment of $16.6 million, which were offset by proceeds from the sale of discontinued operations of $186.1 million.
Net cash provided by (used in) financing activities was $(14.8) million, $405.4 million and $(79.4) million in 2017, 2016 and 2015, respectively. In 2017, net cash used in financing activities was attributed primarily to the repayment of long term debt of $260.0 million, repurchase of our ordinary shares of $24.4 million and payment of dividends of $9.6 million, which were offset primarily by proceeds from issuance of exchangeable notes of $260.1 million and proceeds from issuance of shares upon exercise of share options and purchase of shares under employee share purchase plans of $19.24 million. In 2016, net cash provided by financing activities was attributed primarily to the long term loan of $464.8 million and proceeds from issuance of shares upon exercise of options and purchase of shares under employee share purchase plans of $23.5 million, which were partially offset by payment of dividends of $38.2 million and repurchase of our ordinary shares of $43.6 million. In 2015, net cash used in financing activities was attributed primarily to the repurchase of our ordinary shares of $68.4 million and payment of dividends of $38.2 million, which were offset by proceeds from the issuance of shares upon exercise of options and purchase of shares under employee share purchase plans of $27.5 million. For more information regarding the long term debt, see Note 14 to our Consolidated Financial Statements.
We believe that based on our current operating forecast, the combination of existing working capital and expected cash flows from operations will be sufficient to finance our ongoing operations for the next twelve months.
Research and Development and Intellectual Property
For information on our research and development policies and intellectual property, please see “Research and Development” and “Intellectual Property” under Item 4, “Information on the Company” in this annual report.
Trend Information
For information on trends in our industry, please see Item 4, “Information on the Company—Business Overview—Industry and Technology Trends” in this annual report.
For more information on trends, uncertainties, demands, commitments or events that may have a material effect on revenue, please see Item 3, “Key Information—Risk Factors” in this annual report.
Contractual Obligations
Set forth below are our contractual obligations and other commercial commitments as of December 31, 2017 (in thousands of U.S. dollars).
|
|
Payments Due by Period
|
|
Contractual Obligations
|
|
Total
|
|
|
Less than 1 year
|
|
|
1- 3 years
|
|
|
3-5 years
|
|
|
More than 5 years
|
|
Long-term debt obligations, including estimated interest *
|
|
|
526,622
|
|
|
|
218,785
|
|
|
|
11,352
|
|
|
|
7,188
|
|
|
|
289,297
|
|
Operating Leases
|
|
|
97,378
|
|
|
|
18,626
|
|
|
|
32,127
|
|
|
|
27,593
|
|
|
|
19,392
|
|
Unconditional Purchase Obligations
|
|
|
31,773
|
|
|
|
20,646
|
|
|
|
10,924
|
|
|
|
203
|
|
|
|
-
|
|
Severance Pay**
|
|
|
17,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Contractual Cash Obligations
|
|
|
673,383
|
|
|
|
258,057
|
|
|
|
54,403
|
|
|
|
34,984
|
|
|
|
308,689
|
|
Uncertain Income Tax Positions ***
|
|
|
43,984
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Long-term debt obligations mainly include senior exchangeable notes and long-term loan as disclosed in Note 14 to our Consolidated Financial Statements.
|
**
|
Severance pay relates to accrued obligations to employees as required under applicable labor laws. These obligations are payable only upon termination, retirement or death of the respective employees.
|
***
|
Uncertain income tax positions under ASC 740 are due upon settlement and we are unable to reasonably estimate the ultimate amount or timing of settlement. See Note 12(i) of our Consolidated Financial Statements for further information regarding our liability under ASC 740.
|
|
|
|
|
|
Amount of Commitment Expiration Per Period
|
|
Other Commercial Commitments
|
|
Total
Amounts Committed
|
|
|
Less
than 1 year
|
|
|
1- 3 years
|
|
|
3-5 years
|
|
|
More
than 5 years
|
|
Guarantees – Continuing operations
|
|
|
4,792,805
|
|
|
|
4,202,626
|
|
|
|
400,673
|
|
|
|
189,506
|
|
|
|
-
|
|
Guarantees – Discontinued operations*
|
|
|
19,488,497
|
|
|
|
18,324,591
|
|
|
|
1,163,906
|
|
|
|
-
|
|
|
|
-
|
|
Total Guarantees
|
|
|
24,281,302
|
|
|
|
22,527,217
|
|
|
|
1,564,579
|
|
|
|
189,506
|
|
|
|
--
|
|
* Represents guarantees that were not endorsed and are still in effect with respect to contracts assumed as part of the sale of the Cyber and Intelligence line of business, for which we have a back to back contractual commitment and entitlement to indemnification upon realization of the guarantees.
Item 6. Directors, Senior Management and Employees.
6.A. Directors and Senior Management
The following tables set forth, as of March 20, 2018, the name, age and position of each of our directors and executive officers and, in regard to our directors, any of the committees of our board of directors on which they serve and whether any such director is an outside director:
Members of the Board of Directors
Name
|
Age
|
Position
|
Audit Committee Member
|
Compensation Committee Member
|
Internal Audit Committee Member
|
Mergers and Acquisitions Committee Member
|
Nominations Committee Member
|
Outside Director*
|
David Kostman
|
53
|
Chairman of the Board of Directors
|
X
|
|
|
X
|
X
|
|
Rimon Ben-Shaoul
|
73
|
Director
|
X
|
|
|
X
|
|
|
Dan Falk
|
73
|
Director
|
X
|
X
|
X
|
X
|
X
|
X
|
Yocheved Dvir
|
65
|
Director
|
X
|
X
|
X
|
|
|
X
|
Yehoshua Ehrlich
|
68
|
Director
|
|
|
|
X
|
|
|
Leo Apotheker
|
64
|
Director
|
|
X
|
|
X
|
|
|
Joe Cowan
|
69
|
Director
|
|
X
|
|
X
|
|
|
Zehava Simon
|
59
|
Director
|
X
|
X
|
X
|
|
|
X
|
* See Item 6, “Directors, Senior Management and Employees—Board Practices— Outside Directors.”
Members of Management
Name
|
Age
|
Position
|
Barak Eilam
|
42
|
Chief Executive Officer
|
Miki Migdal
|
57
|
President, Enterprise Product Group
|
Joseph Friscia
|
63
|
President, NICE-Actimize
|
Paul Jarman
|
48
|
Chief Executive Officer, inContact
|
Beth Gaspich
|
52
|
Chief Financial Officer
|
Eran Liron
|
50
|
Executive Vice President, Marketing and Corporate Development
|
Barry Cooper
|
47
|
Chief Operating Officer
|
Tali Mirsky
|
45
|
Corporate Vice President, General Counsel and Corporate Secretary
|
Hagit Ynon
|
46
|
Corporate Vice President, Finance
|
In December 2017, Mr. Yechiam Cohen retired from his position as Corporate Vice President, General Counsel and Corporate Secretary, effective December 31, 2017, and Mrs. Tali Mirsky assumed the position effective March 2018.
In January 2018, Mr. Eran Porat retired from his position as Corporate Vice President, Finance, effective January 2018, and Ms. Hagit Ynon assumed the position effective January 2018.Set forth below is a biographical summary of each of the above-named directors and executive officers of NICE. Each of our directors qualifies as an independent director under applicable NASDAQ rules.
David Kostman has served as one of our directors for most of the period since 2001 and as our Chairman of the Board since February 2013. Mr. Kostman is currently co-CEO and board member of Outbrain, Inc. and serves on the board of directors of ironSource Ltd. and Tivit S.A., and is a member of Nanoosh LLC. Mr. Kostman is also a former board member of publicly traded Retalix Ltd. (acquired by NCR). From 2006 until 2008, Mr. Kostman was a Managing Director in the investment banking division of Lehman Brothers, heading the Global Internet Group. From April 2003 until July 2006, Mr. Kostman was Chief Operating Officer and then Chief Executive Officer of Delta Galil USA, a subsidiary of publicly traded Delta Galil Industries Ltd. From 2000 until 2002, Mr. Kostman was President of the International Division and Chief Operating Officer of publicly traded VerticalNet Inc. Prior to that Mr. Kostman worked in the investment banking divisions of Lehman Brothers from 1994 to 2000, focusing on the technology and Internet sectors, and NM Rothschild & Sons from 1992 to 1993, focusing on mergers and acquisitions and privatizations. Mr. Kostman holds a Bachelor’s degree in Law from Tel Aviv University and a Master’s degree in Business Administration from INSEAD.
Rimon Ben-Shaoul has served as one of our directors since September 2001. Between 2001 and 2005, Mr. Ben-Shaoul has served as Co-Chairman, President, and Chief Executive Officer of Koonras Technologies Ltd., a technology investment company controlled by LEADER Ltd., an Israeli holding company. Since 2002 Mr. Ben-Shaoul serves as Chairman of Grand AutoMotive LLP. Mr. Ben-Shaoul also served as a director of MIND C.T.I. Ltd., BVR Systems Ltd. and several private companies. In addition, he served as the President and Chief Executive Officer of Polar Communications Ltd., which manages media and communications investments. Mr. Ben-Shaoul also served as the Chairman of T.A.T Technologies Ltd., a public company listed on NASDAQ and TASE. Between 1997 and 2001, Mr. Ben-Shaoul was the President and Chief Executive Officer of Clal Industries and Investments Ltd., one of the largest holding companies in Israel with substantial holdings in the high tech industry. During that time, Mr. Ben-Shaoul also served as Chairman of the Board of Directors of Clal Electronics Industries Ltd., Scitex Corporation Ltd., and various other companies within the Clal Group. Mr. Ben-Shaoul also served as a director of ECI Telecom Ltd., Fundtech Ltd., Creo Products, Inc. and Nova Measuring Instruments Ltd. From 1985 to 1997, Mr. Ben-Shaoul was President and Chief Executive Officer of Clal Insurance Company Ltd. and a director of the company and its various subsidiaries. Mr. Ben-Shaoul holds a Bachelor’s degree in Economics and Statistics and a Master’s degree in Business Administration, both from Tel-Aviv University.
Dan Falk has served as one of our statutory outside directors since 2001. From 1999 to 2000, Mr. Falk was President and Chief Operating Officer of Sapiens International Corporation N.V. From 1985 to 1999, Mr. Falk served in various positions in Orbotech Ltd., the last of which were Chief Financial Officer and Executive Vice President. From 1973 to 1985, he served in several executive positions in the Israel Discount Bank. Mr. Falk also serves on the board of directors of Orbotech Ltd., Ormat Technologies Inc. and Attunity Ltd. Mr. Falk holds a Bachelor’s degree in Economics and Political Science and a Master’s degree in Business Administration, both from the Hebrew University, Jerusalem.
Yocheved Dvir has served as one of our statutory outside directors since January 2008. Since 2000, Ms. Dvir has served as a strategic advisor in business development affairs to multiple companies and initiatives that were being founded. Ms. Dvir also serves on the board of directors of Menorah Insurance Company and its subsidiary, Alrov Real Estate and Endey Med. She recently served on the boards of Visa Cal, Trendline Business Information & Communications Ltd., Israel Corporation Ltd., ECI Telecom Ltd., Strauss Industries Ltd., Phoenix Holding and Phoenix Insurance Co. Between 1990 and 2000, Ms. Dvir served as a Senior Vice President of the Migdal Group. Ms. Dvir joined the Migdal Group in 1981 and, until late 2000, held a number of senior financial and managerial positions, including Head of the Group’s Economics Department (1986-1988), Head of the Group’s Corporate Office from 1989 to1992, Head of the Group’s General Insurance Division and Corporate Office from 1993 to 1997, Group CFO from 1997 to 1999, and Head of the Group’s Strategic Development Division and Marketing Array and Risk Manager in 2000. Ms. Dvir holds a Bachelor’s degree in Economics and Statistics from the University of Haifa and completed studies towards a second degree in Statistics from the Hebrew University of Jerusalem.
Yehoshua (Shuki) Ehrlich has served as one of our directors since September 2012. Mr. Ehrlich is an active social investor, serving as Chairman of "Committed to Give", a group formed by Israeli social investors for promoting philanthropy in Israel and several other social organizations. Mr. Ehrlich also serves as a member of the executive board of Israel Venture Network and a board member of AfterDox, an angels' investment group. Between the years 2000 and 2010, Mr. Ehrlich served as Managing Director at Giza Venture Capital, where he focused on the communications, enterprise software and information technology sectors. Additionally, Mr. Ehrlich had a fifteen-year career with Amdocs, a public software company specializing in billing, CRM, order management systems for telecommunications and Internet service providers. In his last role at Amdocs, Mr. Ehrlich served as Senior Vice President of Business Development. Mr. Ehrlich holds a Bachelor of Science in Mathematics and Computer Science from the Tel Aviv University.
Leo Apotheker has served as one of our directors since August 2013. Mr. Apotheker was the Managing Partner and co-founder of Efficiency Capital SAS, a growth capital advisory firm, from 2012 to 2014. From 2010 to 2011, Mr. Apotheker served as Chief Executive Officer of Hewlett Packard. From 2008 to 2010, he served as Chief Executive Officer of SAP AG. In addition, he is currently chairman of the board of Unit4, a leading Dutch software company, and Signavio GmbH, Vice Chairman and Lead Director of Schneider SE, and a member of the board of KMD, P2 Energy Services and Taulia Inc. Mr. Apotheker holds a Bachelor’s degree in Economics and International Relations from the Hebrew University of Jerusalem.
Joe Cowan has served as one of our directors since August 2013. From October 2013 until September 2017, Mr. Cowan was the CEO and director of Epicor, and since September 2016 has been a director of ChannelAdvidsor, Inc. During 2013, Mr. Cowan also served as President of DataDirect Networks, Inc. From 2010 until 2013, Mr. Cowan served as the Chief Executive Officer and President of Online Resources Corp. During 2009, he served as an Operating Executive and Consultant at Vector Capital. From 2007 to 2009, Mr. Cowan served as the Chief Executive Officer of Interwoven Inc. From 2004 to 2006, Mr. Cowan served as the President and Chief Executive Officer of Manugistics Inc. and Manugistics Group Inc. Prior to that, Mr. Cowan served in various senior executive positions, including as the Chief Operating Officer of Baan Co. NV and Avantis GOB NV. He has been a Director of DataDirect Networks, Inc. between 2011 and February 2013. Mr. Cowan has also served on the boards of various publicly traded companies, including ChannelAdvidsor Inc., Interwoven Inc., Online Resources Corporation, Manugistics Group Inc. and Blackboard Inc., as well as several private companies. Mr. Cowan holds a M.S. degree in Electrical Engineering from Arizona State University and holds a B.S. degree in Electrical Engineering from Auburn University.
Zehava Simon has served as one of our statutory outside directors since July 2015. Ms. Simon served as a Vice President of BMC Software Inc. from 2000 until 2013, most recently as Vice President of Corporate Development. From 2002 to 2011, Ms. Simon also served as Vice President and General Manager of BMC Software in Israel. Prior to that, Ms. Simon held various positions at Intel Israel, which she joined in 1982, including acting as leader of Finance and Operations and Business Development for Intel in Israel. Ms. Simon is currently a board member of Audiocodes, a public company traded on NASDAQ and TASE, Nova Measurements, a publicly-traded company on NASDAQ and TASE, and Amiad Water Systems, a public company traded on the London Stock Exchange. Ms. Simon is a former member of the board of directors of Insightec Ltd., M-Systems Ltd. (acquired by SanDisk Corp.) and Tower Semiconductor Ltd. Ms. Simon holds a B.A. in Social Sciences from the Hebrew University, Jerusalem, a law degree (LL.B.) from the Interdisciplinary Center in Herzliya and an M.A. in Business and Management from Boston University.
Barak Eilam has served as Chief Executive Officer since April 2014. In his previous position with NICE, Mr. Eilam was President of our American division from July 2012 to March 2014. Prior to that, Mr. Eilam was the head of sales and the general manager of the Enterprise Group in the Americas. From 2007 to 2009, Mr. Eilam founded and served as the general manager of the NICE Interaction Analytics Global Business Unit. Mr. Eilam has also served in a variety of executive positions within NICE, managing different aspects of the business in product development, sales and product management. Before joining NICE in 1999, Mr. Eilam was an officer for an elite intelligence unit in the Israeli defense forces. Mr. Eilam holds a Bachelor's degree in Electrical and Electronics Engineering from Tel Aviv University.
Miki Migdal has served as President of the NICE Enterprise Product Group since July 2014. Prior to joining NICE, Mr. Migdal was the CEO of SAP Israel and held additional leadership roles at SAP including Senior Vice President of Development at SAP Global and President of SAP Labs Israel. He also served in executive positions at B.V.R Systems, Amdocs and Mercury Interactive (HP Software). Mr. Migdal holds a B.Sc. in Math and Computer Science from Tel Aviv University.
Joseph Friscia has served as President of NICE Actimize since April 2014. Prior to joining NICE, Mr. Friscia served as President of BAE Systems’ Applied Intelligence Americas business. He joined BAE when BAE Systems acquired Norkom Technologies, where he had served as General Manager and Executive Vice President of the Americas. Prior to Norkom, Mr. Friscia was a co-founder of Pegasystems, Inc., the leading Business Process Management software company, from its origin and through taking it public in 1996. Mr. Friscia holds an MBA degree from Adelphi University and a B.A. from Long Island University.
Paul Jarman has served as NICE inContact CEO since November 2016, and served as inContact CEO since January 2005 until we acquired inContact. Prior to becoming CEO, Mr. Jarman served as inContact’s President from December 2002. Prior to December 2002, he served as inContact’s Executive Vice President. Mr. Jarman was instrumental in guiding inContact from its roots in telecommunications to its strategic offering of cloud-based contact center solutions and has been a part of every major enhancement the company has made since 1997. Mr. Jarman led inContact's listing on NASDAQ. Prior to joining inContact, he was an executive with HealthRider, Inc. Mr. Jarman holds a Bachelor of Science degree in Accounting from the University of Utah.
Beth Gaspich has served as our Chief Financial Officer since October 2016. Ms. Gaspich joined NICE as CFO of the Financial Crime and Compliance division NICE Actimize in September 2011, where she was responsible for finance, legal and business operations. Prior to joining NICE, she was Chief Financial Officer for Archive Systems, Inc., a privately held document management software provider. She also served as Vice President of Finance at RiskMetrics Group, Inc., a cloud based risk management software company. Ms. Gaspich was one of the founding members of RiskMetrics Group and assisted in taking the company through a successful public offering on the NYSE in January 2008. Prior to that, Ms. Gaspich held several other senior positions throughout her career at large global financial institutions, including JP Morgan and Price Waterhouse. Ms. Gaspich holds a BA in Accounting from the University of Missouri.
Eran Liron has served as our Executive Vice President, Marketing and Corporate Development since October 2013, and as Executive Vice President, Corporate Development since February 2006. From 2004 to 2006, he served as Director of Corporate Development at Mercury Interactive Corporation, a software company, and prior thereto he held several business development positions at Mercury Interactive. Before joining Mercury, Mr. Liron served in several marketing roles at software startups and at Tower Semiconductor. Mr. Liron holds a Bachelor of Science degree from the Technion – Israel Institute of Technology and a Doctorate in Business from the Stanford Graduate School of Business in California.
Barry Cooper has been with NICE since 2011 and serves as our Chief Operating Officer (COO) since May 2016. Prior to serving as COO, Mr. Cooper served as Vice President, Business Operations for APAC from March, 2011 until June 2013, and as of July 2013 and until assuming the role of COO, he served as Executive Vice President, Professional Services and Cloud. Prior to joining NICE, Mr. Cooper was a Management Consultant at Accenture; the Head of Customer Service, IT and Billing at Time Telekom, Malaysia; and Vice President of Professional Services, APAC for CSG Systems, later Comverse. Mr. Cooper holds a First Class Bachelor of Computer Science and Mathematics with Honors from Salford University in the United Kingdom.
Tali Mirsky has served as our Corporate Vice President, General Counsel and Corporate Secretary since March 2018. From 2010 to early 2018, she served as Global Vice President of Legal Affairs and Corporate Secretary at Frutarom Industries Ltd., where she led the company’s M&A transactions in addition to managing the company’s legal department and handling all legal matters and corporate and securities related items. Prior to that, Tali served as Vice President, General Counsel and Corporate Secretary of Alvarion, led Business and Legal Affairs at Nicast and Midbar Tech and was an associate with Naschitz Brandes & Co law office. She holds an LL.B in Law and Business Administration from IDC, Herzliya and is admitted to practice law in Israel.
Hagit Ynon has served as our Corporate Vice President, Finance since January 2018. Prior to serving as Corporate Vice President Finance, Ms. Ynon served as Vice President Accounting, Treasury and Tax from 2008 until 2017. From 2000 to 2007, Ms. Ynon served as Corporate Controller and other managerial positions in the finance department. Ms. Ynon is a certified public accountant and holds a Bachelor’s degree in Business and Accounting from the College of Management Academic Studies and a Masters in Business Administration from the College of Management Academic Studies.
There are no family relationships between any of the directors or executive officers named above.
(a) Aggregate Executive Compensation
The aggregate compensation paid to or accrued on behalf of all our directors and executive officers as a group of 17 persons during 2017 consisted of approximately $7.7 million in salary, fees, bonus, commissions and directors’ fees and approximately $0.7 million in amounts set aside or accrued to provide pension, retirement or similar benefits, but excluding amounts we expended for automobiles made available to our officers, expenses (including business travel, professional and business association dues and expenses) reimbursed to our officers and other fringe benefits commonly reimbursed or paid by companies in Israel.
We have a performance-based bonus plan for our executive management team. The plan is based on our overall performance, the particular unit performance, individual performance and the results of the customer satisfaction survey conducted annually. The measurements can change year over year and are a combination of financial parameters, including revenues, booking and operating income. The plan is reviewed and approved by our Board of Directors annually, as is any bonus payment under the plan.
During 2017, our officers and directors received, in the aggregate, (i) options to purchase 146,800 ordinary shares, that include 56,800 options with an exercise price equal to the par value of the ordinary shares (the “par value options”), and (ii) 182,500 restricted share units, under our equity based compensation plans. The options (other than the par value options) have a weighted average price of $79.21 and all options will expire six years after the date of grant. The restricted shares units are granted at par value of the ordinary shares. For information regarding our option exchange program, see "Share Ownership–Option Exchanges and Price Adjustment" below.
Pursuant to the requirements of the Israeli Companies Law, 5759–1999 (the “Israeli Companies Law”), remuneration of our directors requires shareholder approval. Compensation and reimbursement for outside directors (as described below) is statuto-rily determined pursuant to the Israeli Companies Law. Effective as of July 1, 2015, our shareholders approved the payment to each of our non-executive directors, including outside directors, of an annual fee of $40,000 and a meeting attendance fee of $1,500 for each Board meeting attended (whether in person or through media), and $1,000 for each Board committee meeting attended (whether in person or through media) (in each case paid in U.S. dollars or in NIS based on the exchange rate on July 1, 2015), subject to additional value added tax, as applicable.
On July 9, 2015, at our 2015 annual general meeting of shareholders, following the recommendation of our compensation committee and approval by our Board of Directors, our shareholders approved an amended compensation policy for directors and officers. In addition, our shareholders approved a special annual cash fee for the Chairman of the Board in the amount of NIS 450,000 (equivalent to approximately $129,348). The special annual fee is subject to adjustment for changes in the Israeli consumer price index after September 2012. At the Company's special general meeting held on December 21, 2016, following the recommendation of our compensation committee and approval by our Board of Directors, our shareholders approved certain amendments to the current compensation policy.
(b) Individual Compensation of Covered Executives
The following describes the compensation of our five most highly compensated executive officers in 2017, based on the total of salary costs, bonus cost and equity costs expensed in 2017 ("Covered Executives").
The compensation specified below is broken down into the following components (all amounts specified below are in terms of cost to the Company, as recorded in our financial statements). U.S. dollar amounts indicated for Salary, Bonus and Equity Costs are in thousands of dollars. For Covered Executives in Israel these amounts are based on the Shekel exchange rate of 3.60, which represents the average rate for 2017, and for the Covered Executive in Singapore are based on the Singapore dollar exchange rate of 1.42, which represents the average rate for 2017.
|
(1) |
Salary Costs. Salary Costs include gross salary, benefits and perquisites, including those mandated by applicable law which may include, to the extent applicable to each Covered Executive, payments, contributions and/or allocations for pension, severance, vacation, travel and accommodation, car or car allowance, medical insurances and risk insurances (e.g., life, disability, accidents), phone, convalescence pay, relocation, payments for social security, and other benefits consistent with the Company's guidelines.
|
|
(2) |
Bonus Costs. Bonus Costs represent bonuses granted to the Covered Executive with respect to the year ended December 31, 2017, paid in accordance with the Company's performance-based bonus plan or as detailed in footnotes below.
|
|
(3) |
Equity Costs. Represents the expense recorded in our financial statements for the year ended December 31, 2017, with respect to equity granted in 2017 and in previous years (if applicable). For assumptions and key variables used in the calculation of such amounts see Note 13b of our audited Consolidated Financial Statements.
|
|
i. |
Barak Eilam – CEO. Salary Costs - $788; Bonus Costs - $1,257; Equity Costs - $1,913 expense recorded in 2017 for equity granted in 2017 and $2,313 expense recorded in 2017 for equity granted in previous years.
|
|
ii. |
Paul Jarman – CEO, inContact. Salary Costs - $424; Bonus Costs - $367; Equity Costs - $2,352 expense recorded in 2017 for equity granted in 2017 and $793 expense recorded in 2017 for equity granted in previous years.
|
|
iii. |
Yaron Hertz – President, NICE Americas. Salary Costs - $386; Bonus Costs - $437 and $997 expense recorded in 2017 for equity granted in 2017 and $161 expense recorded in 2017 for equity granted in previous years.
|
|
iv. |
Joseph Friscia – President, NICE Actimize. Salary Costs - $437; Bonus Costs - $438; Equity Costs - $694 expense recorded in 2017 for equity granted in 2017 and $692 expense recorded in 2017 for equity granted in previous years.
|
|
v. |
Miki Migdal –President, NICE Enterprise Product Group. Salary Costs - $457; Bonus Costs - $406; Equity Costs - $543 expense recorded in 2017 for equity granted in 2017 and $608 expense recorded in 2017 for equity granted in previous years.
|
Board Practices
Corporate Governance Practices
We are incorporated in Israel and therefore are subject to various corporate governance practices under the Israeli Companies Law, relating to such matters as outside directors, the internal audit committee, the internal auditor and approvals of interested party transactions. These matters are in addition to the ongoing listing conditions of the NASDAQ and other relevant provisions of U.S. securities laws. Under applicable NASDAQ rules, a foreign private issuer may generally follow its home country rules of corporate governance in lieu of comparable NASDAQ requirements, except for certain matters such as composition and responsibilities of the audit committee and the independence of its members. For further information see Item 16G, “Corporate Governance” of this annual report.
General Board Practices
Our articles of association provide that the number of directors serving on the Board shall be not less than three but shall not exceed thirteen. Our directors, other than outside directors, are elected at the annual shareholders meeting to serve until the next annual meeting or until their earlier death, resignation, bankruptcy, incapacity or removal by an extraordinary resolution of the general shareholders meeting. Directors may be re-elected at each annual shareholders meeting. The Board may appoint additional directors (whether to fill a vacancy or create new directorships) to serve until the next annual shareholders meeting, provided, however, that the Board shall have no obligation to fill any vacancy unless the number of directors is less than three.
The Board may, subject to the provisions of the Israeli Companies Law, appoint a committee of the Board and delegate to such committee all or any of the powers of the Board, as it deems appropriate. Notwithstanding the foregoing and subject to the provisions of the Israeli Companies law, the Board may, at any time, amend, restate or cancel the delegation of any of its powers to any of its committees. The Board has appointed an internal audit committee under the Israeli Companies Law that has three members, an audit committee that has five members, a compensation committee that has five members, a nominations committee that has two members and a mergers and acquisitions committee that has six members. In addition, from time to time the Board may appoint an ad hoc committee for certain purposes, such as the review, negotiation and recommendation of approval of M&A transactions. We do not have, nor do our subsidiaries have, any directors’ service contracts granting to the directors any benefits upon termination of their service.
Except as discussed below, under the Israeli Companies Law companies incorporated under the laws of Israel whose shares have been offered to the public in or outside of Israel are required to appoint at least two “outside” directors. Pursuant to regulations under the Israeli Companies Law that took effect in April 2016, a NASDAQ -listed company that does not have a controlling shareholder is entitled to opt out of the provisions of the Israeli Companies Law requiring at least two outside directors and certain related requirements, so long as the company complies with the SEC regulations and NASDAQ listing rules regarding independent directors and the composition of the audit and compensation committees. In December 2016, our shareholders approved amendments to our articles of association, pursuant to which our Board of Directors may elect to opt out of such requirements for appointment of outside directors (together the "2016 Relief Amendments"). According to the 2016 Relief Amendments, an outside director that was appointed prior to a company opting out of such requirements may continue in office until the end of his or her then-current term or until the end of the second annual general meeting convened after the applicable company opts out of the requirement, whichever is earlier. At this time, our Board of Directors has not made an election to opt out of such requirements.
Outside directors are required to possess professional qualifications as set out in regulations promulgated under the Israeli Companies Law. The Israeli Companies Law provides that a person may not be appointed as an outside director if (i) such person or person’s relative or affiliate has, at the date of appointment, or had at any time during the two years preceding such date, any affiliation with the company, a controlling shareholder thereof or their respective affiliates; or (ii) in a company that does not have a 25% shareholder, such person has an affiliation with any person who, at the time of appointment, is the chairman, the chief executive officer, the chief financial officer or a 5% shareholder of the company. In general, the term “affiliation” includes: an employment relationship; a business or professional relationship maintained on a regular basis; control; and service as an office holder.
No person may serve as an outside director if the person’s position or other activities create, or may create a conflict of interest with the person’s responsibilities as an outside director or may otherwise interfere with the person’s ability to serve as an outside director. Until the lapse of two years from termination of office, a company or its controlling shareholder may not give any direct or indirect benefit to the former outside director.
Outside directors are to be elected by a majority vote at a shareholders’ meeting, provided that either:
|
· |
the majority of shares voted at the meeting shall include at least a majority of the shares of non-controlling shareholders present at the meeting and voting on the matter (without taking into account the votes of the abstaining shareholders); or
|
|
· |
the total number of shares of non-controlling shareholders voted against the election of the outside directors does not exceed two percent of the aggregate voting rights in the company.
|
The initial term of an outside director is three years and may be extended for up to two additional three-year terms. Thereafter, he or she may be reelected by our shareholders for additional periods of up to three years each only if the internal audit committee and the Board of Directors confirm that, in light of the outside director’s expertise and special contribution to the work of the Board of Directors and its committees, the reelection for such additional period is beneficial to the company. Reelection of an outside director may be effected through one of the following mechanisms: (1) the Board of Directors proposed the reelection of the nominee and the election was approved by the shareholders in the same manner required to appoint outside directors for their initial term; or (2) one or more shareholders holding one percent or more of a company’s voting rights or the outside director proposed the reelection of the nominee, and the reelection is approved by a majority of the votes cast by the shareholders of the company, excluding the votes of controlling shareholders and those who have a personal interest in the matter as a result of their relations with the controlling shareholders, provided that the aggregate votes cast in favor of the reelection by such non-excluded shareholders constitute more than two percent of the voting rights in the company. An outside director may be removed only in a general meeting, by the same percentage of shareholders as is required for electing an outside director, or by a court, and in both cases only if the outside director ceases to meet the statutory qualifications for appointment or if he or she has violated the duty of loyalty to us. Unless we actually adopt the applicable relief provided under the 2016 Relief Amendments, each committee of the Company’s Board of Directors which is empowered to exercise any of the Board’s powers is required to include at least one outside director, provided that each of the internal audit committee and compensation committee must include all of the outside directors. At this time, our Board of Directors has not made an election to opt out of such requirements.
An outside director is entitled to compensation as provided in regulations adopted under the Israeli Companies Law and is otherwise prohibited from receiving any other compensation, directly or indirectly, from the company. In accordance with such regulations, our shareholders approved that our outside directors are to receive compensation equal to that paid to the other members of the Board of Directors. For further information, please see Item 6, “Directors, Senior Management and Employees—Compensation” in this annual report.
Financial and Accounting Expertise
Pursuant to the Israeli Companies Law, our Board of Directors has determined that at least one member of our Board of Directors must be an “accounting and financial expert.” The Israeli Companies Law requires that all outside directors must be “professionally qualified.” Under applicable NASDAQ rules, each member of our audit committee must be financially literate and at least one of the members must have experience or background that results in such member’s financial sophistication. Our Board of Directors has determined that each of Dan Falk and Yocheved Dvir is an “accounting and financial expert” for purposes of the Israeli Companies Law and is financially sophisticated for purposes of applicable NASDAQ rules. See also Item 16A, “Audit Committee Financial Expert” in this annual report.
Under the rules of the NASDAQ, a majority of our directors are required to be “independent” as defined in applicable NASDAQ rules. All of our directors satisfy the respective independence requirements of NASDAQ.
In addition, our Articles of Association provide that, if we do not have a shareholder that holds 25% or more of our issued and outstanding share capital, a majority of the directors must be "independent" as defined in the Israeli Companies Law and the regulations promulgated thereunder. If we have a shareholder that holds 25% or more of our issued and outstanding share capital, then at least one third of the directors must be "independent." All of our directors satisfy the respective independence requirements of the Israeli Companies Law. The qualifications for independent directors under the Israeli Companies Law are similar to those for outside directors, as described above under “Outside Directors”, including the nine-year term limit and the ability to extend such term beyond nine years upon the approval of our internal audit committee and Board of Directors.
The Israeli Companies Law requires public companies to appoint an internal audit committee. The role of the internal audit committee under the Israeli Companies Law is to examine flaws in the management of the company’s business in consultation with the internal auditors and the independent accountants, and to propose remedial measures to the Board. The internal audit committee also reviews interested party transactions for approval as required by law, including approval of the remuneration of a director in any capacity, which also requires Board, Compensation Committee and shareholder approval. The internal audit committee also assesses our internal audit system and the performance of our internal auditor, and oversees the implementation and enforcement of our compliance program. Under the Israeli Companies Law, an internal audit committee must consist of at least three directors, including all of the outside directors. The members of the internal audit committee must satisfy certain independence standards under the Israeli Companies Law, and the chairman of the internal audit committee must be an outside director. The chairman of the Board of Directors, any director employed by the company or by its controlling shareholder or by an entity controlled by the controlling shareholder, a director who regularly provides services to the company or to its controlling shareholder, any director who derives most of its income from the controlling shareholder and a controlling shareholder or any relative of a controlling shareholder, may not be a member of the internal audit committee. Pursuant to the 2016 Relief Amendments, the Company may elect to opt out of the composition and attendance rules set with respect to the internal audit committee under the Israeli Companies Law, so long as the company complies with the SEC regulations and NASDAQ listing rules regarding the composition and attendance rules in that respect. At this time, our Board of Directors has not made an election to opt out of such requirements.
All of the current members of our internal audit committee (presently comprised of Yocheved Dvir (Chairman), Dan Falk and Zehava Simon) meet these qualifications.
Under the Israeli Companies Law, the Board of Directors must appoint an internal auditor, proposed by the internal audit committee. The role of the internal auditor is to examine, among other matters, whether the company’s activities comply with the law and orderly business procedure. Under the Israeli Companies Law, the internal auditor may be an employee of the company but may not be an interested party or office holder, or a relative of any interested party or office holder, and may not be a member of the company’s independent accounting firm or its representative. We have appointed an internal auditor in accordance with the requirements of the Israeli Companies Law.
The NASDAQ rules require that the audit committee of a listed company be composed of at least three directors, each of whom is (i) independent; (ii) does not receive any compensation (except for board fees) from the company; (iii) is not an affiliated person of the company or any subsidiary; and (iv) has not participated in the preparation of the company’s (or a current subsidiary’s) financial statements during the past three years. All of the current members of our audit committee (presently comprised of Rimon Ben-Shaoul (Chairman), David Kostman, Dan Falk, Yocheved Dvir and Zehava Simon) meet the NASDAQ standards described above.
Our audit committee has adopted a charter specifying the committee’s purpose and outlining its duties and responsibilities which include, among other things, (i) appointing, retaining and compensating the company’s independent auditor, subject to Board of Directors and shareholder approval, (ii) pre-approving all services of the independent auditor, (iii) reviewing the annual audited financial statements and quarterly financial statements and the content of our earnings press releases, and (iv) overseeing our accounting and financial reporting processes and the audits of our financial statements. Our audit committee is also authorized to act as our “qualified legal compliance committee.” As such, our audit committee will be responsible for investigating reports made by attorneys appearing and practicing before the SEC in representing us, of perceived material violations of U.S. federal or state securities laws, breaches of fiduciary duty or similar material violations of U.S. law by us or any of our agents.
We believe we currently meet the applicable NASDAQ requirements with respect to our Audit Committee and we intend to continue to take all actions as may be necessary for us to maintain our compliance with applicable NASDAQ requirements with respect to our Audit Committee.
Compensation Committee
As required by NASDAQ rules, our compensation committee approves the compensation of our executive officers. The compensation committee is also authorized to approve the grant of stock options and other securities to eligible grantees under our benefit plans pursuant to guidelines adopted by our Board of Directors. However, grants of stock options and other securities to our executive officers also require approval of our Board of Directors. Under the Israeli Companies Law, the Board of Directors of a public company must establish a compensation committee. Pursuant to the 2016 Relief Amendments, the Company may elect to opt out of the relevant composition and attendance rules set under the Israeli Companies Law, and to comply with the SEC regulations and NASDAQ listing rules that apply to the composition and attendance rules of a compensation committee. At this time, our Board of Directors has not made an election to opt out of such requirements and we have continued to comply with the Israeli Companies Law with respect to the composition and attendance rules of a compensation committee, as our compensation committee consists of at least three directors who satisfy the independence qualifications detailed above in “Internal Audit Committee”, and the chairman of the compensation committee is an outside director.
Under the Israeli Companies Law, the role of the compensation committee is to recommend to the Board of Directors, for ultimate shareholder approval by a special majority, a policy governing the compensation of office holders based on specified criteria, to review modifications to the compensation policy from time to time, to review its implementation and to approve the actual compensation terms of office holders prior to the approval thereof by the Board of Directors.
Pursuant to the NASDAQ rules, our compensation committee is required to consist of at least two members, with all members of the compensation committee required to be independent, unless we elect to take advantage of the exemption provided to "foreign private issuers" to comply with home country practice instead of the listing rules of exchanges such as NASDAQ, which we do not presently intend to do. The determination of whether a director is independent takes into account all factors relevant to whether a director has a relationship with the Company which would be material to such director’s ability to be independent from management in connection with carrying out the duties of a compensation committee member. Factors required for consideration in making this determination specifically include (i) the source of compensation of such director (including any consulting, advisory or other compensatory fee paid to such director) and (ii) whether such director is affiliated with the Company or one of its affiliates or subsidiaries. Pursuant to the NASDAQ rules, we are also required to have a compensation committee charter, which, among other things, must set forth the scope of the compensation committee’s responsibilities and how they will be carried out, as well as grant the compensation committee the power to retain compensation advisers following consideration of certain factors that may be indicative of a conflict of interest by the compensation adviser in rendering compensation advice.
Our Board of Directors adopted a compensation committee charter that includes the requirements of the NASDAQ rules. However, the charter provides that if there is any conflict between the responsibilities and requirements set forth therein and either the Israeli Companies Law or compensation policy approved by our Board of Directors upon the recommendation of our compensation committee and subsequently approved by our shareholders (the “Compensation Policy”), the latter will govern. For information regarding the Compensation Policy, see Item 10 - “Additional Information - Memorandum and Articles of Association – Approval of Office Holder Compensation” in this annual report.
We do not believe that there are any existing conflicts between the compensation committee charter and either of the Israeli Companies Law or the Compensation Policy. However, if any such conflict should develop, such that we are no longer in compliance with the requirements of the NASDAQ rules, we intend to utilize the foreign private issuer exemption described above with respect to such requirement, and in accordance with the NASDAQ rules we will disclose the practice that we follow in lieu of the applicable NASDAQ requirement in our future annual reports.
All of the current members of the compensation committee, Dan Falk (chairman), Yocheved Dvir, Joe Cowan, Leo Apotheker and Zehava Simon, satisfy the respective independence requirements of both the NASDAQ rules and the Israeli Companies Law.
Nominations Committee
As required by NASDAQ rules, our nominations committee recommends candidates for election to our Board of Directors pursuant to a written charter. Both of the current members of this committee, David Kostman and Dan Falk, are independent directors.
Mergers and Acquisitions Committee
Our Board of Directors has delegated powers with respect to the review and recommendation of mergers and acquisitions and related investments and transactions, which are then subject to approval by the Board of Directors. The committee also has limited authority to approve mergers and acquisitions for consideration up to a certain amount. All of the current members of this committee, David Kostman (chairman), Dan Falk, Rimon Ben Shaoul, Yehoshua Ehrlich, Leo Apotheker and Joe Cowan, are independent directors.
As of December 31, 2017, we had 5,208 employees worldwide, which represented an increase of approximately 5.6% from December 31, 2016.
The following table sets forth the number of our full-time employees at the end of each of the last three fiscal years as well as the main category of activity and geographic location of such employees:
|
|
At December 31,
|
|
Category of Activity
|
|
2015
|
|
|
|
2016*
|
|
|
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operations
|
|
|
107
|
|
|
|
66
|
|
|
|
67
|
|
Customer Support
|
|
|
1,374
|
|
|
|
1,928
|
|
|
|
2,028
|
|
Sales & Marketing
|
|
|
682
|
|
|
|
1,069
|
|
|
|
1,169
|
|
Research & Development
|
|
|
801
|
|
|
|
1,294
|
|
|
|
1,396
|
|
General & Administrative
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic Location
|
|
|
|
|
|
|
|
|
|
|
|
|
Israel
|
|
|
946
|
|
|
|
944
|
|
|
|
913
|
|
Americas
|
|
|
1,263
|
|
|
|
2,544
|
|
|
|
2,557
|
|
Europe
|
|
|
564
|
|
|
|
530
|
|
|
|
510
|
|
Asia Pacific
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
* The substantial increase in number of employees in 2016 resulted mainly from acquisitions and an increase in personnel in certain locations (for more information, please see Item 5, “Operating and Financial Review and Prospects—Recent Acquisitions” in this annual report).
We also utilize temporary employees in various activities. On average, we employed 68 temporary employees and obtained services from 876 consultants (not included in the numbers set forth above) during 2017.
Our future success will depend in part upon our ability to attract and retain highly skilled and qualified personnel. Although competition for such personnel is generally intense, we believe that adequate personnel resources are currently available in Israel to meet our requirements.
In almost all jurisdictions, we are not a party to any collective bargaining agreement with our employees or with any labor organization. However, we are subject to certain labor related statutes and certain provisions of collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordinating Bureau of Economic Organizations (includ-ing the Industrialists’ Association of Israel) that apply to our Israeli employ-ees by order of the Israeli Ministry of Labor and Welfare. These statutes and provisions principally deal with the length of the work day and the work week, minimum wages, insurance coverage of work-related accidents, determination of severance pay and the provisions of other employment matters. Israeli law generally requires the payment of severance pay by employers upon an employee’s death, retirement or termination of employment by the employer without due cause. We currently fund our ongoing severance payment obligations in Israel by making monthly payments to approved severance funds or insurance policies. For more information please see Note 2p of our Consolidated Financial Statements. In addition, according to the National Insurance Law, Israeli employers and employees are required to pay predetermined sums to the National Insurance Institute, an organization similar to the U.S. Social Security Administration. These contributions entitle the employees to benefits in periods of unemployment, work injury, maternity leave, disability, reserve military service and bankruptcy or winding-up of the employer. Since January 1, 1995 these contributions also include payments for national health insurance. The payments to the National Insurance Institute are equal to approximately 16.37% of an employee’s wages (up to a certain cap as determined from time to time by the law), of which the employee contributes approximately 60.58% and the employer contributes approximately 39.42%.
In addition, we pay severance benefits to our employees located elsewhere in accordance with local laws and practices of the countries in which they are employed, including our U.S. based employees pursuant to the U.S. Federal Department labor legislation and requirements and local state regulations.
We have employment agreements with our officers. Pursuant to these employ-ment agreements, each party may terminate the employment without cause by giving a 30, 60 or 90 day prior written notice (six to twelve months in the case of certain senior officers). In addition, we may terminate such agreement for cause with no prior notice. The agreements generally include non-competition and non-disclosure provisions, although the enforceability of non-competition provisions in employment agreements may be limited under applicable law.
Share Ownership
As of March 8, 2018, our directors and executive officers serving at that time beneficially owned an aggregate of 385,633 options to purchase ordinary shares that were vested on such date or that are scheduled to vest within 60 days thereafter, or approximately 0.63% of our outstanding ordinary shares. The options have an average exercise price of $48.27 per share and expire between 2019 and 2026. No individual director or executive officer beneficially owns 1% or more of our outstanding ordinary shares.
The following is a description of each of our option equity plans, under which awards were outstanding during 2017.
2008 Share Incentive Plan and 2016 Share Incentive Plan
In June 2008 the Company adopted the 2008 Share Incentive Plan (the “2008 Plan”) and in February 2016 the Company adopted the 2016 Share Incentive Plan (the “2016 Plan”, and together with the 2008 Plan, the “Plans”). The Company adopted the Plans to provide incentives to employees, directors, consultants and/or contractors by rewarding performance and encouraging behavior that will improve the Company’s profitability.
Under each of the Plans, the Company's employees, directors, consultants and/or contractors may be granted any equity-related award, including: any type of an option to acquire the Company ordinary shares; share appreciation right; share and/or restricted share award (“RSA”); restricted stock unit (“RSU”) and/or other share unit; and/or other share-based award and/or other right or benefit under the Plans, including any such equity-related award that is a performance based award (each an "Award"). In regard to the 2008 Plan, please see the discussion below regarding performance-based awards beginning calendar year 2014.
Generally, under the terms of the Plans, unless determined otherwise by the administrator of the Plans, 25% of an Award granted becomes exercisable on the first anniversary of the date of grant and 6.25% becomes exercisable once every quarter during the subsequent three years. Specifically with respect to RSUs and options granted with an exercise price equal to the nominal value of an ordinary share ("par value options"), unless determined otherwise by the Board of Directors, 25% of the RSUs and the par value options granted become vested on each of the four consecutive annual anniversaries following the date of grant. Certain executive officers are entitled to acceleration of vesting of Awards in the event of a change of control, subject to certain conditions. Awards with a vesting period expire six years after the date of grant. Pursuant to a resolution of the Company's Board of Directors dated February 4, 2014, options that are performance-based and that were granted during calendar year 2014 and thereafter shall expire seven years following the date of grant. The maximum number of shares that may be subject to Awards granted under each of the Plans is calculated each calendar year as 3.5% of the Company’s issued and outstanding share capital as of December 31 of the preceding calendar year. Such amount is reset for each calendar year. Awards are non-transferable except by will or the laws of descent and distribution.
Following an amendment made in December 2010 to the 2008 Plan and also applied under the 2016 Plan (the “2010 Amendment”), options granted under such plan are granted at an exercise price equal to the average of the closing prices of one ADR as quoted on the NASDAQ market during the 30 consecutive calendar days preceding the date of grant, unless determined otherwise by the administrator of the Plans (including par value options in some cases).
Prior to the 2010 Amendment, the options were granted at an exercise price of not less than the fair market value of the ordinary shares on the date of the grant, subject to certain exceptions that could be approved by the Company's Board of Directors, including in some cases par value options.
The Company’s Board of Directors also adopted an addendum to the Plans for Awards granted to residents of Israel (the "Addendum") and resolved to elect the "Capital Gains Route" (as defined in Section 102(b)(2)) of the Israeli Income Tax Ordinance-5721-1961 (“Tax Ordinance”) for the grant of Awards to Israeli grantees. There is also a U.S. addendum under each of the Plans that applies to non-qualified stock options for purposes of U.S. tax laws.
The Plans are generally administered by our Board of Directors and compensation committee, which determine the grantees under the Plan and the number of Awards to be granted. As of March 8, 2018, options and restricted share units to purchase 722,158 ordinary shares were outstanding under the 2008 Plan at a weighted average exercise price of $20.47. As of March 8, 2018, options and restricted share units to purchase 2,092,265 ordinary shares were outstanding under the 2016 Plan at a weighted average exercise price of $7.13.
Nexidia Inc. 2005 Stock Incentive Plan
In 2005, Nexidia adopted the Nexidia Inc. 2005 Stock Incentive Plan (the “Nexidia Plan”), to attract and retain Nexidia’s employees, directors, consultants and advisors and to align the interests of such recipients with the interests of Nexidia’s shareholders. Under the Nexidia Plan, the grantees can receive incentive and non-qualified options to acquire shares of Nexidia’s common stock, restricted stock awards, restricted stock units and stock appreciation rights.
Pursuant to the terms of the Nexidia acquisition agreement, we assumed and converted Nexidia’s stock options and restricted stock units originally granted under the Nexidia Plan into stock options and restricted stock units of NICE, respectively.
As of March 8, 2018, assumed Nexidia options to purchase 11,863 shares of NICE and 85,550 assumed restricted share units were outstanding under the Nexidia Plan, at a weighted average exercise price of $0.78. We have registered, through the filing of a registration statement on Form S-8 with the SEC under the Securities Act, 173,860 ordinary shares for issuance under the Nexidia Plan.
inContact, Inc. 2008 Equity Incentive Plan
In 2008, inContact adopted the inContact, Inc. 2008 Equity Incentive Plan, as subsequently amended in June 14, 2012 (as amended, the “inContact Plan”) to enhance inContact’s ability to attract and retain those employees, officers, directors and consultants who are expected to make important contributions to inContact and any of its subsidiaries and to align the interests of such recipients with the interests of inContact’s shareholders. Under the inContact Plan, the grantees can receive incentive and non-qualified options to acquire shares of inContact’s common stock and can receive stock appreciation rights.
Pursuant to the terms of the inContact Merger Agreement, we assumed and converted inContact’s stock options, restricted stock awards and restricted stock units originally granted under the inContact Plan into stock options, restricted stock awards and restricted stock units of NICE, respectively.
As of March 8, 2018, assumed inContact options to purchase 159,859 shares of NICE and 84,719 assumed restricted share units and restricted shares were outstanding under the inContact Plan, at a weighted average exercise price of $27.28. We have registered, through the filing of a registration statement on Form S-8 with the SEC under the Securities Act, 476,114 ordinary shares for issuance under the inContact Plan.
e-Glue Software Technologies Inc., 2004 Stock Option Plan
In 2004, e-Glue adopted the 2004 Stock Option Plan that was further amended by e-Glue on June 9, 2010 (the “2004 e-Glue Plan”), for the grant of awards to employees, directors and service providers of e-Glue and its subsidiaries. The 2004 e-Glue Plan provides for the grant of options to acquire e-Glue’s stock, for the grant of restricted stock and for the grant of restricted share units.
Pursuant to the terms of the e-Glue acquisition agreement, we assumed the outstanding stock options and restricted share units granted by e-Glue under the 2004 e-Glue Plan that did not expire upon closing of the e-Glue acquisition. Following such assumption, the options represent rights to purchase ordinary shares of NICE or restricted share units of NICE, pursuant to a set formula (such options and restricted share units, together the “Assumed e-Glue Options”). Some of the Assumed e-Glue Options have a three year vesting period, with a third becoming vested and exercisable one year from their date of grant and the remainder vesting and become exercisable in equal installments on an annual basis over the following two years. The remaining portion of the Assumed e-Glue Options vest as follows: 25% vest and become exercisable one year from their date of grant, and the remaining 75% vested and became exercisable on December 31, 2011. Certain Assumed e-Glue Options are subject to acceleration rights if employment is terminated within a limited time period and under certain circumstances. Assumed e-Glue Options generally expire ten years after the date of grant. When applicable, the Assumed e-Glue Options shall be held by, and registered in the name of, a trustee, according to Section 102(b) of the Tax Ordinance.
As of March 8, 2018, assumed e-Glue Options and restricted share unit to purchase 420 ordinary shares of NICE were outstanding under the 2004 e-Glue Plan. The exercise price per share underlying the options and restricted share units is equal to the nominal value of an ordinary share. We have registered, through the filing of a registration statement on Form S-8 with the SEC under the Securities Act, 76,035 ADRs for issuance under the 2004 e-Glue Plan.
Fizzback Group (Holdings) Limited Employee Share Option Scheme
In July 2010, Fizzback adopted the Fizzback Group (Holdings) Limited Employee Share Option Scheme, as amended (the "Fizzback Plan"), to grant options to employees, directors and consultants, as applicable, of Fizzback. Under the Fizzback Plan, the grantees could be granted options which are deemed "qualifying options" for the purposes of the EMI Code (as that term is defined in the United Kingdom’s Income Tax (Earnings and Pensions) Act 1993) to acquire Fizzback’s ordinary shares, restricted share units and unapproved options.
Pursuant to the terms of the Fizzback share purchase agreement, we replaced the options and restricted share units originally granted under the Fizzback Plan with stock options to purchase ordinary shares of NICE and restricted share units of NICE, respectively.
Under the Fizzback Plan, the exercise price per option shall be determined by the Board of Directors in its sole and absolute discretion provided that such price shall not be less than the nominal value per option, or (when applicable) such price as from time to time adjusted pursuant to the Fizzback Plan. If a grantee ceases to be an employee, all options which have not become exercisable or which, having become exercisable, have not been exercised, shall lapse.
Options generally expire, inter alia, ten years after the date of grant, upon an insolvent liquidation of Fizzback or upon the grantee being adjudged bankrupt.
As of March 8, 2018, assumed Fizzback options and restricted share units to purchase 1,742 ordinary shares of NICE were outstanding under the Fizzback Plan, at a weighted average exercise price of $0.69. We have registered, through the filing of a registration statement on Form S-8 with the SEC under the Securities Act, 165,695 ordinary shares for issuance under the Fizzback Plan.
Merced Plans
Merced Systems, Inc. 2001 Stock Plan
In 2001, Merced adopted the Merced Systems, Inc. 2001 Stock Plan, as amended (the "2001 Merced Plan"), to afford an incentive to employees and consultants of Merced and to promote the success of Merced’s business. Under the 2001 Merced Plan, the grantees could be granted options to acquire Merced’s ordinary shares and restricted shares.
Pursuant to the terms of the Merced acquisition agreement, we assumed and converted Merced's options and replaced Merced’s restricted shares that were originally granted under the 2001 Merced Plan into stock options to purchase ordinary shares of NICE and with restricted shares of NICE, respectively.
Under the 2001 Merced Plan, the exercise price per share of incentive stock options granted to an employee shall be no less than 100% of the fair market value per share on the date of grant, or 110% of the fair market value if the employee was a 10% shareholder of Merced at the date of grant. The exercise price per share of non-statutory stock options granted shall be no less than 85% of the fair market value per share on the date of grant, or 110% of the fair market value if the person was a 10% shareholder of Merced at the date of grant, if required by applicable law and, if not so required, the exercise price per share shall be determined by the plan administrator. Notwithstanding the foregoing, options may be granted with an exercise price per share other than as required above pursuant to a merger or other corporate transaction.
An option granted under the 2001 Merced Plan is exercisable at the rate of at least 20% per year over five years from the date the option was granted. Options generally expire ten years after the date of grant.
Merced Systems, Inc. 2011 Stock Plan
In 2011, Merced adopted the Merced Systems, Inc. 2011 Stock Plan (the "2011 Merced Plan"), to afford an incentive to employees and consultants of Merced and to promote the success of Merced’s business. Under the 2011 Merced Plan, the grantees could be granted options to acquire Merced’s ordinary shares and restricted share units.
Pursuant to the terms of the Merced acquisition agreement, we assumed and converted Merced's options and restricted share units originally granted under the 2011 Merced Plan into stock options to purchase ordinary shares of NICE and restricted share units of NICE, respectively.
Under the 2011 Merced Plan, the exercise price per share of incentive stock options granted to an employee shall be no less than 100% of the fair market value per share on the date of grant, or 110% of the fair market value if the employee was a 10% shareholder of Merced at the date of grant. The exercise price per share of non-statutory stock options shall be no less than 85% of the fair market value per share on the date of grant, or 110% of the fair market value if the person was a 10% shareholder of Merced at the date of grant, if required by applicable law and, if not so required, the exercise price per share shall be determined by the plan administrator. Notwithstanding the foregoing, options may be granted with an exercise price per share other than as required above pursuant to a merger or other corporate transaction.
An option granted under the 2011 Merced Plan is exercisable at the rate of at least 20% per year over five years from the date the option was granted. Options generally expire ten years after the date of grant.
As of March 8, 2018, assumed Merced options, restricted share units and restricted shares to purchase 4,619 ordinary shares of NICE were outstanding under the 2001 Merced Plan and the 2011 Merced Plan, at a weighted average exercise price of $14.13. We have registered, through the filing of a registration statement on Form S-8 with the SEC under the Securities Act, 343,288 ordinary shares for issuance under the 2001 Merced Plan and the 2011 Merced Plan.
Item 7. Major Shareholders and Related Party Transactions
The following table sets forth certain information with respect to the beneficial ownership of our ordinary shares, with respect to each person known to us to be the beneficial owner of 5% or more of our outstanding ordinary shares, reported as of March 20, 2018. None of our shareholders has any different voting rights than any other shareholder.
Name and Address
|
|
Number of Shares
|
|
|
Percent of Shares Beneficially Owned (1)
|
|
Janus Henderson Group plc
201 Bishopsgate EC2M 3AE
United Kingdom
|
|
|
4,947,800
|
(2)
|
|
|
8.1
|
%
|
|
|
|
|
|
|
|
|
|
Massachusetts Financial Services Company
111 Huntington Avenue
Boston, Massachusetts 02199
|
|
|
4,594,141
|
(3)
|
|
|
7.5
|
%
|
__________
(1) Based upon 61,212,874 ordinary shares issued and outstanding as of March 20, 2018.
(2) Janus Henderson Group plc reported that these shares are held by managed portfolios. This information is based upon a Schedule 13G filed by Janus Henderson Group plc with the SEC on February 13, 2018.
(3) This information is based upon a Schedule 13G/A filed by Massachusetts Financial Service Company with the SEC on February 9, 2018.
As of March 14, 2018, we had approximately 44 registered ADS holders of record in the United States, with our ADS holders holding in total approximately 49% of our outstanding ordinary shares, as reported by JPMorgan Chase Bank, N.A., the depositary for our ADSs.
As of October 26, 2017, Migdal Insurance & Financial Holdings Ltd. (“Migdal”) reported that it held 3,005,795, or 4.95%, of our ordinary shares. This information is based upon a Schedule 13G filed by Migdal with the SEC on October 31, 2017. Of these shares, (i) 2,791,731 ordinary shares are held for members of the public through, among others, provident funds, mutual funds, pension funds and insurance policies, which are managed by subsidiaries of Migdal, according to the following segmentation: 1,517,114 ordinary shares are held by profit-participating life assurance accounts, 1,102,469 ordinary shares are held by Provident funds and companies that manage Provident funds, and 172,148 ordinary shares are held by companies for the management of funds for joint investments in trusteeship, each of which subsidiaries operates under independent management and makes independent voting and investment decisions, and (ii) 214,064 are beneficially held for their own account (Nostro account).
As of December 29, 2017, Psagot Investment House Ltd. (“Psagot”) reported that it held 2,979,017, or 4.89%, of our ordinary shares. This information is based upon a Schedule 13G/A filed by Psagot with the SEC on February 12, 2018. These securities are beneficially owned by portfolio accounts managed by Psagot Securities Ltd., Psagot Exchange Traded Notes Ltd., mutual funds managed by Psagot Mutual Funds Ltd., and provident funds and pension funds managed by Psagot Provident Funds and Pension Ltd. managed savings managed by Psagot Insurance Company Ltd. according to the following segmentation: 1,410,642 ordinary shares are held by portfolio accounts managed by Psagot Securities Ltd., 781,272 ordinary shares are held by Psagot Exchange Traded Notes Ltd., 63,676 ordinary shares are held by mutual funds managed by Psagot Mutual Funds Ltd. (of this amount, 12,000 shares may also be considered beneficially owned by Psagot Securities Ltd., but are not included in the shares beneficially owned by Psagot Securities Ltd., as indicated above), 712,203 ordinary shares are held by provident funds and pension funds managed by Psagot Provident Funds and Pension Ltd. and 11,224 ordinary shares are held by Psagot Insurance Company Ltd. Each of the foregoing companies is a wholly-owned subsidiary of Psagot Investment House Ltd.
To our knowledge, we are not directly or indirectly owned or controlled by another corporation or by any foreign government and there are no arrangements that might result in a change in control of our company.
Related Party Transactions
Item 8. Financial Information.
Consolidated Statements and Other Financial Information
See Item 18, “Financial Statements” in this annual report.
From time to time we or our subsidiaries may be involved in legal proceedings and/or litigation arising in the ordinary course of our business. While the outcome of these matters cannot be predicted with certainty, we do not believe they will have a material effect on our consolidated financial position, results of operations, or cash flows.
We are not involved in any legal proceedings that we believe, individually or in the aggregate, will have a material adverse effect on our business, financial condition or results of operation, except as noted below.
Patent Lawsuit by NICE
On August 27, 2015, we initiated a lawsuit in the United States District Court for the District of Delaware by filing a complaint against ClickFox for infringement of NICE's U.S. Patent No. 8,976,955 (“the ‘955 patent”) entitled “System and method for tracking web interactions with real time analytics”. On October 11, 2017, the Court of Appeals affirmed without opinion the district court’s judgment granting ClickFox’s motion to dismiss.
California Lawsuit
In May 2009, inContact was served a lawsuit titled California College, Inc., et al., v. UCN, Inc., et al. in connection with the sale of services with those Insidesales.com, Inc. California College originally sought damages in excess of $20.0 million. Insidesales.com and inContact filed cross-claims against one another, which they subsequently agreed to dismiss with prejudice. In October 2011, California College reached a settlement with Insidesales.com, the terms of which have not been disclosed and remain confidential. In June of 2013, California College amended its damages claim to $14.4 million, of which approximately $5.0 million was alleged to be pre-judgment interest. On September 10, 2013, the court issued an order on inContact's Motion for Partial Summary Judgment. The court determined that factual disputes exist as to several of the claims, but dismissed California College's cause of action for intentional interference with prospective economic relations and the claim for prejudgment interest. Dismissing the claim for prejudgment interest effectively reduced the claim for damages to approximately $9.2 million. The trial court granted inContact’s motion to stay the trial without date pending an interlocutory appeal to the Utah Supreme Court of the trial court’s ruling with respect to allowing California College’s experts to testify at trial. The briefs were filed in the matter and oral arguments were made in August 2017. The Utah Court of Appeals has yet to rule on the matter. At this stage we are unable to evaluate the probability of a favorable or unfavorable outcome in this litigation.
Gordon Complaint
On June 10, 2016, a complaint captioned Natalie Gordon v. inContact, Inc., et al., was filed in the Third Judicial District Court of Salt Lake County, State of Utah (the “Court”) naming as defendants inContact and its Board of Directors (the “Gordon Action”). On August 4, 2016 the parties entered into a Memorandum of Understanding for the settlement of the three actions. The parties have completed the negotiation of the settlement agreement, and the Utah Third District Court has approved the settlement, formally dismissing this action.
Our Board of Directors previously approved a dividend plan under which we paid quarterly cash dividends to holders of our ordinary shares and ADRs subject to declaration by the Board. The annual dividend amount under the dividend plan was $0.64 per share or $0.16 per share quarterly. Under Israeli law, dividends may be paid only out of profits and other surplus (as defined in the law) as of our most recent financial statements or as accrued over a period of two years, whichever is higher, provided that there is no reasonable concern that the dividend distribution will prevent us from meeting our existing and foreseeable obligations as they come due.
On January 6, 2017, our Board of Directors approved the termination of this dividend plan in connection with our adoption of a capital return strategy to optimize our long term growth profile. Accordingly, we do not have any plans at this time to make any future dividend payments. Payment of future dividends, if any, will be at the discretion of our Board of Directors and will depend on various factors, such as our statutory profits, financial condition, operating results and current and anticipated cash needs. In the event cash dividends are declared by us, we may decide to pay such dividends in Israeli currency. Under current Israeli regulations, any cash dividend in Israeli currency paid in respect of ordinary shares purchased by non-residents of Israel with non-Israeli currency may be freely repatriated in such non-Israeli currency, at the rate of exchange prevailing at the time of conversion. For more information regarding the taxation implications of the dividend plan, see “Item 10 - Additional Information - Taxation” of this annual report.
There are no significant changes that occurred since December 31, 2017, except as otherwise disclosed in this annual report and in the annual consolidated financial statements included in this annual report.
Item 9. |
The Offer and Listing.
|
Our ADSs have been quoted on the NASDAQ Stock Market under the symbol “NICEV” from our initial public offering in January 1996 until April 7, 1999, and thereafter under the symbol “NICE.” Prior to that time, there was no public market for our ordinary shares in the United States. Each ADS represents one ordinary share. The following table sets forth, for the periods indicated, the high and low reported market (sale) prices for our ADSs.
|
|
ADSs
|
|
|
|
High
|
|
|
Low
|
|
Annual
|
|
|
|
|
|
|
2013
|
|
$
|
42.12
|
|
|
$
|
33.63
|
|
2014
|
|
|
51.75
|
|
|
|
37.08
|
|
2015
|
|
|
68.38
|
|
|
|
47.95
|
|
2016
|
|
|
69.79
|
|
|
|
54.12
|
|
2017
|
|
|
92.33
|
|
|
|
65.59
|
|
|
|
|
|
|
|
|
|
|
Quarterly
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly 2017
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
70.84
|
|
|
$
|
65.59
|
|
Second Quarter
|
|
|
81.16
|
|
|
|
66.57
|
|
Third Quarter
|
|
|
83.95
|
|
|
|
73.65
|
|
Fourth Quarter
|
|
|
92.33
|
|
|
|
78.49
|
|
|
|
|
|
|
|
|
|
|
Quarterly 2018
|
|
|
|
|
|
|
|
|
First Quarter (through March 29, 2018)
|
|
|
98.48
|
|
|
|
84.49
|
|
|
|
|
|
|
|
|
|
|
Monthly
|
|
|
|
|
|
|
|
|
September 2017
|
|
$
|
83.95
|
|
|
$
|
77.24
|
|
October 2017
|
|
|
83.78
|
|
|
|
78.49
|
|
November 2017
|
|
|
88.52
|
|
|
|
81.35
|
|
December 2017
|
|
|
92.33
|
|
|
|
86.01
|
|
January 2018
|
|
|
95.65
|
|
|
|
90.36
|
|
February 2018
|
|
|
98.06
|
|
|
|
84.49
|
|
March 2018 (through March 29, 2018)
|
|
|
98.48
|
|
|
|
89.28
|
|
On March 29, 2018, the last reported price of our ADSs was $93.93 per ADS.
JPMorgan Chase Bank, N.A. is the depositary for our ADSs. Its address is 4 New York Plaza, Floor 12, New York, New York 10004.
Trading in the Ordinary Shares
Our ordinary shares have been listed on the Tel-Aviv Stock Exchange, or TASE, since 1991. Our ordinary shares are not listed on any other stock exchange and have not been publicly traded outside Israel (other than through ADSs as noted above). The table below sets forth the high and low reported market (sale) prices of our ordinary shares (in NIS and U.S. dollars) on the TASE. The translation into dollars is based on the daily representative rate of exchange published by the Bank of Israel.
|
|
Ordinary Shares |
|
|
|
High |
|
|
Low
|
|
|
|
NIS |
|
|
$
|
|
|
NIS
|
|
|
$
|
|
Annual
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013
|
|
|
149.10
|
|
|
|
42.21
|
|
|
|
122.10
|
|
|
|
33.27
|
|
2014
|
|
|
203.30
|
|
|
|
51.94
|
|
|
|
130.60
|
|
|
|
36.90
|
|
2015
|
|
|
262.6
|
|
|
|
68.76
|
|
|
|
189.4
|
|
|
|
47.95
|
|
2016
|
|
|
268.0
|
|
|
|
69.76
|
|
|
|
207.2
|
|
|
|
53.29
|
|
2017
|
|
|
320.4
|
|
|
|
92.28
|
|
|
|
239.3
|
|
|
|
65.58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
269.5
|
|
|
|
71.19
|
|
|
|
239.3
|
|
|
|
65.58
|
|
Second Quarter
|
|
|
288.7
|
|
|
|
81.44
|
|
|
|
240.9
|
|
|
|
66.66
|
|
Third Quarter
|
|
|
289.9
|
|
|
|
82.48
|
|
|
|
263.4
|
|
|
|
73.36
|
|
Fourth Quarter
|
|
|
320.4
|
|
|
|
|
|
|
|
280.9
|
|
|
|
79.86
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Monthly
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 2017
|
|
|
289.9
|
|
|
|
82.48
|
|
|
|
274.9
|
|
|
|
76.45
|
|
October 2017
|
|
|
293.4
|
|
|
|
83.59
|
|
|
|
280.9
|
|
|
|
79.86
|
|
November 2017
|
|
|
311.0
|
|
|
|
88.76
|
|
|
|
281.7
|
|
|
|
80.35
|
|
December 2017
|
|
|
320.4
|
|
|
|
92.28
|
|
|
|
306.3
|
|
|
|
86.73
|
|
January 2018
|
|
|
326.0
|
|
|
|
95.13
|
|
|
|
308.1
|
|
|
|
90.04
|
|
February 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 2018 (through March 29, 2018)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 29, 2018, the last reported price of our ordinary shares on the TASE was NIS 325.7 (or $92.69) per share.
Item 10. Additional Information.
Memorandum and Articles of Association
Organization and Register
We are a company limited by shares organized in the State of Israel under the Israeli Companies Law. We are registered with the Registrar of Companies of the State of Israel and have the company number 52-0036872.
Objectives and Purposes
Our objectives and purposes include a wide variety of business purposes, including all kinds of research, development, manufacture, distribution, service and maintenance of products in all fields of technology and engineering and to engage in any other kind of business or commercial activity. Our objectives and purposes are set forth in detail in Section 2 of our memorandum of association.
Directors
Our articles of association provide that the number of directors serving on the Board shall be not less than three but shall not exceed thirteen. As discussed above in Item 6, “Directors, Senior Management and Employees – Board Practices – Outside Directors”, in December 2016, our shareholders approved amendments to our articles of association, pursuant to which our Board of Directors may elect to opt out of such requirements and we would not be required to have outside directors serve on our Board of Directors. Our directors, other than outside directors, are elected at the annual shareholders meeting to serve until the next annual meeting or until their earlier death, resignation, bankruptcy, incapacity or removal by resolution of the general shareholders meeting. Directors may be re-elected at each annual shareholders meeting. The Board may appoint additional directors (whether to fill a vacancy or create new directorship) to serve until the next annual shareholders meeting, provided, however, that the Board shall have no obligation to fill any vacancy unless the number of directors is less than three. Our officers serve at the discretion of the Board.
The Board of Directors may meet and adjourn its meetings according to the Company’s needs but must meet at least once every three months. A meeting of the Board may be called at the request of any two directors. The quorum required for a meeting of the Board consists of a majority of directors who are lawfully entitled to participate in the meeting and vote thereon. The adoption of a resolution by the Board requires approval by a simple majority of the directors present at a meeting in which such resolution is proposed. In lieu of a Board meeting, a resolution may be adopted if all of the directors lawfully entitled to vote thereon consent not to convene a meeting.
Subject to the Israeli Companies law, the Board may appoint a committee of the Board and delegate to such committee all or any of the powers of the Board, as it deems appropriate. Under the Israeli Companies Law, the Board of Directors must appoint an internal audit committee comprised of at least three directors. The function of the internal audit committee is to review irregularities in the management of the Company’s business and recommend remedial measures. The committee is also required, under the Israeli Companies Law, to approve certain related party transactions and to assess our internal audit system and the performance of our internal auditor. Notwithstanding the foregoing, the Board may, at any time, amend, restate or cancel the delegation of any of its powers to any of its committees. The Board has appointed an internal audit committee which has three members, an audit committee which has five members, a compensation committee which has five members, a nominations committee which has two members and a mergers and acquisitions committee which has six members. For more information on the Company’s committees, please see Item 6, “Directors, Senior Management and Employees—Board Practices” in this annual report.
Fiduciary Duties of Officers
The Israeli Companies Law codifies the fiduciary duties that “office holders,” including directors and executive officers, owe to a company. An office holder’s fiduciary duties consist of a duty of care and a duty of loyalty. The duty of loyalty includes avoiding any conflict of interest between the office holder’s position in the company and his personal affairs, avoiding any competition with the company, avoiding exploiting any business opportunity of the company in order to receive personal advantage for himself or others, and revealing to the company any information or documents relating to the company’s affairs which the office holder has received due to his position as an office holder.
Approval of Certain Transactions
The Israeli Companies Law requires that an office holder of a company promptly disclose any personal interest that he or she may have and all related material information known to him or her, in connection with any existing or proposed transaction by the company. In addition, if the transaction is an extraordinary transaction as defined under Israeli law, the office holder must also disclose any personal interest held by the office holder’s spouse, siblings, parents, grandpar-ents, descendants, spouse’s descendants and the spouses of any of the foregoing. In addition, the office holder must also disclose any interest held by any corporation in which the office holder is a 5% or greater shareholder, director or general manager or in which he or she has the right to appoint at least one director or the general manager. An extraordinary transaction is defined as a transaction not in the ordinary course of business, not on market terms, or that is likely to have a material impact on the company’s profitability, assets or liabilities.
In the case of a transaction which is not an extraordinary transaction, after the office holder complies with the above disclosure requirement, only Board approval is required unless the articles of association of the company provide otherwise. The transaction must not be adverse to the company’s interest. Furthermore, if the transaction is an extraordinary transaction, then, in addition to any approval stipulated by the articles of association, it also must be approved by the company’s internal audit committee and then by the Board of Directors, and, under certain circumstances, by a meeting of the shareholders of the company. An office holder who has a personal interest in a transaction that is considered at a meeting of the Board of Directors or the internal audit committee generally may not be present at the deliberations or vote on this matter, unless the chairman of the Board or chairman of the internal audit committee, as the case may be, determined that the presence of such person is necessary to present the transaction to the meeting. If a majority of the directors have a personal interest in an extraordinary transaction with the company, shareholder approval of the transaction is required.
It is the responsibility of the audit committee to determine whether or not a transaction should be deemed an extraordinary transaction. In addition, as a result of a recent amendment to the Israeli Companies Law, the audit committee must also establish (i) procedures for the consideration of any transaction with a controlling shareholder, even if it is not extraordinary, such as a competitive process with third parties or negotiation by independent directors, and (ii) approval requirements for controlling shareholder transactions that are not negligible.
The Israeli Companies Law applies the same disclosure requirements to a controlling share-holder of a public company, which includes a shareholder that holds 25% or more of the voting rights if no other shareholder owns more than 50% of the voting rights in the company. Extraor-dinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, and the terms of management fees of a controlling shareholder or compensation of a controlling shareholder who is an office holder, require the approval of the audit committee, the Board of Directors and the shareholders of the company by simple majority; provided that either such majority vote must include at least a simple majority of the shareholders who have no personal interest in the transaction and are present at the meeting (without taking into account the votes of the abstaining shareholders), or that the total shareholdings of those who have no personal interest in the transaction who vote against the transaction represent no more than two percent of the voting rights in the company. Any such extraordinary transaction whose term is longer than three years requires further shareholder approval every three years, unless (with respect to transactions not involving management fees or employment terms) the internal audit committee approves that a longer term is reasonable under the circumstances.
In addition, under the Israeli Companies Law, a private placement of securities requires approval by the Board of Directors and the shareholders of the company if it will cause a person to become a controlling shareholder or if:
|
· |
the securities issued amount to 20% or more of the company’s outstanding voting rights before the issuance;
|
|
· |
some or all of the consideration is other than cash or listed securities or the transaction is not on market terms; and
|
|
· |
the transaction will increase the relative holdings of a shareholder that holds 5% or more of the company’s outstanding share capital or voting rights or that will cause any person to become, as a result of the issuance, a holder of more than 5% of the company’s outstanding share capital or voting rights.
|
According to the Company’s articles of association, certain resolutions, such as resolutions regarding mergers and windings up, require approval of the holders of 75% of the shares represented at the meeting and voting thereon.
Approval of Office Holder Compensation
Under the Israeli Companies Law, we are required to adopt a compensation policy, recommended by the compensation committee, and approved by the Board of Directors and the shareholders, in that order, at least once every three years. Following the recommendation of our compensation committee and approval by our Board of Directors, our shareholders approved such compensation policy at our 2013 annual general meeting of shareholders held on August 27, 2013, and an amended compensation policy at our 2015 annual general meeting of shareholders held on July 9, 2015. At the Company's special general meeting held on December 21, 2016, following the recommendation of our compensation committee and approval by our Board of Directors, our shareholders approved certain amendments to the current compensation policy. The shareholder approval requires a majority of the votes cast by shareholders, excluding any controlling shareholder and those who have a personal interest in the matter (similar to the threshold described above). In general, all office holders’ terms of compensation – including fixed remuneration, bonuses, equity compensation, retirement or termination payments, indemnification, liability insurance and the grant of an exemption from liability - must comply with the company's compensation policy. Although NASDAQ rules generally require shareholder approval when an equity based compensation plan is established or materially amended, as a foreign company we follow the aforementioned requirements of the Israeli Companies Law.
In addition, the compensation terms of directors, the chief executive officer, and any employee or service provider who is considered a controlling shareholder generally must be approved separately by the compensation committee, the Board of Directors and the shareholders of the company, in that order. Notwithstanding, a company's compensation committee and board of directors are permitted to approve the compensation terms of a chief executive officer or of a director, without convening a general meeting of shareholders, provided however, that such terms: (1) are not more beneficial than such officer’s former terms or than the terms of his predecessor, or are essentially the same in their effect; (2) are in line with the compensation policy; and (3) are brought for shareholder approval at the next general meeting of shareholders.
The compensation terms of other officers require the approval of the compensation committee and the Board of Directors. An amendment of existing compensation terms of an office holder who is not a director, if the compensation committee determines that the amendment is not material, requires the approval of the compensation committee only. Pursuant to a recent amendment to regulations promulgated under the Israeli Companies Law governing the relaxation in transactions with interested parties - an amendment of the existing compensation terms of office holders who are subordinate to the chief executive officer, if the amendment is not material and the changes are in line with the existing compensation policy, requires only the chief executive officer’s approval (in accordance to such amendment, on December 21, 2016, our shareholders approved an amendment to the compensation policy, which provided our Chief Executive Officer the authority to approve non-material changes to the compensation terms of office holders subordinated to him, without seeking the approval of the compensation committee).
Under the Israeli Companies Law, a shareholder has a duty to act in good faith towards the company and other shareholders and to refrain from abusing his or her power in the company including, among other things, voting in a general meeting of shareholders on the following matters:
|
· |
any amendment to the articles of association;
|
|
· |
an increase of the company’s authorized share capital;
|
|
· |
approval of interested party transactions which require shareholder approval.
|
In addition, any controlling shareholder, any shareholder who knows that it possesses power to determine the outcome of a shareholder vote and any shareholder who, pursuant to the provisions of a company’s articles of association, has the power to appoint or prevent the appointment of an office holder in the company, is under a duty to act with fairness towards the company. The Israeli Companies Law does not describe the substance of this duty but provides that a breach of his duty is tantamount to a breach of fiduciary duty of an officer of the company.
Exemption, Insurance and Indemnification of Directors and Officers
We provide our directors with indemnification letters whereby we agree to indemnify them to the fullest extent permitted by law. On September 19, 2011, at our 2011 annual general meeting of shareholders, after the approval of the audit committee and the Board, our shareholders approved a modified form of indemnification letter to ensure that our directors are afforded protection to the fullest extent permitted by law.
Exemption of Office Holders
Under the Israeli Companies Law, an Israeli company may not exempt an office holder from liability for breach of his duty of loyalty, but may exempt in advance an office holder from liability to the company, in whole or in part, for a breach of his duty of care (except in connection with distributions), provided the articles of association of the company allow it to do so. Our articles of association do not allow us to do so.
Our articles of association provide that, subject to the provisions of the Israeli Companies Law, including the receipt of all approvals as required therein or under any applicable law, we may enter into an agreement to insure an office holder for any responsibility or liability that may be imposed on such office holder in connection with an act performed by such office holder in such office holder's capacity as an office holder of us with respect to each of the following:
|
· |
a violation of his duty of care to us or to another person,
|
|
· |
a breach of his duty of loyalty to us, provided that the office holder acted in good faith and had reasonable grounds to assume that his act would not prejudice our interests,
|
|
· |
a financial obligation imposed upon him for the benefit of another person,
|
|
· |
a payment which the office holder is obligated to make to an injured party as set forth in Section 52(54)(a)(1)(a) of the Israeli Securities Law, 5728-1968, as amended (the "Securities Law") and Litigation Expenses (as defined below) that the office holder incurred in connection with a proceeding under Chapters H'3, H'4 or I'1 of the Securities Law, and
|
|
· |
any other event, occurrence or circumstance in respect of which we may lawfully insure an office holder.
|
Indemnification of Office Holders
Our articles of association provide that, subject to the provisions of the Israeli Companies Law, including the receipt of all approvals as required therein or under any applicable law we may indemnify an office holder with respect to any liability or expense for which indemnification may be provided under the Companies Law, including the following liabilities and expenses, provided that such liabilities or expenses were imposed upon or incurred by such office holder in such office holder's capacity as an office holder of us:
|
· |
a monetary liability imposed on or incurred by an office holder pursuant to a judgment in favor of another person, including a judgment imposed on such office holder in a settlement or in an arbitration decision that was approved by a court of law;
|
|
· |
reasonable Litigation Expenses, expended by the office holder as a result of an investigation or proceeding instituted against him by a competent authority, provided that such investigation or proceeding concluded without the filing of an indictment against him and either (A) concluded without the imposition of any financial liability in lieu of criminal proceedings or (B) concluded with the imposition of a financial liability in lieu of criminal proceedings but relates to a criminal offense that does not require proof of criminal intent (mens rea) or in connection with a financial sanction;
|
|
· |
“conclusion of a proceeding without filing an indictment” in a matter in which a criminal investigation has been instigated and “financial liability in lieu of a criminal proceeding,” have the meaning ascribed to them under the Israeli Companies Law. The term “Litigation Expenses” shall include, without limitation, attorneys’ fees and all other costs, expenses and obligations paid or incurred by an office holder in connection with investigating, defending, being a witness or participating in (including on appeal), or preparing to defend, be a witness or participate in any claim or proceeding relating to any matter for which indemnification may be provided;
|
|
· |
reasonable Litigation Expenses, which the office holder incurred or with which the office holder was charged by a court of law, in a proceeding brought against the office holder, by the Company, on its behalf or by another person, or in a criminal prosecution in which the office holder was acquitted, or in a criminal prosecution in which the office holder was convicted of an offense that does not require proof of criminal intent (mens rea);
|
|
· |
a payment which the office holder is obligated to make to an injured party as set forth in Section 52(54)(a)(1)(a) of the Securities Law, and Litigation Expenses that the office holder incurred in connection with a proceeding under Chapters H'3, H'4 or I'1 of the Securities Law; and
|
|
· |
any other event, occurrence or circumstance in respect of which we may lawfully indemnify an office holder.
|
The foregoing indemnification may be procured by us (a) retroactively and (b) as a commitment in advance to indemnify an office holder, provided that, in respect of the first bullet above, such commitment shall be limited to (A) such events that in the opinion of the Board of Directors are foreseeable in light of our actual operations at the time the undertaking to indemnify is provided, and (B) to the amounts or criterion that the Board of Directors deems reasonable under the circumstances; and further provided that such events and amounts or criterion are set forth in the undertaking to indemnify, and which shall in no event exceed, in the aggregate, the greater of: (i) 25% of our shareholder’s equity at the time of the indemnification or (ii) 25% of our shareholder’s equity at the end of fiscal year of 2010.
We have undertaken to indemnify our directors and officers pursuant to applicable law. We have obtained directors' and officers' liability insurance for the benefit of our directors and officers. The Company currently has a directors and officers liability insurance policy limited to $100 million (the “Policy”), at an annual premium of approximately $360,664. Our internal audit committee, Board of Directors, and shareholders have approved the Company’s “Side A” Difference in Conditions extension of the Policy, limited to an additional $25 million, which provides the directors and officers with personal asset protection in situations when other sources of insurance or indemnification fail or are not available (the “Extended Policy”). The Extended Policy portion is at an additional annual premium of approximately $50,000.
Limitations on Exemption, Insurance and Indemnification
The Israeli Companies Law provides that a company may not exempt or indemnify an office holder, or enter into an insurance contract, which would provide coverage for any monetary liability incurred as a result of any of the following:
|
· |
a breach by the office holder of his duty of loyalty unless, with respect to insurance coverage or indemnification, the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
|
· |
a breach by the office holder of his duty of care if the breach was done intentionally or recklessly (other than if solely done in negligence);
|
|
· |
any act or omission done with the intent to derive an illegal personal benefit; or
|
|
· |
a fine, civil fine or ransom levied on an Office Holder, or a financial sanction imposed upon an Office Holder under Israeli Law.
|
In addition, under the Israeli Companies Law, any exemption of, indemnification of, or procurement of insurance coverage for, our office holders must be approved by our audit committee and our Board of Directors and, if the beneficiary is a director, by our shareholders. We have obtained such approvals for the procurement of liability insurance covering our officers and directors and for the grant of indemnification letters to our officers and directors.
Rights of Ordinary Shares
Our ordinary shares confer upon our shareholders the right to receive notices of, and to attend, shareholder meetings, the right to one vote per ordinary share at all shareholders’ meetings for all purposes, and to share equally, on a per share basis, in such dividends as may be declared by our Board of Directors; and upon liquidation or dissolution, the right to participate in the distribution of any surplus assets of the Company legally available for distribution to shareholders after payment of all debts and other liabilities of the Company. All ordinary shares rank pari passu in all respects with each other. Our Board of Directors may, from time to time, make such calls as it may think fit upon a shareholder in respect of any sum unpaid in respect of shares held by such shareholder which is not payable at a fixed time, and each shareholder shall pay the amount of every call so made upon him (and of each installment thereof if the same is payable in installments).
Meetings of Shareholders
An annual general meeting of our shareholders shall be held once in every calendar year at such time and at such place either within or without the State of Israel as may be determined by our Board of Directors.
Our Board of Directors may, whenever it thinks fit, convene a special general meeting at such time and place, within or without the State of Israel, as may be determined by the Board of Directors. Special general meetings may also be convened upon shareholder request in accordance with the Israeli Companies Law and our articles of association.
The quorum required for a meeting of shareholders consists of at least two shareholders present in person or by proxy who hold or represent between them at least 25% of the outstanding voting shares, unless otherwise required by applicable rules. Although NASDAQ generally requires a quorum of 33-1/3%, we have an exception under the NASDAQ rules and follow the generally accepted business practice for companies in Israel, which have a quorum requirement of 25%. A meeting adjourned for lack of a quorum generally is adjourned to the same day in the following week at the same time and place or any time and place as the chairman may designate with the consent of a majority of the voting power represented at the meeting and voting on the matter adjourned. At such reconvened meeting the required quorum consists of any two members present in person or by proxy.
Mergers and Acquisitions
A merger of the Company shall require the approval of the holders of a majority of 75% of the voting power represented at the annual or special general meeting in person or by proxy or by written ballot, as shall be permitted, and voting thereon in accordance with the provisions of the Israeli Companies Law. Upon the request of a creditor of either party of the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that as a result of the merger, the surviving company will be unable to satisfy the obligations of any of the parties to the merger. In addition, a merger may not be completed unless at least (i) 50 days have passed from the time that the requisite proposal for the merger has been filed by each party with the Israeli Registrar of Companies and (ii) 30 days have passed since the merger was approved by the shareholders of each party.
The Israeli Companies Law also provides that an acquisition of shares of a public company must be made by means of a tender offer if, as a result of the acquisition, the purchaser would become a 25% or greater shareholder of the company and there is no existing 25% or greater shareholder in the company. An acquisition of shares of a public company must be made by means of a tender offer if, as a result of the acquisition, the purchaser would become a 45% or greater shareholder of the company and there is no existing 45% or greater shareholder in the company. These requirements do not apply if the acquisition (i) occurs in the context of a private placement by the company that received shareholder approval, (ii) was from a 25% shareholder of the company and resulted in the acquirer becoming a 25% shareholder of the company or (iii) was from a 45% shareholder of the company and resulted in the acquirer becoming a 45% shareholder of the company. The tender offer must be extended to all shareholders, but the offeror is not required to purchase more than 5% of the company’s outstanding shares, regardless of how many shares are tendered by shareholders. The tender offer may be consummated only if (i) at least 5% of the company’s outstanding shares will be acquired by the offeror and (ii) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer.
If as a result of an acquisition of shares the acquirer will hold more than 90% of a company’s outstanding shares, the acquisition must be made by means of a tender offer for all of the outstanding shares. If as a result of a full tender offer the acquirer would own more than 95% of the outstanding shares, then all the shares that the acquirer offered to purchase will be transferred to it. The law provides for appraisal rights if any shareholder files a request in court within six months following the consummation of a full tender offer, but the acquirer is entitled to stipulate that tendering shareholders forfeit their appraisal rights. If as a result of a full tender offer the acquirer would own 95% or less of the outstanding shares, then the acquirer may not acquire shares that will cause his shareholding to exceed 90% of the outstanding shares. Shareholders may request an appraisal in connection with a tender offer for a period of six months following the consummation of the tender offer, but the purchaser is entitled to stipulate as a condition of such tender offer that any tendering shareholder renounce its appraisal rights.
Material Contracts
Nexidia Acquisition Agreement
On January 11, 2016, we entered into an Agreement and Plan of Merger to acquire Nexidia, a leading provider of advanced customer analytics. We acquired Nexidia for total consideration of approximately $135.0 million in cash. The acquisition allows us to offer a combined offering, featuring analytics capabilities with accuracy, scalability and performance, enabling organizations to expand their analytics usage in critical business use cases. Organizations will benefit from the combined offering, which features a best-in-class, analytics-based solution.
inContact Acquisition Agreement
On May 17, 2016, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with inContact Inc. and Victory Merger Sub Inc., a wholly owned subsidiary of ours (the “Merger Sub”). On November 14, 2016, pursuant to the terms of the Merger Agreement, Merger Sub merged with and into inContact, with inContact surviving the merger as a wholly owned subsidiary of ours. At the effective time of the merger, each outstanding share of inContact common stock (the “inContact Shares”) (other than (i) shares owned by inContact or us, (ii) for which inContact stockholders exercised appraisal rights under Delaware law, or (iii) outstanding restricted stock) was cancelled and converted into the right to receive $14.00, without interest. Also, at the effective time of the merger, outstanding vested inContact RSUs and stock options were cancelled in exchange for the right to receive in cash (a) in the case of RSUs, $14.00 for each inContact share subject to such vested RSU, less any required tax withholding, and (b) in the case of stock options, the excess, if any, of $14.00 over the applicable per share exercise price for each inContact share underlying a vested stock option, less any required tax withholding. Additionally, outstanding unvested inContact RSUs, stock options and restricted stock at the effective time of the merger were cancelled and converted into RSUs with ADSs to be received upon settlement, options to acquire ADSs and restricted ADSs, respectively, in each case with the number of ADSs subject to such award (and in the case of options, the exercise price) adjusted pursuant to an exchange ratio determined based upon the average closing price of ADSs for the ten trading days immediately preceding the closing date for the transaction. Other than the number of ADSs subject to such unvested equity awards (and in the case of options, the adjusted exercise price), the unvested equity awards remain subject to the same terms and conditions that the cancelled equity awards were subject to, including as to vesting and settlement.
On November 14, 2016, in connection with the consummation of the inContact acquisition, we and Nice Systems entered into a secured Credit Agreement with the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent. The Credit Agreement provides for a term loan facility of $475 million and a revolving facility of $75 million. The Credit Agreement is guaranteed by most of our Israeli and U.S. material subsidiaries, including NICE Systems, and secured by substantially all assets of our and the guarantors assets, subject to certain customary exceptions.
Unless terminated earlier, loans outstanding under the term loan facility mature and commitments under the revolving facility expire on November 14, 2021. The term loan amortizes in equal quarterly installments in annual amounts (expressed as percentages of the loans made under the term loan facility on November 14, 2016 (the initial funding date of the term loan facility)) at the repayment rate of 1.25% during the period from March 2017 to December 2019 and 2.50% during the period from March 2020 to September 2021, with the remaining balance due on the final maturity date of the term loan facility.
We have the right to prepay borrowings under the Credit Agreement and to reduce the unutilized portion of the revolving credit facility, in each case, at any time without premium or penalty (except for Eurodollar breakage fees, if any). In January 2017, we used the net proceeds of the Notes offering described below to repay a principal amount of $260 million, which resulted in $5.3 million amortization of debt issuance costs. In addition, the contractual principal payments for the long term loan have changed and we will pay the entire remaining principal of $215 million on the final maturity date of the term loan facility. We are required to prepay borrowings under the term loan facility with all of the net cash proceeds of sales or dispositions of assets or other property, subject to certain reinvestment rights and other exceptions. The interest rates under the Credit Agreement are variable based on LIBOR or an alternate base rate at the time of the borrowing, plus a margin to be determined based on our leverage as measured by a ratio of consolidated total net indebtedness to consolidated EBITDA (the “Consolidated Total Net Leverage Ratio”) and ranging from 1.25% to 2.00%, in the case of LIBOR rate loans, or 0.25% to 1.00%, in the case of base rate loans. A commitment fee will accrue on the average daily unused portion of the revolving facility at the rate ranging from 0.25% to 0.50%, depending on the Consolidated Total Net Leverage Ratio, and is initially set at 0.375% per annum.
The Credit Agreement contains customary covenants, which include, among others, limitations or restrictions on the incurrence of indebtedness, the incurrence of liens and entry into sales and leaseback transactions, mergers, transfers, leases, licenses, sublicenses or dispositions of any asset, including any Equity Interest (as defined in the Credit Agreement) owned by us or any of our subsidiaries, transactions with affiliates and certain transactions limiting the ability of subsidiaries to pay dividends, in each case, subject to certain exceptions. The Credit Agreement also includes a requirement, to be tested quarterly, that we maintain a Consolidated Total Net Leverage Ratio, as of the last day of any fiscal quarter ending on or after March 31, 2017 and on or prior to December 31, 2018, that does not exceed 3.00 to 1.00 and as of the last day of any fiscal quarter ending thereafter, does not exceed 2.50 to 1.00. For these ratios, consolidated EBITDA and consolidated interest expense are calculated in a manner defined in the Credit Agreement. The Credit Agreement also includes customary events of defaults.
On January 18, 2017, NICE Systems issued $287.5 million aggregate principal amount of the Notes. The Notes are the general unsecured obligations of NICE Systems, guaranteed by us. The sale of the Notes generated net proceeds of approximately $260.1 million. The Notes were issued pursuant to an indenture (the “Indenture”) among us, NICE Systems and U. S. Bank National Association, as trustee (the “trustee”).
The Notes bear interest at a fixed rate of 1.25% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on July 15, 2017. The Notes will mature on January 15, 2024, unless earlier prepaid, redeemed or exchanged, and are not redeemable at NICE Systems’ option prior to their maturity date, except in the event of certain tax law changes.
Subject to satisfaction of certain conditions and during certain periods, at the option of the holders the Notes are exchangeable for (at our election) (i) cash, (ii) ADSs or (iii) a combination thereof. The exchange rate was initially set at 12.0260 ADSs per $1,000 principal amount of Notes (equivalent to an initial exchange price of approximately $83.15 per ADS). The exchange rate is subject to adjustment in some events. In addition, following certain corporate events that occur prior to the maturity date or NICE Systems’ delivery of a notice of tax redemption, in certain circumstances NICE Systems will increase the exchange rate for a holder who elects to exchange its Notes in connection with such a corporate event or tax redemption, as the case may be.
If we or NICE Systems undergo a fundamental change (as defined in the Indenture), holders may require NICE Systems to prepay for cash all or part of their Notes at a prepayment price equal to 100% of the principal amount of the Notes to be prepaid, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change prepayment date.
The Indenture contains customary events of default. In the case of an event of default arising from certain events of bankruptcy, insolvency or reorganization, with respect to us, NICE Systems or any of our subsidiaries that is a significant subsidiary (as defined in the Indenture), all outstanding Notes will become due and payable immediately without further action or notice. If any other event of default, other than for the failure to file reports described below, occurs and is continuing, then the Trustee or the holders of at least 25% in principal amount of the then outstanding Notes may declare the Notes to be due and payable. The Indenture further provides that with respect to an event of default arising from the Company’s failure to comply with the obligations to timely file any document or report that it is required to file with the SEC pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as applicable, we may elect to pay additional interest on the Notes as the sole remedy for such event of default during the period indicated below. Additional interest will accrue on the Notes at a rate equal to (i) 0.25% per annum of the principal amount of the Notes outstanding for each day during the period beginning on, and including, the date on which such event of default first occurred and ending on the earlier of (x) the date on which such event of default is cured or validly waived and (y) the 90th day immediately following, and including, the date on which such event of default first occurred and (ii) if such event of default has not been cured or validly waived prior to the 91st day immediately following, and including, the date on which such event of default first occurred, 0.50% per annum of the principal amount of notes outstanding for each day during the period beginning on, and including, the 91st day immediately following, and including, the date on which such event of default first occurred and ending on the earlier of (x) the date on which the event of default is cured or validly waived and (y) the 180th day immediately following, and including, the date on which such event of default first occurred.
Holders of ADSs are able to convert dividends and liquidation distributions into freely repatriable non-Israeli currencies at the rate of exchange prevailing at the time of repatriation, pursuant to regulations issued under the Currency Control Law, 5738–1978, provided that Israeli income tax has been withheld by us with respect to amounts that are being repatriated to the extent applicable or an exemption has been obtained.
Our ADSs may be freely held and traded pursuant to the General Permit and the Currency Control Law. The ownership or voting of ADSs by non-residents of Israel, except with respect to citizens of countries that are in a state of war with Israel, are not restricted in any way by our memorandum of association or articles of association or by the laws of the State of Israel.
Taxation
The following is a discussion of Israeli and United States tax consequences material to our shareholders. The discussion is not intended, and should not be construed, as legal or professional tax advice and does not exhaust all possible tax considerations.
Holders of our ADSs should consult their own tax advisors as to the United States, Israeli or other tax consequences of the purchase, ownership and disposition of our ADSs, including, in particular, the effect of any foreign, state or local taxes.
Israeli Tax Considerations
The following is a summary of the principal tax laws applicable to companies in Israel, with special reference to their effect on us. The following also contains a discussion of the material Israeli tax consequences to purchasers of our ordinary shares or ADSs. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. To the extent that the discussion is based on new tax legislation which has not been subject to judicial or administrative interpretation, we cannot assure you that the views expressed in the discussion will be accepted by the appropriate tax authorities or the courts. The discussion is not intended, and should not be construed, as a legal or professional tax advice and is not exhaustive of all possible tax considerations.
General Corporate Tax Structure
Generally, Israeli companies are subject to corporate tax on taxable income at the rate of 25% for the 2016 tax year, 24% for the 2017 tax year and 23% for the 2018 tax year and thereafter.
Israeli companies are generally subject to capital gains tax at the corporate tax rate. However, the effective tax rate payable by a company that generates income qualifying for benefits under the Israeli Law for the Encouragement of Capital Investments-1959 may be considerably less.
We are permitted to measure our Israeli taxable income in U.S. dollars pursuant to regulations published by the Israeli Minister of Finance, which provide the conditions for doing so. We believe that we meet, and will continue to meet, the necessary conditions and as such, we measure our results for tax purposes based on the U.S. dollar/NIS exchange rate on December 31 of the relevant tax year.
Tax Benefits under the Law for the Encouragement of Capital Investments, 1959, as amended.
We have derived and expect to continue to derive significant tax benefits in Israel relating to our “Approved, Privileged, and Preferred Enterprise” programs for which we were eligible up to and including the 2016 tax year, and relating to the newly introduced Preferred Technological Enterprise program for the 2017 and subsequent tax years, pursuant to the Law for Encouragement of Capital Investments-1959 (the “Investments Law”), including its various amendments. To be eligible for these tax benefits, one must continue to meet certain conditions. In the event we are considered as having failed to comply with these conditions, in whole or in part, the eligibility for the benefits may be canceled and we may be required to refund the relevant amount, including interest and inflation adjustments. As of December 31, 2017, we believe that we are in compliance with all the conditions required by the Investments Law.
For the 2013 through 2016 tax years, our Israeli entities were eligible for benefits under the “Preferred Enterprise” regime, which included the following benefits:
|
· |
A reduced flat corporate tax rate for industrial enterprises, provided that more than 25% of their annual income was derived from export. In 2016 the reduced tax rate was 16% for industrial facilities located in Israel (except for Development Area A).
|
|
· |
The reduced tax rates applied on “Preferred Income” were not contingent upon making a minimum qualifying investment in productive assets.
|
|
· |
A reduced dividend withholding tax rate of 15% for tax year 2013, and 20% for tax year 2014 and thereafter on dividends paid from Preferred Income to both Israeli and non-Israeli investors, with an exemption from such withholding tax applying to dividends paid to an Israeli company.
|
In December 2016, the Israeli Knesset passed a number of changes to the Investments Law. These changes became retroactively effective beginning January 1, 2017, following promulgation of Regulations by the Finance Ministry in May 2017 to implement the “Nexus Principles” based on OECD guidelines published as part of the Base Erosion and Profit Shifting (BEPS) project. The Regulations provide rules for implementation of the new tax regime that applies to us effective from the 2017 tax year and onwards.
Benefits under the new “Preferred Technology Enterprise” regime, effective for the 2017 and subsequent tax years, will include:
|
· |
A reduced 12% corporate tax rate (or 7.5% for entities located in Development Area A) on qualifying income deriving from eligible intellectual property (“Preferred Technology Income”), subject to a number of base conditions being fulfilled, including a minimal amount or ratio of annual R&D expenditure and R&D employees, as well as having at least 25% of annual income derived from export.
|
|
· |
A 12% capital gains tax rate on the sale of a preferred intangible asset to a foreign affiliated enterprise, provided that the asset was initially purchased from a foreign resident at an amount of NIS 200 Million or more.
|
|
· |
A withholding tax rate of 20% for dividends paid from Preferred Technology Income (with an exemption from such withholding tax applying to dividends paid to an Israeli company). Such rate may be reduced to 4% on dividends paid to a foreign resident company, subject to certain conditions regarding percentage of foreign ownership of the distributing entity.
|
The effective tax rate applying to our Preferred Technology Enterprise is calculated based on the Nexus Principals introduced by the OECD, taking into account eligible and ineligible R&D expenses incurred by us, as prescribed in the Regulations.
Income from sources other than the Preferred Technology Income are taxable at regular corporate tax rates.
Full details regarding our Preferred and Preferred Technology Enterprises may be found in Note 12(a)(1) of our Consolidated Financial Statements.
Tax Benefits and Grants for Research and Development
Israeli tax law allows, under specified conditions, a tax deduction for expenditures, including capital expenditures, for the year in which they are incurred. These expenses must relate to scientific research and development projects and must be approved by the relevant Israeli government ministry, determined by the field of research, and the research and development must be conducted for the promotion of the company and carried out by or on behalf of the company seeking such deduction. However, the amount of such deductible expenses shall be reduced by the sum of any funds received through government grants for the financing of such scientific research and development projects. Expenditures not so approved are deductible over a three‑year period.
Tax Benefits under the Law for the Encouragement of Industry (Taxes), 1969
Under the Law for the Encouragement of Industry (Taxes), 1969 (the “Industry Encouragement Law”), Industrial Companies (as defined below) are entitled to the following tax benefits, among others:
|
· |
deductions over an eight‑year period for purchases of know‑how and patents;
|
|
· |
deductions over a three-year period of expenses involved with the issuance and listing of shares on a stock market;
|
|
· |
the right to elect, under specified conditions, to file a consolidated tax return with other related Israeli Industrial Companies; and
|
|
· |
accelerated depreciation rates on equipment and buildings.
|
Eligibility for benefits under the Industry Encouragement Law is not subject to receipt of prior approval from any governmental authority. Under the Industry Encouragement Law, an “Industrial Company” is defined as a company which is an Israeli resident for tax purposes, which at least 90% of the income of which, in any tax year, determined in Israeli currency, exclusive of income from government loans, capital gains, interest and dividends, is derived from an “Industrial Enterprise” owned by it.
An “Industrial Enterprise” is defined as an enterprise whose major activity in a given tax year is industrial production activity. We believe that we currently qualify as an Industrial Company within the definition of the Industry Encouragement Law. No assurance can be given that we will continue to qualify as an Industrial Company or that the benefits described above will be available in the future.
Capital Gains Tax on Sales of Our Ordinary Shares
Israeli law generally imposes a capital gains tax on the sale of any capital assets by residents of Israel, as defined for Israeli tax purposes, and on the sale of assets located in Israel, including shares in Israeli companies, by both residents and non-residents of Israel, unless a specific exemption is available or unless a tax treaty between Israel and the shareholder’s country of residence provides otherwise. The Tax Ordinance distinguishes between real gain and inflationary surplus. The inflationary surplus is a portion of the total capital gain equivalent to the increase of the relevant asset’s purchase price attributable to an increase in the Israeli consumer price index, or a foreign currency exchange rate, between the date of purchase and the date of sale. The real gain is the excess of the total capital gain over the inflationary surplus.
The following discussion refers to the sale of our ordinary shares. However, the same tax treatment would apply to the sale of our ADSs.
Taxation of Israeli Residents
As of January 1, 2012, the tax rate generally applicable to the capital gains derived from the sale of shares, whether listed on a stock market or not, is 25% for Israeli individuals, unless such shareholder is considered a “significant shareholder” at any time during the 12-month period preceding such sale (i.e., such shareholder holds directly or indirectly, including jointly with others, at least 10% of any means of control in the company) in which case the tax rate will be 30%. Israeli companies are subject to the corporate tax rate on capital gains derived from the sale of listed shares. However, different tax rates may apply to dealers in securities and shareholders who acquired their shares prior to an initial public offering.
As of January 1, 2013, shareholders that are individuals who have taxable income that exceeds NIS 800,000 in a tax year (linked to the CPI each year), will be subject to an additional tax, referred to as Income Surtax, at the rate of 2% on their taxable income for such tax year which is in excess of such threshold. Under an amendment enacted in December 2016 to the Tax Ordinance, for tax year 2017 and thereafter the rate of High Income Tax was increased to 3% and will be applicable to annual income exceeding NIS 640,000 (linked to the CPI each year). For this purpose taxable income will include taxable capital gains from the sale of our shares and taxable income from dividend distributions.
Taxation of Non-Israeli Residents
Non-Israeli residents are generally exempt from Israeli capital gains tax on any gains derived from the sale of shares publicly traded on the TASE provided such gains did not derive from a permanent establishment of such shareholders in Israel. Non-Israeli residents are also exempt from Israeli capital gains tax on any gains derived from the sale of shares of Israeli companies publicly traded on a recognized stock market outside of Israel, provided such shareholders did not acquire their shares prior to the issuer’s initial public offering (in which case a partial exemption may be available), that the gains did not derive from a permanent establishment of such shareholders in Israel. However, non-Israeli corporations will not be entitled to such exemption if Israeli residents (i) have a controlling interest of more than 25% in such non-Israeli corporation, or (ii) are the beneficiaries of or are entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.
In addition, the sale, exchange or disposition of our ordinary shares by a shareholder who is a U.S. resident (for purposes of the U.S.-Israel Tax Treaty), and who holds ordinary shares as a capital asset, is also exempt from Israeli capital gains tax under the U.S.-Israel Tax Treaty unless either (i) the shareholder holds, directly or indirectly, shares representing 10% or more of our voting power during any part of the 12-month period preceding such sale or (ii) the capital gains arising from such sale are attributable to a permanent establishment of the shareholder located in Israel. If the above conditions are not met, the U.S. resident would be subject to Israeli tax, to the extent applicable. However, under the U.S.-Israel Tax Treaty, the gain would be treated as foreign source income for United States foreign tax credit purposes and such U.S. resident would be permitted to claim a credit for such taxes against the United States federal income tax imposed on such sale, exchange or disposition, subject to the limitations under the United States federal income tax laws applicable to foreign tax credits.
Taxation of Dividends Paid on our Ordinary Shares
The following discussion refers to dividends paid on our ordinary shares. However, the same tax treatment would apply to dividends paid on our ADSs.
Taxation of Israeli Residents
Israeli resident individuals are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares, other than bonus shares (share dividends) or stock dividends. As of January 1, 2012, the tax rate applicable to such dividends is 25% or 30% for a shareholder that is considered a significant shareholder at any time during the 12-month period preceding such distribution. Dividends paid out of profits sourced from ordinary income are subject to withholding tax at the rate of 25% or 30%. Dividends paid from income derived from our Approved and Privileged Enterprises are subject to withholding tax at the rate of 15%. Dividends paid as of January 1, 2014 from income derived from our Preferred Enterprise and Preferred Technology Enterprise will be subject to withholding tax at the rate of 20%. We cannot assure you that we will designate the profits that are being distributed in a way that will reduce shareholders’ tax liability.
All dividend distributions to Israeli resident corporations are not subject to a withholding tax.
For information with respect to the applicability of Income Surtax on distribution of dividends, please see "Capital Gains Tax on Sales of Our Ordinary Shares" and "Taxation of Israeli Residents" above in this Item 10.
Taxation of Non-Israeli Residents
Non-residents of Israel, both companies and individuals, are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares, at the aforementioned rates applicable to Israeli residents, which tax will be withheld at source, unless a different rate is provided in a treaty between Israel and the shareholder’s country of residence.
Under the U.S.-Israel Treaty, the maximum Israeli withholding tax on dividends paid by us is 25%. The U.S.-Israel Tax Treaty further provides for a 12.5% Israeli dividend withholding tax rate on dividends paid by an Israeli company to a U.S. corporation owning at least 10% or more of such Israeli company’s issued voting power for, in general, the part of the tax year which precedes the date of payment of the dividend and the entire preceding tax year. The lower 12.5% rate applies only to dividends paid from regular income (and not derived from an Approved, Privileged or Preferred Enterprise) in the applicable period and does not apply if the company has more than 25% of its gross income derived from certain types of passive income (if the conditions mentioned above are met, dividends from income of an Approved, Privileged or Preferred Enterprise are subject to a 15% withholding tax rate under the U.S.-Israel Tax Treaty). Residents of the United States generally will have withholding tax in Israel deducted at source. They may be entitled to a credit or deduction for United States federal income tax purposes in the amount of the taxes withheld, subject to detailed rules contained in United States tax legislation.
A non-resident of Israel who has dividend income derived from or accrued in Israel, from which tax was withheld at source, is generally exempt from the duty to file tax returns in Israel with respect to such income, provided such income was not derived from a business conducted in Israel by the taxpayer.
U.S. Federal Income Tax Considerations
The following is a summary of the material U.S. Federal income tax consequences that apply to U.S. holders (defined below) who hold ADSs as capital assets for tax purposes. This summary is based on the U.S. Internal Revenue Code of 1986, as amended (the “Code”), existing final, temporary and proposed regulations thereunder, judicial decisions and published positions of the Internal Revenue Service and the U.S.-Israel income tax treaty in effect as of the date of this annual report, all of which are subject to change at any time (including changes in interpretation), possibly with retroactive effect. On December 22, 2017, the United States enacted the U.S. Tax Reform which alters significantly the U.S. Federal income tax system, generally beginning in 2018. Given the complexity of this new law, U.S. holders should consult their own tax advisors regarding its potential impact on the U.S. Federal income tax consequences to them in light of their particular circumstances.
This summary is also based in part on representations by JPMorgan Chase Bank, N.A., the depositary for our ADSs, and assumes that each obligation under the Deposit Agreement between us and JPMorgan Chase Bank, N.A. and any related agreement will be performed in accordance with its terms.
This summary does not address all U.S. Federal income tax matters that may be relevant to a particular prospective holder or all tax considerations that may be relevant with respect to an investment in ADSs.
This summary does not address tax considerations applicable to a holder of an ADS that may be subject to special tax rules including, without limitation, the following:
|
· |
dealers or traders in securities, currencies or notional principal contracts;
|
|
· |
financial institutions;
|
|
· |
real estate investment trusts;
|
|
· |
investors subject to the alternative minimum tax;
|
|
· |
tax-exempt organizations;
|
|
· |
regulated investment companies;
|
|
· |
investors that actually or constructively own 10 percent or more of our voting shares;
|
|
· |
investors that will hold the ADSs as part of a hedging or conversion transaction or as a position in a straddle or a part of a synthetic security or other integrated transaction for U.S. Federal income tax purposes;
|
|
· |
investors that are treated as partnerships or other pass through entities for U.S. Federal income tax purposes and persons who hold the ADSs through partnerships or other pass through entities;
|
|
· |
investors whose functional currency is not the U.S. dollar; and
|
|
· |
expatriates or former long-term residents of the United States.
|
This summary does not address the effect of any U.S. Federal taxation other than U.S. Federal income taxation. In addition, this summary does not include any discussion of state, local or foreign taxation or the indirect effects on the holders of equity interests in a holder of an ADS.
You are urged to consult your own tax advisor regarding the foreign and U.S. Federal, state and local and other tax consequences of an investment in ADSs.
For purposes of this summary, a “U.S. holder” is a beneficial owner of ADSs that is, for U.S. Federal income tax purposes:
|
· |
an individual who is a citizen or a resident of the United States;
|
|
· |
a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any political subdivision thereof;
|
|
· |
an estate whose income is subject to U.S. Federal income tax regardless of its source; or
|
|
(a) |
a court within the United States is able to exercise primary supervision over administration of the trust; and
|
|
(b) |
one or more United States persons have the authority to control all substantial decisions of the trust.
|
If an entity that is classified as a partnership for U.S. federal tax purposes holds ADSs, the U.S. federal income tax treatment of its partners will generally depend upon the status of the partners and the activities of the partnership. Entities that are classified as partnerships for U.S. federal tax purposes and persons holding ADSs through such entities should consult their own tax advisors.
In general, if you hold ADSs, you will be treated as the holder of the underlying shares represented by those ADSs for U.S. Federal income tax purposes. Accordingly, no gain or loss will be recognized if you exchange ADSs for the underlying shares represented by those ADSs.
U.S. Taxation of ADSs
Distributions
Subject to the discussion under “Passive Foreign Investment Companies” below, the gross amount of any distribution, including the amount of any Israeli taxes withheld from these distributions (see “Israeli Tax Considerations”), actually or constructively received by a U.S. holder with respect to ADSs will be taxable to the U.S. holder as a dividend to the extent of our current and accumulated earnings and profits as determined under U.S. Federal income tax principles. Distributions in excess of earnings and profits will be non-taxable to the U.S. holder to the extent of, and will be applied against and reduce, the U.S. holder’s adjusted tax basis in the ADSs. Distributions in excess of earnings and profits and such adjusted tax basis will generally be taxable to the U.S. holder as a capital gain from the sale or exchange of property. We do not maintain calculations of our earnings and profits under U.S. Federal income tax principles. If we do not report to a U.S. holder the portion of a distribution that exceeds earnings and profits, the distribution will generally be taxable as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as a capital gain under the rules described above. The amount of any distribution of property other than cash will be the fair market value of that property on the date of distribution. The U.S. holder will not, except as provided by Section 245 of the Code, be eligible for any dividends received deduction in respect of the dividend otherwise allowable to corporations.
Under the Code, certain dividends received by non-corporate U.S. holders will be subject to a maximum income tax rate of 20%. This reduced income tax rate is only applicable to dividends paid by a “qualified foreign corporation” that is not a “passive foreign investment company” and only with respect to shares held by a qualified U.S. holder (i.e., a non-corporate holder) for a minimum holding period (generally 61 days during the 121-day period beginning 60 days before the ex-dividend date). We should be considered a qualified foreign corporation because (i) we are eligible for the benefits of a comprehensive tax treaty between Israel and the U.S., which includes an exchange of information program, and (ii) the ADSs are readily tradable on an established securities market in the U.S. In addition, based on our current business plans, we do not expect to be classified as a “passive foreign investment company” (see “Passive Foreign Investment Companies” below). Accordingly, dividends paid by us to individual U.S. holders on shares held for the minimum holding period should be eligible for the reduced income tax rate. In addition to the income tax on dividends discussed above, certain non-corporate U.S. holders will also be subject to the 3.8% Medicare tax on dividends as discussed below under “Medicare Tax on Unearned Income”.
The amount of any distribution paid in a currency other than U.S. dollars (a “foreign currency”) including the amount of any withholding tax thereon, will be included in the gross income of a U.S. holder in an amount equal to the U.S. dollar value of the foreign currencies calculated by reference to the exchange rate in effect on the date of receipt, regardless of whether the foreign currencies are converted into U.S. dollars. If the foreign currencies are converted into U.S. dollars on the date of receipt, a U.S. holder generally should not be required to recognize foreign currency gain or loss in respect of the dividend. If the foreign currencies received in the distribution are not converted into U.S. dollars on the date of receipt, a U.S. holder will have a basis in the foreign currencies equal to its U.S. dollar value on the date of receipt. Any gain or loss on a subsequent conversion or other disposition of the foreign currencies will be treated as ordinary income or loss.
Generally, dividends received by a U.S. holder with respect to ADSs will be treated as foreign source income for the purposes of calculating that holder’s foreign tax credit limitation. Subject to certain conditions and limitations, any Israeli taxes withheld on dividends at the rate provided by the U.S.-Israel tax treaty may be deducted from taxable income or credited against a U.S. holder’s U.S. Federal income tax liability. The limitation on foreign taxes eligible for the U.S. foreign tax credit is calculated separately with respect to “passive” income and “general” income. The rules relating to foreign tax credits and the timing thereof are complex. U.S. holders should consult their own tax advisors regarding the availability of a foreign tax credit under their particular situation.
Sale or Other Disposition of ADSs
If a U.S. holder sells or otherwise disposes of its ADSs, gain or loss will be recognized for U.S. Federal income tax purposes in an amount equal to the difference between the amount realized on the sale or other disposition and such holder’s adjusted tax basis in the ADSs. Subject to the discussion below under the heading “Passive Foreign Investment Companies,” such gain or loss generally will be a capital gain or loss, and will be long-term a capital gain or loss if the holder had held the ADSs for more than one year at the time of the sale or other disposition. Long-term capital gains realized by individual U.S. holders generally are subject to a lower marginal U.S. Federal income tax rate (currently up to 20%) than the marginal tax rate on ordinary income. In addition to the income tax on gains discussed above, certain non-corporate U.S. holders will also be subject to the 3.8% Medicare tax on net gains as discussed below under “Medicare Tax on Unearned Income”. Under most circumstances, any gain that a holder recognizes on the sale or other disposition of ADSs will be U.S. sourced for purposes of the foreign tax credit limitation and any recognized losses will be allocated against U.S. source income.
If a U.S. holder receives foreign currency upon a sale or exchange of ADSs, gain or loss, if any, recognized on the subsequent sale, conversion or disposition of such foreign currency will be ordinary income or loss, and will generally be income or loss from sources within the United States for foreign tax credit limitation purposes. However, if such foreign currency is converted into U.S. dollars on the date received by the U.S. holder, the U.S. holder generally should not be required to recognize any gain or loss on such conversion.
A U.S. holder who holds shares through an Israeli stockbroker or other Israeli intermediary may be subject to Israeli withholding tax on any capital gain recognized if the U.S. holder does not obtain approval of an exemption from the Israeli Tax Authorities or claim any allowable refunds or reductions. U.S. holders are advised that any Israeli tax paid under circumstances in which an exemption from (or a refund of or a reduction in) such tax was available will not give rise to a deduction or credit for foreign taxes paid for U.S. federal income tax purposes. If applicable, U.S. holders are advised to consult their Israeli stockbroker or intermediary regarding the procedures for obtaining an exemption or reduction.
Medicare Tax on Unearned Income
Certain U.S. holders that are individuals, estates or trusts are required to pay an additional 3.8% tax on all or a portion of their “net investment income,” which includes dividends and net gains from the sale or other dispositions of ADSs (other than ADSs held in a trade or business).
Passive Foreign Investment Companies
For U.S. Federal income tax purposes, we will be considered a passive foreign investment company (“PFIC”) for any taxable year in which either 75% or more of our gross income is passive income, or at least 50% of the average value of all of our assets for the taxable year produce or are held for the production of passive income. For this purpose, passive income includes dividend, interest, royalty, rent, annuity and the excess of gain over losses from the disposition of assets which produce passive income. If we were determined to be a PFIC for U.S. Federal income tax purposes, highly complex rules would apply to U.S. holders owning ADSs.
Based on our estimated gross income, the average value of our gross assets and the nature of our business, we do not believe that we will be classified as a PFIC in the current taxable year. Our status in any taxable year will depend on our assets and activities in each year and because this is a factual determination made annually at the end of each taxable year, there can be no assurance that we will not be considered a PFIC for any future taxable year. If we were treated as a PFIC in any year during which a U.S. holder owns ADSs, certain adverse tax consequences could apply. Given our current business plans, however, we do not expect that we will be classified as a PFIC in future years.
You are urged to consult your own tax advisor regarding the possibility of us being classified as a PFIC and the potential tax consequences arising from the ownership and disposition (directly or indirectly) of an interest in a PFIC.
Backup Withholding and Information Reporting
Payments of dividends with respect to ADSs and the proceeds from the sale, retirement, or other disposition of ADSs made by a U.S. paying agent or other U.S. intermediary will be reported to the IRS and to the U.S. holder as may be required under applicable U.S. Treasury regulations. We, or an agent, a broker, or any paying agent, as the case may be, may be required to withhold tax (backup withholding), currently at the rate of 28%, if a non-corporate U.S. holder that is not otherwise exempt fails to provide an accurate taxpayer identification number and comply with other IRS requirements concerning information reporting. Certain U.S. holders (including, among others, corporations and tax-exempt organizations) are not subject to backup withholding. Any amount of backup withholding withheld may be used as a credit against your U.S. Federal income tax liability provided that the required information is timely furnished to the IRS. U.S. holders should consult their tax advisors as to their qualification for exemption from backup withholding and the procedure for obtaining an exemption.
Foreign Asset Reporting
Certain U.S. Holders who are individuals are required to report information relating to an interest in our ADSs on IRS Form 8938, subject to certain exceptions (including an exception for shares held in accounts maintained by financial institutions). U.S. Holders are encouraged to consult their tax advisors regarding their information reporting obligations, if any, with respect to their ownership and disposition of our ADSs.
Documents on Display
We are subject to certain of the information reporting requirements of the Securities and Exchange Act of 1934, as amended. As a “foreign private issuer” we are exempt from the rules and regulations under the Securities Exchange Act prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Securities Exchange Act, with respect to their purchase and sale of our shares. In addition, we are not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Securities Exchange Act. NASDAQ rules generally require that companies send an annual report to shareholders prior to the annual general meeting, however we rely upon an exception under the NASDAQ rules and follow the generally accepted business practice for companies in Israel. Specifically, we file annual reports on Form 20-F, which contain financial statements audited by an independent accounting firm, electronically with the SEC and post a copy on our website. We also furnish to the SEC quarterly reports on Form 6-K containing unaudited financial information after the end of each of the first three quarters.
You may read and copy any document we file with the SEC at its public reference facilities at, 100 F Street, N.E., Washington, D.C. 20549 and at the SEC’s regional offices at 500 West Madison Street, Suite 1400, Chicago, IL 60661-2511. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100 F Street, N.E., Washington, D.C. 20549. The SEC also maintains a web site that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of this web site is http://www.sec.gov. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities. In addition, our ADSs are quoted on the NASDAQ Global Select Market, so our reports and other information can be inspected at the offices of the National Association of Securities Dealers, Inc. at 1735 K Street, N.W., Washington, D.C. 20006.
Item 11. |
Quantitative and Qualitative Disclosures About Market Risk.
|
Market risks relating to our operations result primarily from weak economic conditions in the markets in which we sell our products and changes in interest and exchange rates. To manage the volatility related to the latter exposure, we may enter into various derivative transactions. Our objective is to reduce, where it is deemed appropriate to do so, fluctuations in earnings and cash flows associated with changes in currency exchange rates. It is our policy and practice to use derivative financial instruments only to manage such exposures. We do not use financial instruments for trading purposes and we are not a party to any leveraged derivative.
Foreign Currency Risk
We conduct our business primarily in U.S. dollars but also in the currencies of Israel, United Kingdom, the European Union and India as well as other currencies. Thus, we are exposed to foreign exchange fluctuations, primarily in NIS, GBP, EUR and INR. We monitor foreign currency exposure and from time to time we may use various instruments to preserve the value of sale transactions and commitments, however, this cannot assure us protection against risks of currency fluctuations. For more information regarding foreign currency related risks, please refer to Item 3, “Key Information—General Risks Relating to Our Business” of this annual report. We use currency forward contracts and option contracts in order to protect against the increase in value of forecasted non-dollar currency cash flows and to hedge future anticipated payments.
As of December 31, 2017, we had outstanding currency option and forward contracts to hedge payroll and facilities expenses, denominated in NIS and INR, in the total amount of approximately $54.0 million. The fair value of those contracts was approximately $1.25 million. These transactions were for a period of up to one year.
The following table details the balance sheet exposure (i.e., the difference between assets and liabilities) in our main foreign currencies, as of December 31, 2017, against the relevant functional currency.
|
|
Functional currencies
|
|
|
|
(In U.S. dollars in millions)
|
|
|
|
USD
|
|
|
GBP
|
|
|
EUR
|
|
|
CAD
|
|
|
MXN
|
|
|
AUD
|
|
|
BRL
|
|
|
SGD
|
|
|
Other currencies
|
|
Foreign currencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD
|
|
|
-
|
|
|
|
12.1
|
|
|
|
(0.8
|
)
|
|
|
(2.9
|
)
|
|
|
1.9
|
|
|
|
1.2
|
|
|
|
(2.4
|
)
|
|
|
(1.3
|
)
|
|
|
-
|
|
GBP
|
|
|
10.7
|
|
|
|
-
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
EUR
|
|
|
6.8
|
|
|
|
20.9
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
CAD
|
|
|
2.4
|
|
|
|
0.3
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
AUD
|
|
|
3.3
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
MXN
|
|
|
2.7
|
|
|
|
0.0
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
CHF
|
|
|
(0.1
|
)
|
|
|
0.4
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
JPY
|
|
|
1.3
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
INR
|
|
|
(6.3
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
SGD
|
|
|
(4.2
|
)
|
|
|
0.1
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
0.0
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
HKD
|
|
|
(3.3
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.0
|
)
|
|
|
-
|
|
ILS
|
|
|
(3.0
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Other currencies
|
|
|
0.1
|
|
|
|
0.0
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(0.4
|
)
|
|
|
) (0.0
|
)
|
The table below presents the fair value of firmly committed transactions for lease obligations denominated in currencies other than the functional currency:
|
|
(In U.S. dollars in millions)
|
|
|
|
New Israeli Shekel
|
|
|
Other currencies
|
|
|
Total
|
|
Less than 1 year
|
|
|
5.70
|
|
|
|
0.88
|
|
|
|
6.58
|
|
1-3 years
|
|
|
10.74
|
|
|
|
1.55
|
|
|
|
12.29
|
|
3-5 years
|
|
|
10.74
|
|
|
|
1.37
|
|
|
|
12.11
|
|
Over 5 years
|
|
|
-
|
|
|
|
2.75
|
|
|
|
2.75
|
|
Total
|
|
|
27.18
|
|
|
|
6.55
|
|
|
|
33.73
|
|
Interest Rate Risk
We are subject to interest rate risk on our investments and on our borrowings.
In November 2016 we completed the acquisition of inContact and utilized $475 million in debt financing with a variable interest rate toward payment of the consideration in the transaction.
As of December 31, 2017 the outstanding principal amount of the term debt was $215 million.
The floating rate term loan is exposed to a market risk due to fluctuations in interest rates which may affect our interest expense.
On January 18, 2017 we issued $287.5 million aggregate principal amount of the Notes. The Notes bear interest at a fixed rate of 1.25% per year.
Our outstanding debt obligations, the corresponding interest rates, currency and repayment schedules as of December 31, 2017 are set forth in the table below in U.S. dollar equivalent terms:
Currency
|
|
Total amount
|
|
|
Interest rate
|
|
|
2018
|
|
|
2019
|
|
|
2020
|
|
|
2021
|
|
|
2022
|
|
|
2023 & thereafter
|
|
|
|
(U.S. dollars in millions)
|
|
Fixed Rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD
|
|
$
|
287,500
|
|
|
|
1.25
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
287,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Floating Rate:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD
|
|
|
215,000
|
|
|
|
3.30
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
215,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total:
|
|
|
502,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
215,000
|
|
|
|
|
|
|
$
|
287,500
|
|
Debt issuance costs, net of amortization
|
|
|
(8,668
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unamortized discount
|
|
|
(46,190
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total:
|
|
$
|
447,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our investments are exposed to market risk due to fluctuations in interest rates, which may affect our interest income, interest expense and the fair market value of our marketable securities portfolio.
Our marketable securities portfolio consists of investment-grade corporate debentures, U.S. Government agencies and U.S. treasuries. As of December 31, 2017, 48.4% of our portfolio was in such securities.
We invest in dollar deposits with U.S. banks, European banks, Israeli banks and money market funds. As of December 31, 2017, 51.6% of our portfolio was in such deposits. Since these investments are for short periods, interest income is sensitive to changes in interest rates.
The weighted average duration of the securities portfolio, as of December 31, 2017, is 1.6 years. The securities in our marketable securities portfolio are rated generally as A- according to Standard and Poor’s rating or A3, according to Moody’s rating. Securities representing 3% of the marketable securities portfolio are rated as AAA; securities representing 37% of the marketable securities portfolio are rated as AA; securities representing 59% of the marketable securities portfolio are rated as A; and securities representing 1% of the marketable securities portfolio are rated below A- after being downgraded during the last two years .
The table below presents the fair value of marketable securities which are subject to risk of changes in interest rate, segregated by maturity dates:
|
|
Amortized Cost
|
|
|
Estimated fair value
|
|
|
|
Up to 1 year
|
|
|
1-3 years
|
|
|
4-5 years
|
|
|
Total
|
|
|
Up to 1 year
|
|
|
1-3 years
|
|
|
4-5 years
|
|
|
Total
|
|
Corporate debentures
|
|
|
63.0
|
|
|
|
122.5
|
|
|
|
4.3
|
|
|
|
189.8
|
|
|
|
63.0
|
|
|
|
121.8
|
|
|
|
4.2
|
|
|
|
189.0
|
|
U.S. treasuries
|
|
|
-
|
|
|
|
-
|
|
|
|
7.0
|
|
|
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
6.8
|
|
|
|
6.8
|
|
U.S. government agencies
|
|
|
1.0
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1.0
|
|
|
|
1.0
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1.0
|
|
Total
|
|
|
64.0
|
|
|
|
122.5
|
|
|
|
11.3
|
|
|
|
197.8
|
|
|
|
64.0
|
|
|
|
121.8
|
|
|
|
11.0
|
|
|
|
196.8
|
|
Other risks and uncertainties that could affect actual results and outcomes are described in Item 3, “Key Information—Risk Factors” in this annual report.
Item 12. |
Description of Securities Other than Equity Securities.
|
American Depositary Shares and Receipts
Set forth below is a summary of certain provisions in relation to charges and other payments under the Deposit Agreement, as amended, among NICE, JPMorgan Chase Bank, N.A. as depositary (the "Depositary"), and the owners and holders from time to time of ADRs issued thereunder (the “Deposit Agreement”). This summary is not complete and is qualified in its entirety by the Deposit Agreement, a form of which has been filed as Exhibit 1 to the Registration Statement on Form F-6 (Registration No. 333-203623) filed with the SEC on April 24, 2015.
Charges of the Depositary
The depositary may charge each person to whom ADSs are issued, including, without limitation, issuances against deposits of shares, issuances in respect of share distributions, rights and other distributions, issuances pursuant to a stock dividend or stock split declared by us or issuances pursuant to a merger, exchange of securities or any other transaction or event affecting the ADSs or deposited securities, and each person surrendering ADSs for withdrawal of deposited securities or whose ADRs are cancelled or reduced for any other reason, $0.05 for each ADS issued, delivered, reduced, cancelled or surrendered, as the case may be. The depositary may sell (by public or private sale) sufficient securities and property received in respect of a share distribution, rights or other distribution prior to such deposit to pay such charge.
The following additional charges shall be incurred by the ADR holders, by any party depositing or withdrawing shares or by any party surrendering ADSs or to whom ADSs are issued (including, without limitation, issuance pursuant to a stock dividend or stock split declared by us or an exchange of stock regarding the ADSs or the deposited securities or a distribution of ADSs), whichever is applicable:
|
· |
a fee of $1.50 per ADR for transfers of certificated or direct registration ADRs;
|
|
· |
a fee of up to $0.05 per ADS for any cash distribution made pursuant to the deposit agreement;
|
|
· |
a fee of up to $0.05 per ADS per calendar year (or portion thereof) for services performed by the depositary in administering the ADRs (which fee may be charged on a periodic basis during each calendar year and shall be assessed against holders of ADRs as of the record date or record dates set by the depositary during each calendar year and shall be payable in the manner described in the next succeeding provision);
|
|
· |
a fee for the reimbursement of such fees, charges and expenses as are incurred by the depositary or any of its agents (including, without limitation, the custodian and expenses incurred on behalf of holders in connection with compliance with foreign exchange control regulations or any law or regulation relating to foreign investment) in connection with the servicing of the shares or other deposited securities, the sale of securities (including, without limitation, deposited securities), the delivery of deposited securities or otherwise in connection with the depositary's or its custodian's compliance with applicable law, rule or regulation (which fees and charges shall be assessed on a proportionate basis against holders as of the record date or dates set by the depositary and shall be payable at the sole discretion of the depositary by billing such holders or by deducting such charge from one or more cash dividends or other cash distributions);
|
|
· |
stock transfer or other taxes and other governmental charges;
|
|
· |
cable, telex and facsimile transmission and delivery charges incurred at the request of an ADR holder in connection with the deposit or delivery of shares;
|
|
· |
transfer or registration fees for the registration of transfer of deposited securities on any applicable register in connection with the deposit or withdrawal of deposited securities;
|
|
· |
in connection with the conversion of foreign currency into U.S. dollars, the fees, expenses and other charges charged by JPMorgan Chase Bank, N.A. or its agent (which may be a division, branch or affiliate) so appointed in connection with such conversion; and
|
|
· |
fees of any division, branch or affiliate of the depositary utilized by the depositary to direct, manage or execute any public or private sale of securities under the deposit agreement.
|
The depositary may generally refuse to provide services until it is reimbursed applicable amounts, including stock transfer or other taxes and other governmental charges, and is paid its fees for applicable services.
The fees and charges an ADR holder may be required to pay may vary over time and may be changed by us and by the depositary. Our ADR holders will receive prior notice of the increase in any such fees and charges.
We will pay all other charges and expenses of the depositary and any agent of the depositary (except the custodian) pursuant to agreements from time to time between us and the depositary. The charges described above may be amended from time to time by agreement between us and the depositary.
Fees paid by the Depositary
Our depositary has agreed to reimburse us for certain expenses we incur that are related to establishment and maintenance of the ADR program upon such terms and conditions as we and the depositary may agree from time to time. The depositary may make available to us a set amount or a portion of the depositary fees charged in respect of the ADR program or otherwise upon such terms and conditions as we and the depositary may agree from time to time.
From January 1, 2017 to December 31, 2017, NICE received from the depositary $123,509 as reimbursement for its expenses incurred in relation to the maintenance and administration of the ADR program.
Item 13. Defaults, Dividend Arrearages and Delinquencies.
None.
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds.
None.
Item 15. Controls and Procedures.
Disclosure Controls and Procedures
An evaluation was performed under the supervision and with the participation of NICE’s management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of NICE’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that NICE’s disclosure controls and procedures were effective as of such date.
Management’s Annual Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over our financial reporting, as such term is defined in Rule 15d-15(f) under the Securities Exchange Act. Our internal control over our financial reporting system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective can only provide reasonable assurance with respect to financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2017. Our management based its assessment on criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, our management has concluded that, as of December 31, 2017, our internal control over financial reporting is effective.
Attestation Report of the Independent Registered Public Accounting Firm
Our independent registered public accounting firm, Kost, Forer, Gabbay & Kasierer, a member of EY Global independently assessed the effectiveness of our internal control over financial reporting and has issued an attestation report, which is included under Item 18 on page F-3 of this annual report.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the period covered by this annual report that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.
Item 16A. Audit Committee Financial Expert.
Our Board of Directors has determined that each of Dan Falk and Yocheved Dvir meets the definition of an audit committee financial expert, as defined in Item 407 of Regulation S-K, and is independent under the applicable regulations.
Item 16B. Code of Ethics.
We have adopted a Code of Ethics that applies to our principal executive and financial officers, and that also applies to all of our employees. The Code of Ethics is publicly available on our website at www.nice.com. Written copies are available upon request without charge. If we make any substantive amendments to the Code of Ethics or grant any waiver from a provision of this code to our chief executive officer, principal financial officer or corporate controller, we will either disclose the nature of such amendment or waiver on our website or in our annual report on Form 20-F.
Item 16C. Principal Accountant Fees and Services.
Fees Paid to Independent Auditors
Fees billed or expected to be billed by Kost, Forer, Gabbay & Kasierer, a member of EY Global, and other members of EY Global for professional services for each of the last two fiscal years were as follows:
Services Rendered
|
|
2016 Fees
|
|
|
2017 Fees
|
|
Audit (1)
|
|
$
|
799,489
|
|
|
$
|
953,414
|
|
Audit-related (2)
|
|
$
|
560,123
|
|
|
$
|
197,097
|
|
Tax (3)
|
|
$
|
190,761
|
|
|
$
|
650,119
|
|
Total
|
|
$
|
1,550,373
|
|
|
$
|
1,800,630
|
|
(1)
|
Audit fees refer to audit services for each of the years shown in this table which include fees associated with the annual audit for each of 2016 and 2017 (including an audit in each such year in accordance with section 404 of the Sarbanes-Oxley Act), certain procedures regarding our quarterly financial results submitted on Form 6-K, consultations concerning financial accounting and various accounting issues and performance of local statutory audits.
|
(2)
|
Audit-related fees relate to assurance and associated services that traditionally are performed by the independent auditor, which include due diligence investigations and audit services related to other statutory or regulatory filings, mainly those related to mergers and acquisitions.
|
(3)
|
Tax fees refer to professional services rendered by our auditors, which include tax compliance, tax advice on actual or contemplated transactions, tax consulting associated with transfer pricing and global mobility of employees.
|
Our audit committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by our external auditors, Kost, Forer, Gabbay & Kasierer, a member of EY Global. The policy, which is designed to ensure that such services do not impair the independence of our auditors, requires pre-approval from the audit committee on an annual basis for the various audit and non-audit services that may be performed by our auditors. If a type of service, that is to be provided by our auditors, has not received such general pre-approval, it will require specific pre-approval by our audit committee. Any proposed services exceeding pre-approved cost levels or budgeted amounts will also require specific pre-approval by our audit committee. The policy prohibits retention of the independent auditors to perform the prohibited non-audit functions defined in Section 201 of the Sarbanes-Oxley Act of 2002 or the rules of the SEC, and also considers whether proposed services are compatible with the independence of the public auditors.
Item 16D. Exemptions from the Listing Standards for Audit Committees.
Not applicable.
Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers.
During 2017, we repurchased our ordinary shares as described in the table below.
Period
|
|
(a) Total number of shares purchased
|
|
|
(b) Average price paid per share
|
|
|
(c) Total number of shares purchased as part of publicly announced plans or programs
|
|
|
(d) Maximum number (or approximately dollar value) of shares that may yet be purchased under the plans or programs
|
|
|
|
(In U.S. dollars, except share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
January 1 – January 31
|
|
|
2,226
|
|
|
|
66.54
|
|
|
|
2,226
|
|
|
|
161,438,536
|
|
February 1 - February 28
|
|
|
9,900
|
|
|
|
68.89
|
|
|
|
9,900
|
|
|
|
160,756,528
|
|
March 1 - March 31
|
|
|
127,723
|
|
|
|
67.65
|
|
|
|
127,723
|
|
|
|
152,115,637
|
|
April 1 - April 30
|
|
|
96,922
|
|
|
|
67.80
|
|
|
|
96,922
|
|
|
|
145,544,524
|
|
May 1 - May 31
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
145,544,524
|
|
June 1 - June 30
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
145,544,524
|
|
July 1 - July 31
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
145,544,524
|
|
August 1 - August 31
|
|
|
56,181
|
|
|
|
75.94
|
|
|
|
56,181
|
|
|
|
141,277,914
|
|
September 1 - September 30
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
141,277,914
|
|
October 1 - October 31
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
141,277,914
|
|
November 1 - November 30
|
|
|
48,825
|
|
|
|
84.24
|
|
|
|
48,825
|
|
|
|
137,165,086
|
|
December 1 - December 31
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
137,165,086
|
|
Total
|
|
|
341,777
|
|
|
|
71.45
|
|
|
|
341,777
|
|
|
|
|
|
On May 6, 2015 our Board of Directors authorized a program to repurchase up to $100,000 of the Company's issued and outstanding ordinary shares and ADRs. On January 10, 2017, we announced that our Board of Directors authorized a program to repurchase up to $150 million of the Company's issued and outstanding ordinary shares and ADRs. This share repurchase program commenced on April 7, 2017 following completion of the prior program. Repurchases may be made from time to time in the open market or in privately negotiated transactions in accordance with applicable securities laws and regulations. The timing and amount of the repurchase transactions will be determined by management and may depend on a variety of factors including market conditions, alternative investment opportunities and other considerations.
These programs do not obligate us to acquire any particular amount of ordinary shares and ADRs and each program may be modified or discontinued at any time without prior notice.
Item 16F. Change in Registrant’s Certifying Accountant.
Item 16G. Corporate Governance.
We follow the Israeli Companies Law, the relevant provisions of which are summarized in this annual report, rather than comply with the NASDAQ requirements relating to: (i) the quorum for shareholder meetings (see Item 10, “Additional Information – Memorandum and Articles of Association – Meetings of Shareholders” in this annual report); (ii) shareholder approval with respect to issuance of securities under equity based compensation plans (see Item 10, “Additional Information – Memorandum and Articles of Association – Approval of Certain Transactions” and “Approval of Office Holder Compensation” in this annual report); and (iii) sending annual reports to shareholders (see Item 10, “Additional Information – Documents on Display” in this annual report).
Item 16H. Mine Safety Disclosure.
Item 17. Financial Statements.
Not Applicable.
Item 18. Financial Statements.
See pages F-1 through F-64 of this annual report attached hereto.
Exhibit No.
|
|
Description
|
|
|
|
|
|
|
|
2.1
|
|
Form of Share Certificate (filed as Exhibit 4.1 to Amendment No. 1 to NICE Ltd.’s Registration Statement on Form F-1 (Registration No. 333-99640) filed with the SEC on December 29, 1995, and incorporated herein by reference).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101 |
|
The following financial information from NICE Ltd.’s Annual Report on Form 20-F for the year ended December 31, 2017, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at December 31, 2017 and 2016; (ii) Consolidated Statements of Income for the years ended December 31, 2017, 2016 and 2015; (iii) Statements of Changes in Shareholders’ Equity and Comprehensive Income for the years ended December 31, 2017, 2016 and 2015; (iv) Consolidated Statements of Cash Flows for the years ended December 31, 2017, 2016 and 2015; and (v) Notes to Consolidated Financial Statements.
|
NICE LTD. AND ITS SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2017
IN U.S. DOLLARS
|
Page
|
|
|
|
F-2 - F-4
|
|
|
|
F-5 - F-6
|
|
|
|
F-7
|
|
|
|
F-8
|
|
|
|
F-9 - F-10
|
|
|
|
F-11 - F-12
|
|
|
|
F-13 - F-64
|
|
Kost Forer Gabbay & Kasierer
144 Menachem Begin Road, Building A
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
NICE LTD.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of NICE Ltd. and its subsidiaries (the “Company") as of December 31, 2017 and 2016, the related consolidated statements of income, comprehensive income, changes in shareholders' equity and cash flows for each of the three years in the period ended December 31, 2017 and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the consolidated financial position of the Company at December 31, 2017 and 2016 and the consolidated result of its operations and its cash flows for each of the three years in the period ended December 31, 2017, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated March 30, 2018 expressed an unqualified opinion thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ Kost, Forer, Gabbay and Kasierer
KOST FORER GABBAY & KASIERER
|
A Member of EY Global
|
We have served as the Company‘s auditor since 1995.
Tel-Aviv, Israel
|
March 30, 2018
|
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of
NICE LTD.
Opinion on Internal Control over Financial Reporting
We have audited NICE Ltd.'s and its subsidiaries (the “Company") internal control over financial reporting as of December 31, 2017, based on criteria established in Internal Control–Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the “COSO criteria"). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2017, based on the COSO criteria.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2017 and 2016 and the related consolidated statement of income, comprehensive income, changes in shareholders' equity and cash flows for each of the three years in the period ended December 31, 2017 and the related notes and our report dated March 30, 2018 expressed an unqualified opinion thereon.
Basis for Opinion
The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management's Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
|
Kost Forer Gabbay & Kasierer
144 Menachem Begin Road, Building A
Tel-Aviv 6492102, Israel
|
Tel: +972-3-6232525
Fax: +972-3-5622555
ey.com
|
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ Kost, Forer, Gabbay and Kasierer
KOST FORER GABBAY & KASIERER
|
A Member of EY Global
|
Tel-Aviv, Israel
|
March 30, 2018
|
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
328,302
|
|
|
$
|
157,026
|
|
Short-term investments
|
|
|
63,951
|
|
|
|
30,287
|
|
Trade receivables (net of allowance for doubtful accounts of $ 9,554 and $ 7,499 at December 31, 2017 and 2016, respectively)
|
|
|
230,729
|
|
|
|
260,220
|
|
Prepaid expenses and other current assets
|
|
|
70,074
|
|
|
|
61,700
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
693,056
|
|
|
|
509,233
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM ASSETS:
|
|
|
|
|
|
|
|
|
Long-term investments
|
|
|
132,820
|
|
|
|
98,726
|
|
Other long-term assets
|
|
|
19,496
|
|
|
|
18,701
|
|
Property and equipment, net
|
|
|
118,275
|
|
|
|
87,678
|
|
Deferred tax assets
|
|
|
11,850
|
|
|
|
14,093
|
|
Other intangible assets, net
|
|
|
551,347
|
|
|
|
618,735
|
|
Goodwill
|
|
|
1,318,242
|
|
|
|
1,284,710
|
|
|
|
|
|
|
|
|
|
|
Total long-term assets
|
|
|
2,152,030
|
|
|
|
2,122,643
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
2,845,086
|
|
|
$
|
2,631,876
|
|
The accompanying notes are an integral part of the consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands (except share and per share data)
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
Current maturities of long-term loan
|
|
$
|
-
|
|
|
$
|
21,164
|
|
Trade payables
|
|
|
29,438
|
|
|
|
25,634
|
|
Deferred revenues and advances from customers
|
|
|
184,564
|
|
|
|
149,801
|
|
Accrued expenses and other liabilities
|
|
|
309,350
|
|
|
|
276,211
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
523,352
|
|
|
|
472,810
|
|
|
|
|
|
|
|
|
|
|
LONG-TERM LIABILITIES:
|
|
|
|
|
|
|
|
|
Deferred revenues and advances from customers
|
|
|
37,550
|
|
|
|
22,710
|
|
Accrued severance pay
|
|
|
17,250
|
|
|
|
16,885
|
|
Deferred tax liabilities
|
|
|
57,796
|
|
|
|
146,952
|
|
Long-term loan
|
|
|
447,642
|
|
|
|
444,016
|
|
Other long-term liabilities
|
|
|
11,935
|
|
|
|
17,171
|
|
|
|
|
|
|
|
|
|
|
Total long-term liabilities
|
|
|
572,173
|
|
|
|
647,734
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHAREHOLDERS' EQUITY:
|
|
|
|
|
|
|
|
|
Share capital-
|
|
|
|
|
|
|
|
|
Ordinary shares of NIS 1 par value:
|
|
|
|
|
|
|
|
|
Authorized: 125,000,000 shares at December 31, 2017 and 2016; Issued: 73,455,167 and 72,323,566 shares at December 31, 2017 and 2016, respectively; Outstanding: 60,925,954 and 59,988,783 shares at December 31, 2017 and 2016, respectively
|
|
|
18,595
|
|
|
|
18,280
|
|
Additional paid-in capital
|
|
|
1,420,813
|
|
|
|
1,317,539
|
|
Treasury shares at cost – 12,529,213 and 12,334,783 Ordinary shares at December 31, 2017 and 2016, respectively
|
|
|
(507,705
|
)
|
|
|
(488,573
|
)
|
Accumulated other comprehensive loss
|
|
|
(32,914
|
)
|
|
|
(46,824
|
)
|
Retained earnings
|
|
|
850,772
|
|
|
|
710,910
|
|
|
|
|
|
|
|
|
|
|
Total shareholders' equity
|
|
|
1,749,561
|
|
|
|
1,511,332
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders' equity
|
|
$
|
2,845,086
|
|
|
$
|
2,631,876
|
|
The accompanying notes are an integral part of the consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
U.S. dollars in thousands (except share and per share data)
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
Products
|
|
$
|
318,946
|
|
|
$
|
306,252
|
|
|
$
|
317,900
|
|
Services
|
|
|
652,040
|
|
|
|
623,783
|
|
|
|
573,033
|
|
Cloud
|
|
|
361,166
|
|
|
|
85,507
|
|
|
|
35,934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
1,332,152
|
|
|
|
1,015,542
|
|
|
|
926,867
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Products
|
|
|
51,065
|
|
|
|
53,032
|
|
|
|
66,363
|
|
Services
|
|
|
225,020
|
|
|
|
250,022
|
|
|
|
222,784
|
|
Cloud
|
|
|
192,588
|
|
|
|
34,679
|
|
|
|
14,435
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of revenues
|
|
|
468,673
|
|
|
|
337,733
|
|
|
|
303,582
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
863,479
|
|
|
|
677,809
|
|
|
|
623,285
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development, net
|
|
|
181,107
|
|
|
|
141,528
|
|
|
|
128,485
|
|
Selling and marketing
|
|
|
361,328
|
|
|
|
268,349
|
|
|
|
225,817
|
|
General and administrative
|
|
|
129,071
|
|
|
|
116,569
|
|
|
|
90,349
|
|
Amortization of acquired intangibles
|
|
|
41,902
|
|
|
|
17,187
|
|
|
|
12,528
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses
|
|
|
713,408
|
|
|
|
543,633
|
|
|
|
457,179
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
150,071
|
|
|
|
134,176
|
|
|
|
166,106
|
|
Financial income (expenses) and other, net
|
|
|
(20,411
|
)
|
|
|
10,305
|
|
|
|
5,304
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes on income
|
|
|
129,660
|
|
|
|
144,481
|
|
|
|
171,410
|
|
Taxes on income (tax benefit)
|
|
|
(13,631
|
)
|
|
|
21,412
|
|
|
|
30,832
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations
|
|
|
143,291
|
|
|
|
123,069
|
|
|
|
140,578
|
|
Discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on disposal and income (loss) from operations
|
|
|
-
|
|
|
|
(8,235
|
)
|
|
|
152,459
|
|
Taxes on income (tax benefit)
|
|
|
-
|
|
|
|
(2,086
|
)
|
|
|
34,206
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) on discontinued operations
|
|
|
-
|
|
|
|
(6,149
|
)
|
|
|
118,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
143,291
|
|
|
$
|
116,920
|
|
|
$
|
258,831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share from continuing operations
|
|
$
|
2.37
|
|
|
$
|
2.06
|
|
|
$
|
2.36
|
|
Basic earnings per share from discontinued operations
|
|
$
|
-
|
|
|
$
|
(0.10
|
)
|
|
$
|
1.99
|
|
Basic earnings per share
|
|
$
|
2.37
|
|
|
$
|
1.96
|
|
|
$
|
4.35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share from continuing operations
|
|
$
|
2.31
|
|
|
$
|
2.02
|
|
|
$
|
2.29
|
|
Diluted earnings per share from discontinued operations
|
|
$
|
-
|
|
|
$
|
(0.10
|
)
|
|
$
|
1.93
|
|
Diluted earnings per share
|
|
$
|
2.31
|
|
|
$
|
1.92
|
|
|
$
|
4.22
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in computing:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share
|
|
|
60,444
|
|
|
|
59,667
|
|
|
|
59,552
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share
|
|
|
62,119
|
|
|
|
61,035
|
|
|
|
61,281
|
|
The accompanying notes are an integral part of the consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
U.S. dollars in thousands
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
143,291
|
|
|
$
|
116,920
|
|
|
$
|
258,831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in foreign currency translation adjustment
|
|
|
13,529
|
|
|
|
(24,801
|
)
|
|
|
(14,602
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in net unrealized gains (losses)
|
|
|
(854
|
)
|
|
|
5,102
|
|
|
|
(2,081
|
)
|
Less - reclassification adjustment for net gains realized and included in net income
|
|
|
-
|
|
|
|
(3,388
|
)
|
|
|
(32
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change (net of tax effect of $(113), $113 and ($338))
|
|
|
(854
|
)
|
|
|
1,714
|
|
|
|
(2,113
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized gains (losses)
|
|
|
6,821
|
|
|
|
600
|
|
|
|
(954
|
)
|
Less - reclassification adjustment for net gains (losses) realized and included in net income
|
|
|
(5,586
|
)
|
|
|
(132
|
)
|
|
|
4,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change
|
|
|
1,235
|
|
|
|
468
|
|
|
|
3,056
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
|
13,910
|
|
|
|
(22,619
|
)
|
|
|
(13,659
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
157,201
|
|
|
$
|
94,301
|
|
|
$
|
245,172
|
|
The accompanying notes are an integral part of the consolidated financial statements.
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
U.S. dollars in thousands
|
|
Share
capital
|
|
|
Additional
paid-in
capital
|
|
|
Treasury shares
|
|
|
Accumulated other comprehensive loss
|
|
|
Retained earnings
|
|
|
Total
shareholders'
equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2017
|
|
$
|
18,280
|
|
|
$
|
1,317,539
|
|
|
$
|
(488,573
|
)
|
|
$
|
(46,824
|
)
|
|
$
|
710,910
|
|
|
$
|
1,511,332
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of share options
|
|
|
315
|
|
|
|
17,133
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
17,448
|
|
Stock-based compensation
|
|
|
-
|
|
|
|
56,980
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
56,980
|
|
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units (147,347 ordinary shares)
|
|
|
-
|
|
|
|
(3,642
|
)
|
|
|
5,296
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,654
|
|
Equity components of exchangeable note
|
|
|
-
|
|
|
|
30,895
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
30,895
|
|
Treasury shares purchased
|
|
|
-
|
|
|
|
-
|
|
|
|
(24,428
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(24,428
|
)
|
Other comprehensive income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
13,910
|
|
|
|
-
|
|
|
|
13,910
|
|
Dividends paid ($ 0.16 per share)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(9,637
|
)
|
|
|
(9,637
|
)
|
Effect of adopting ASU 2016-09: Improvements to Employee Share-Based Payment Accounting (see note 2aa)
|
|
|
-
|
|
|
|
1,908
|
|
|
|
-
|
|
|
|
-
|
|
|
|
6,208
|
|
|
|
8,116
|
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
143,291
|
|
|
|
143,291
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2017
|
|
$
|
18,595
|
|
|
$
|
1,420,813
|
|
|
$
|
(507,705
|
)
|
|
$
|
(32,914
|
)
|
|
$
|
850,772
|
|
|
$
|
1,749,561
|
|
|
|
Share
capital
|
|
|
Additional
paid-in
capital
|
|
|
Treasury shares
|
|
|
Accumulated other comprehensive loss
|
|
|
Retained earnings
|
|
|
Total
shareholders'
equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2016
|
|
$
|
17,977
|
|
|
$
|
1,234,206
|
|
|
$
|
(445,021
|
)
|
|
$
|
(24,205
|
)
|
|
$
|
632,192
|
|
|
$
|
1,415,149
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of share options
|
|
|
303
|
|
|
|
23,321
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
23,624
|
|
Equity awards assumed for acquisitions
|
|
|
-
|
|
|
|
11,675
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
11,675
|
|
Stock-based compensation
|
|
|
-
|
|
|
|
40,547
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
40,547
|
|
Excess tax benefit from share-based payment arrangements
|
|
|
-
|
|
|
|
7,868
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
7,868
|
|
Issuance of treasury shares under stock purchase plans, upon exercise of options and vesting of restricted stock units (2,290 ordinary shares)
|
|
|
-
|
|
|
|
(78
|
)
|
|
|
78
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Treasury shares purchased
|
|
|
-
|
|
|
|
-
|
|
|
|
(43,630
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(43,630
|
)
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(22,619
|
)
|
|
|
-
|
|
|
|
(22,619
|
)
|
Dividends paid ($ 0.64 per share)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(38,202
|
)
|
|
|
(38,202
|
)
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
116,920
|
|
|
|
116,920
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2016
|
|
$
|
18,280
|
|
|
$
|
1,317,539
|
|
|
$
|
(488,573
|
)
|
|
$
|
(46,824
|
)
|
|
$
|
710,910
|
|
|
$
|
1,511,332
|
|
The accompanying notes are an integral part of the consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
U.S. dollars in thousands
|
|
Share
capital
|
|
|
Additional
paid-in
capital
|
|
|
Treasury shares
|
|
|
Accumulated other comprehensive loss
|
|
|
Retained earnings
|
|
|
Total
shareholders'
equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2015
|
|
$
|
17,615
|
|
|
$
|
1,171,424
|
|
|
$
|
(376,637
|
)
|
|
$
|
(10,546
|
)
|
|
$
|
411,600
|
|
|
$
|
1,213,456
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of share options
|
|
|
362
|
|
|
|
26,736
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
27,098
|
|
Stock-based compensation
|
|
|
-
|
|
|
|
28,451
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
28,451
|
|
Excess tax benefit from share-based payment arrangements
|
|
|
-
|
|
|
|
7,595
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
7,595
|
|
Treasury shares purchased
|
|
|
-
|
|
|
|
-
|
|
|
|
(68,384
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(68,384
|
)
|
Other comprehensive loss
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(13,659
|
)
|
|
|
-
|
|
|
|
(13,659
|
)
|
Dividends paid ($ 0.64 per share)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(38,239
|
)
|
|
|
(38,239
|
)
|
Net income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
258,831
|
|
|
|
258,831
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of December 31, 2015
|
|
$
|
17,977
|
|
|
$
|
1,234,206
|
|
|
$
|
(445,021
|
)
|
|
$
|
(24,205
|
)
|
|
$
|
632,192
|
|
|
$
|
1,415,149
|
|
The accompanying notes are an integral part of the consolidated financial statements.
CONSOLIDATED STATEMENTS OF
CASH FLOWS
U.S. dollars in thousands
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
143,291
|
|
|
$
|
116,920
|
|
|
$
|
258,831
|
|
Adjustments required to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
156,301
|
|
|
|
77,801
|
|
|
|
57,964
|
|
Stock-based compensation
|
|
|
56,980
|
|
|
|
40,547
|
|
|
|
28,451
|
|
Equity in losses of affiliated company
|
|
|
-
|
|
|
|
-
|
|
|
|
537
|
|
Accrued severance pay, net
|
|
|
(788
|
)
|
|
|
3
|
|
|
|
104
|
|
Amortization of premium and discount and accrued interest on marketable securities
|
|
|
646
|
|
|
|
2,441
|
|
|
|
2,799
|
|
Deferred taxes, net
|
|
|
(70,805
|
)
|
|
|
(25,905
|
)
|
|
|
10,576
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade receivables, net
|
|
|
37,735
|
|
|
|
(31,784
|
)
|
|
|
(56,363
|
)
|
Prepaid expenses and other current assets
|
|
|
(6,839
|
)
|
|
|
2,078
|
|
|
|
(1,482
|
)
|
Trade payables
|
|
|
2,665
|
|
|
|
4,392
|
|
|
|
2,166
|
|
Accrued expenses and other liabilities
|
|
|
25,541
|
|
|
|
17,994
|
|
|
|
38,488
|
|
Deferred revenues
|
|
|
41,624
|
|
|
|
9,379
|
|
|
|
54,914
|
|
Long term liabilities
|
|
|
(5,169
|
)
|
|
|
7,529
|
|
|
|
2,453
|
|
Loss (gain) on disposal of discontinued operations
|
|
|
-
|
|
|
|
9,148
|
|
|
|
(147,334
|
)
|
Realized gain on marketable securities
|
|
|
-
|
|
|
|
(3,388
|
)
|
|
|
(32
|
)
|
Amortization of discount on long-term debt
|
|
|
13,547
|
|
|
|
379
|
|
|
|
-
|
|
Other
|
|
|
(67
|
)
|
|
|
678
|
|
|
|
256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
394,662
|
|
|
|
228,212
|
|
|
|
252,328
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(39,889
|
)
|
|
|
(27,278
|
)
|
|
|
(16,596
|
)
|
Purchase of investments
|
|
|
(133,423
|
)
|
|
|
(47,221
|
)
|
|
|
(287,593
|
)
|
Proceeds from investments
|
|
|
64,295
|
|
|
|
449,880
|
|
|
|
92,542
|
|
Payments for business acquisitions, net of cash acquired
|
|
|
(76,027
|
)
|
|
|
(1,156,249
|
)
|
|
|
-
|
|
Investments in affiliates and other purchases
|
|
|
-
|
|
|
|
(1,500
|
)
|
|
|
(1,500
|
)
|
Capitalization of internal use software costs
|
|
|
(27,936
|
)
|
|
|
(8,502
|
)
|
|
|
(1,380
|
)
|
Proceeds (repayment) from sale of discontinued operations
|
|
|
-
|
|
|
|
(9,148
|
)
|
|
|
186,134
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(212,980
|
)
|
|
|
(800,018
|
)
|
|
|
(28,393
|
)
|
The accompanying notes are an integral part of the consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of shares upon exercise of options
|
|
|
19,240
|
|
|
|
23,525
|
|
|
|
27,532
|
|
Purchase of treasury shares
|
|
|
(24,428
|
)
|
|
|
(43,630
|
)
|
|
|
(68,384
|
)
|
Dividends paid
|
|
|
(9,637
|
)
|
|
|
(38,202
|
)
|
|
|
(38,239
|
)
|
Capital lease payments
|
|
|
(137
|
)
|
|
|
(1,087
|
)
|
|
|
-
|
|
Proceeds from issuance of debt, net of costs
|
|
|
-
|
|
|
|
464,841
|
|
|
|
-
|
|
Proceeds from issuance of exchangeable senior notes, net
|
|
|
260,135
|
|
|
|
-
|
|
|
|
-
|
|
Repayment of long-term debt
|
|
|
(260,000
|
)
|
|
|
-
|
|
|
|
-
|
|
Earn out payments related to acquisitions
|
|
|
-
|
|
|
|
-
|
|
|
|
(297
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
(14,827
|
)
|
|
|
405,447
|
|
|
|
(79,388
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash
|
|
|
4,421
|
|
|
|
(2,546
|
)
|
|
|
(6,113
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
171,276
|
|
|
|
(168,905
|
)
|
|
|
138,434
|
|
Cash and cash equivalents at the beginning of the year
|
|
|
157,026
|
|
|
|
325,931
|
|
|
|
187,497
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at the end of the year
|
|
$
|
328,302
|
|
|
$
|
157,026
|
|
|
$
|
325,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flows activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
33,029
|
|
|
$
|
28,396
|
|
|
$
|
53,646
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
7,910
|
|
|
$
|
2,201
|
|
|
$
|
107
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in other receivables with respect to exercise of share options
|
|
$
|
138
|
|
|
$
|
(99
|
)
|
|
$
|
434
|
|
The accompanying notes are an integral part of the consolidated financial statements.
a. General:
NICE Ltd. and its subsidiaries (the "Company") is a global enterprise software leader providing solutions for the Customer Engagement and Financial Crime & Compliance markets. The Company’s solutions use advanced omnichannel analytics and automation based on an open cloud platform to improve customer experience as well as prevent financial crime.
The Company’s core mission is to empower organizations to act smarter and respond faster both to provide superior customer service and to prevent financial crime. The Company’s software is used by customer service organizations of enterprises of all sizes and verticals and by compliance and fraud prevention groups in financial institutions.
With an integrated cloud platform and advanced analytics solutions, the Company helps organizations understand their customers, engage their employees and improve their processes. Additionally, the Company helps them predict needs and identify risks to create an exceptional customer experience, prevent fraud and ensure compliance. These capabilities are enhanced through the utilization of advanced automation and artificial intelligence capabilities.
|
1. |
Acquisition of inContact:
|
On November 14, 2016, the Company completed the acquisition of all of the outstanding shares of inContact, Inc. ("inContact"), a leading provider of cloud contact center software and agent optimization tools, for a total consideration of $1,050,054. The acquisition enables the Company to offer a fully integrated and complete cloud contact center where companies can interact with customers.
Upon acquisition, inContact became a wholly-owned subsidiary of the Company. The acquisition was accounted for as a business combination. This method requires, among other things, that assets acquired and liabilities assumed in the business combination be recognized at their fair values as of the acquisition date.
The following table summarizes the components of the purchase consideration transferred:
Cash (*)
|
|
$
|
1,039,028
|
|
Assumed options and restricted shares (**)
|
|
|
11,026
|
|
|
|
|
|
|
Total purchase consideration
|
|
$
|
1,050,054
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
|
(*) |
Includes cash consideration for the redemption of inContact's convertible bonds in an amount of $139,438 and for inContact's outstanding vested options and restricted shares as of acquisition date which were cancelled and converted into an amount of $25,366 in cash.
|
|
(**) |
Pursuant to the merger agreement, the Company assumed or replaced all outstanding unvested options, Restricted Stock Awards ("RSAs") and Restricted Stock Units (“RSUs”) and converted them or replaced them with the Company’s options, RSAs and RSUs, as applicable, based on an agreed exchange ratio. Each assumed or replaced option, RSA and RSU is subject to the same terms and conditions, including vesting, exercisability and expiration, as originally applied to any such option, RSA and RSU immediately prior to the acquisition of inContact.
|
Out of the total estimated fair value of the replacement award, a portion was allocated to the purchase consideration and the remainder was allocated to future services and will be expensed over the remaining service period on an accelerated basis as share-based compensation. The fair value of replacement award was determined using a Black-Scholes-Merton valuation model with the following assumptions: expected life of 12-74 months, risk-free interest rate of 0.58%-1.22%, expected volatility of 21.05%-25.92% and no dividend yield.
The following table summarizes the fair values of the assets acquired and liabilities assumed:
Cash
|
|
$
|
37,136
|
|
Short term investments
|
|
|
26,714
|
|
Trade receivables
|
|
|
40,667
|
|
Other receivables and prepaid expenses
|
|
|
10,235
|
|
Property and equipment
|
|
|
28,554
|
|
Identified intangibles
|
|
|
538,000
|
|
Goodwill
|
|
|
559,372
|
|
|
|
|
|
|
Total assets acquired
|
|
|
1,240,678
|
|
|
|
|
|
|
Trade payables
|
|
|
(16,337
|
)
|
Accrued expenses and other liabilities
|
|
|
(22,802
|
)
|
Deferred revenue
|
|
|
(3,967
|
)
|
Deferred tax liabilities, net
|
|
|
(147,518
|
)
|
|
|
|
|
|
Total liabilities assumed
|
|
|
(190,624
|
)
|
|
|
|
|
|
Net assets acquired
|
|
$
|
1,050,054
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
The following table presents details of the identified intangible assets acquired as of the date of the acquisition:
|
|
Fair
value
|
|
|
Estimated useful life
(in years)
|
|
|
|
|
|
|
|
|
Trademarks
|
|
$
|
36,400
|
|
|
2-8 |
|
Core technology
|
|
|
353,700
|
|
|
4-8 |
|
Customer relationships
|
|
|
147,900
|
|
|
5-7 |
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
538,000
|
|
|
|
|
|
Goodwill generated from this business combination is primarily attributable to synergies between the Company's and inContact's respective products and services. The goodwill is not deductible for income tax purposes.
inContact Inc. constituted approximately 4.2% of the Company's consolidated total assets as of December 31, 2016, and 1.2% attributed to the period from the date of acquisition of the Company's consolidated net income (excluding amortization of related acquired intangible assets) for the year then ended.
The following table presents the unaudited pro forma financial information for the years ended December 31, 2016 and 2015, as if the acquisition occurred on January 1, 2015:
|
|
Year ended December 31
|
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
1,237,329
|
|
|
$
|
1,142,018
|
|
Net income
|
|
$
|
31,195
|
|
|
$
|
139,123
|
|
The unaudited pro forma financial information for the years ended December 31, 2016 and 2015 has been calculated after adjusting the Company's results and those of inContact to reflect the business combination accounting effects resulting from this acquisition as if the acquisition occurred as of January 1, 2015, including: (i) acquisition related transaction costs; (ii) amortization expense from acquired intangible assets; (iii) post acquisition share-based compensation expense; (iv) debt financing costs incurred for the issuance of a loan received as part of the acquisition financing; and (v) the associated tax effect of these unaudited pro forma adjustments. The pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of 2015.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
The fair value of assets acquired and liabilities assumed from the acquisition of inContact was based on a preliminary valuation which has been finalized during 2017 as part of the measurement period (please refer also to note 8). In accordance with ASU 2015-16, measurement period adjustments determined to be material will be recognized in the period in which the Company determines the amounts, including the effect on earnings of any amounts it would have recorded in previous periods if the accounting had been completed at the acquisition date.
2. Acquisition of Nexidia:
On March 22, 2016, the Company completed the acquisition of Nexidia Inc. ("Nexidia"), a provider of advanced customer analytics. The Company acquired Nexidia for a total consideration of $135,150. The acquisition of Nexidia allows the Company to offer a combined offering, featuring analytics capabilities with accuracy, scalability and performance, enabling organizations to expand their analytics usage in critical business use cases.
Upon acquisition, Nexidia became a wholly-owned subsidiary of the Company. The acquisition was accounted for as a business combination. This method requires, among other things, that assets acquired and liabilities assumed in the business combination be recognized at their fair values as of the acquisition date.
The following table summarizes the components of the purchase consideration transferred:
Cash
|
|
$
|
134,501
|
|
Assumed options
|
|
|
649
|
|
|
|
|
|
|
Total purchase consideration
|
|
$
|
135,150
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
The following table summarizes the fair values of the assets acquired and liabilities assumed:
Cash (net of loan payoff amount)
|
|
$
|
1,879
|
|
Trade receivables
|
|
|
8,300
|
|
Other receivables and prepaid expenses
|
|
|
4,892
|
|
Property and equipment
|
|
|
2,774
|
|
Identified intangibles
|
|
|
63,400
|
|
Goodwill
|
|
|
75,647
|
|
|
|
|
|
|
Total assets acquired
|
|
|
156,892
|
|
|
|
|
|
|
Trade payables
|
|
|
(1,556
|
)
|
Accrued expenses and other liabilities
|
|
|
(6,371
|
)
|
Deferred revenue
|
|
|
(9,341
|
)
|
Deferred tax liabilities, net
|
|
|
(4,474
|
)
|
|
|
|
|
|
Total liabilities assumed
|
|
|
(21,742
|
)
|
|
|
|
|
|
Net assets acquired
|
|
$
|
135,150
|
|
The following table presents details of the identified intangible assets acquired as of the date of the acquisition:
|
|
Fair
value
|
|
|
Estimated useful life
(in years)
|
|
|
|
|
|
|
|
|
Trademarks
|
|
$
|
7,500
|
|
|
12
|
|
Technology
|
|
|
17,400
|
|
|
5
|
|
Customer backlog
|
|
|
10,900
|
|
|
1 |
|
Customer relationships
|
|
|
27,600
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
Total intangible assets
|
|
$
|
63,400
|
|
|
|
|
|
Goodwill generated from this business combination is primarily attributable to synergies between the Company's and Nexidia's respective products and services. The goodwill is not deductible for income tax purposes.
The results of Nexidia operations have been included in the consolidated statements of income since March 22, 2016. Pro forma results of operations related to this acquisition have not been prepared because they are not material to the Company's consolidated statements of income.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
3. Acquisition of VPI:
On March 11, 2016, the Company completed the acquisition of Voiceprint International, Inc. ("VPI"), a provider of workforce optimization software and services for enterprises, contact centers, first responders and trading floors. The Company acquired VPI for total consideration of $21,720 in cash.
Upon acquisition, VPI became a wholly-owned subsidiary of the Company. The acquisition was accounted for as a business combination. This method requires, among other things, that assets acquired and liabilities assumed in a business combination be recognized at their fair values as of the acquisition date. The Company recorded customer relationships and goodwill in amount of $8,500 and $16,873, respectively. The estimated useful life of the customer relationships is 6 years.
Goodwill generated from this business combination is attributed to synergies between the Company's and VPI's respective products and services. The goodwill is not deductible for income tax purposes.
The results of VPI operations have been included in the consolidated financial statements since March 11, 2016. Pro forma results of operations related to this acquisition have not been prepared because they are not material to the Company's consolidated statement of income.
4. Acquisitions in 2017:
During 2017 the Company acquired certain companies. These acquisitions were not individually or in aggregate significant. The financial results of the acquired companies are included in the Company’s consolidated financial statements from their respective acquisition dates, and the results from each of these companies were not individually material to the Company’s consolidated financial statements. In the aggregate, the total preliminary purchase price for these acquisitions was approximately $76,870 in cash. The Company preliminarily recorded $2,291 of net tangible liabilities and $51,015 of identifiable intangible assets, based on their estimated fair values, and $28,145 of residual goodwill. The preliminary fair value estimates for the assets acquired and liabilities assumed for these acquisitions completed during 2017 were based upon preliminary calculations and valuations, and the estimates and assumptions for these acquisitions are subject to change as the Company obtains additional information during the respective measurement periods (up to one year from the respective acquisition dates).
During 2017 and 2016 acquisition related costs amounted to $970 and $9,348 respectively, and were included in general and administrative expenses. During 2015, the Company did not record any acquisition related costs.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
|
c. |
Discontinued operations:
|
During 2015, the Company divested its Physical Security as well as its Cyber and Intelligence operations, which were a major part of the Security Solutions segment, to allow it to focus on its core markets as part of the execution of its long-term strategy.
In July 2015 the Company completed the sale of the Cyber and Intelligence operation to Elbit Systems for a total consideration of $151,583, comprised of $111,583 in cash and $40,000 earn out based on future business performance conditions, which were not met.
The Cyber and Intelligence operation offers solutions which provide law enforcement agencies, intelligence organizations and signal intelligence agencies with tools for generating intelligence from communications. The sale resulted in a capital gain of $101,847, which was presented as part of the net income on discontinued operations in the consolidated statements of income for the year ended December 31, 2015.
On September 18, 2015, the Company completed the sale of the Physical Security operation to Battery Ventures for a total consideration of $92,475, comprised of $74,551 in cash, note receivable of $2,924 and up to $15,000 earn out based on future business performance. The Physical Security operation provides video surveillance technologies and capabilities to security-aware organizations.
The sale resulted in a gain of $45,487, which was presented as part of the net income on discontinued operations in the consolidated statements of income for the year ended December 31, 2015. The carrying amount used in determining the gain on disposal of the operations included goodwill in the amount of $35,554. The amount of goodwill that was included in that carrying amount was based on the relative fair values of the disposed operations and the portion of the operation that was retained within the segment.
Following the divestiture of one of the discontinued operations, the buyer made certain claims in relation to the transaction in accordance with the procedures set in the acquisition agreement between the parties. During 2016, the parties reached a settlement agreement which resulted in a reduction of the gain on disposal of discontinued operations recorded in discontinued operations. Refer to Note 11c for further details.
Following the sale, Physical Security's and Intelligence's results of operations and statement of financial position balances are disclosed as a discontinued operation, including the resulting gain from sales. All prior periods' comparable results of operation, assets and liabilities have been retroactively included in discontinued operations.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
The results of the discontinued operations including prior periods' comparable results, assets and liabilities which have been retroactively included in discontinued operations as separate line items in the statements of income and balance sheets are presented below:
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
(*)2015
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
68,672
|
|
Cost of sales
|
|
|
-
|
|
|
|
-
|
|
|
|
26,956
|
|
Operating expenses
|
|
|
-
|
|
|
|
850
|
|
|
|
36,307
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
-
|
|
|
|
(850
|
)
|
|
|
5,409
|
|
Other income (expenses), net
|
|
|
-
|
|
|
|
1,763
|
|
|
|
(284
|
)
|
Gain (loss) on disposal of the discontinued operations
|
|
|
-
|
|
|
|
(9,148
|
)
|
|
|
147,334
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before taxes on income
|
|
|
-
|
|
|
|
(8,235
|
)
|
|
|
152,459
|
|
Taxes on income (tax benefit)
|
|
|
-
|
|
|
|
(2,086
|
)
|
|
|
34,206
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) on discontinued operations
|
|
$
|
-
|
|
|
$
|
(6,149
|
)
|
|
$
|
118,253
|
|
(*) Represent the results of the discontinued operations until their disposal.
Depreciation expense totaled $0, $0 and $724 for the years 2017, 2016 and 2015, respectively.
Amortization expense totaled $0, $0 and $4,362 for the years 2017, 2016 and 2015, respectively.
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES
|
The consolidated financial statements were prepared in accordance with United States Generally Accepted Accounting Principles ("U.S. GAAP").
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
|
b. |
Financial statements in United States dollars:
|
The currency of the primary economic environment in which the operations of NICE Ltd. and certain subsidiaries are conducted is the U.S. dollar ("dollar"); thus, the dollar is the functional currency of NICE Ltd. and certain subsidiaries.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
NICE Ltd. and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been remeasured to dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income as financial income or expenses, as appropriate.
For those subsidiaries whose functional currency has been determined to be a non-dollar currency, assets and liabilities are translated at year-end exchange rates and statement of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity.
|
c. |
Principles of consolidation:
|
Intercompany transactions and balances have been eliminated upon consolidation.
Cash equivalents are short-term unrestricted highly liquid investments that are readily convertible into cash, with original maturities of three months or less at acquisition.
|
e. |
Marketable securities:
|
The Company accounts for investments in debt securities in accordance with ASC 320, "Investments - Debt and Equity Securities". Management determines the appropriate classification of its investments in debt securities at the time of purchase and re-evaluates such determinations at each balance sheet date.
Marketable securities classified as "available-for-sale" are carried at fair value, based on quoted market prices. Unrealized gains and losses are reported in a separate component of shareholders' equity in accumulated other comprehensive income (loss). Gains and losses are recognized when realized, on a specific identification basis, in the Company's consolidated statements of income.
The Company's securities are reviewed for impairment in accordance with ASC 320-10-35. If such assets are considered to be impaired, the impairment charge is recognized in earnings when a decline in the fair value of its investments below the cost basis is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company's intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. For securities with an unrealized loss that the Company intends to sell, or it is more likely than not that the Company will be required to sell before recovery of their amortized cost basis, the entire difference between amortized cost and fair value is recognized in earnings. For securities that do not meet these criteria, the amount of impairment recognized in earnings is limited to the amount related to credit losses, while declines in fair value related to other factors are recognized in accumulated other comprehensive income (loss).
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
f. |
Property and equipment, net:
|
Property and equipment are stated at cost, net of accumulated depreciation.
Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:
|
%
|
|
|
Computers and peripheral equipment
|
20 - 33
|
Office furniture and equipment
|
7 - 20
|
Internal use software
|
33
|
Leasehold improvements are amortized by the straight-line method over the term of the lease or the estimated useful life of the improvements, whichever is shorter.
|
g. |
Internal use software costs:
|
The Company capitalizes development costs incurred during the application development stage which are related to internal use technology that supports its cloud services. Under ASC350-40, Internal-Use Software is included in property and equipment, net in the consolidated balance sheets. Capitalization of such costs begins when the preliminary project stage is complete and ceases at the point in which the project is substantially complete and is ready for its intended purpose. Costs incurred in the process of software production are charged to expenses as incurred.
|
h. |
Other intangible assets, net:
|
Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual rates ranges:
|
%
|
|
|
Core technology
|
12.5 - 50
|
Customer relationships
|
14.7 - 33.3
|
Trademarks
|
12.5 - 50
|
Customer backlog
|
50 - 100
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
i. |
Impairment of long-lived assets:
|
The Company's long-lived assets and identifiable intangibles that are subject to amortization are reviewed for impairment in accordance with ASC 360, "Property, Plant, and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include any significant changes in the manner of the Company's use of the assets and significant negative industry or economic trends.
Upon determination that the carrying value of a long-lived asset may not be recoverable based upon a comparison of aggregate undiscounted projected future cash flows to the carrying amount of the asset, an impairment charge is recorded for the excess of the carrying amount over fair value. In 2017, 2016 and 2015, no impairment charge was recognized.
Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, "Intangible - Goodwill and Other," ("ASC 350") goodwill is not amortized, but rather is subject to an annual impairment test.
ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value.
ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the two-step impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test.
During the fourth quarter of each of the years presented, the Company performed a qualitative assessment for its reporting units and concluded that the qualitative assessment did not result in a more likely than not indication of impairment, and therefore no further impairment testing was required. Accordingly, during the years 2017, 2016 and 2015, no impairment charge was recognized.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
k. |
Exchangeable senior notes:
|
The Company applies ASC 815 “Derivative and Hedging” (“ASC 815”) and ASC 470 “Debt (“ASC 470”). Under these standards, the Company separately accounts for the liability and equity components of convertible debt instruments that may be settled in cash in a manner that reflects the Company’s nonconvertible debt borrowing rate. The liability component at issuance is recognized at fair value, based on the fair value of a similar instrument that does not have a conversion feature. The equity component is based on the excess of the principal amount of the debentures over the fair value of the liability component, after adjusting for an allocation of debt issuance costs, and is recorded as capital in excess of par. Debt discounts are amortized as additional non-cash interest expense over the expected life of the debt.
The Company generates revenues from sales of software products, services and cloud, which include software license, SaaS and network connectivity, hosting, support and maintenance, implementation, configuration, project management, consulting, training, as well as hardware sales. The Company sells its products directly through its sales force and indirectly through a global network of distributors, system integrators and strategic partners, all of whom are considered end-users.
The basis for the Company's software revenue recognition is substantially governed by the accounting guidance contained in ASC 985-605, "Software-Revenue Recognition". Revenues from sales of software products are recognized when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable and collectability is probable. Revenues from maintenance and professional services are recognized ratably over the contractual period and as services are performed, respectively. In transactions where a customer's contractual terms include a provision for customer acceptance, revenues are recognized either when such acceptance has been obtained or as the acceptance provision has lapsed.
For multiple element arrangements within the scope of software revenue recognition guidance, revenues are allocated to the different elements in the arrangement under the "residual method" when Vendor Specific Objective Evidence ("VSOE") of fair value exists for all undelivered elements and no VSOE exists for the delivered elements. Under the residual method, the Company defers revenue for the fair value of its undelivered elements and recognizes revenue for the remainder of the arrangement fee attributable to the elements initially delivered in the arrangement when the basic criteria in ASC 985-605 have been met. Any discount in the arrangement is allocated to the delivered elements.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
For arrangements that contain both software and non-software components that function together to deliver the products' essential functionality, the Company allocates revenue to each element based on its relative selling price. In such circumstances, the accounting principles establish a hierarchy to determine the selling price to be used for allocating revenue to deliverables. The selling price for a deliverable is based on its VSOE, if available, third party evidence ("TPE"), if VSOE is not available, or best estimated selling price ("BESP"), if neither VSOE nor TPE are available.
The Company establishes VSOE of fair value using the price charged for a deliverable when sold separately. When VSOE cannot be established, the Company attempts to establish fair value of each element based on TPE. TPE is determined based on competitor prices for similar deliverables when sold separately. Generally, the Company's go-to-market strategy differs from that of its peers and the Company's offerings contain a significant level of differentiation such that the comparable pricing of products with similar functionality cannot be obtained. Furthermore, the Company is unable to reliably determine what similar competitor products' selling prices are on a standalone basis. Therefore, the Company is typically not able to determine TPE. The BESP price is established considering several external and internal factors including, but not limited to, historical sales, pricing practices and geographies in which the Company offers its products. The determination of the BESP is subject to discretion.
The Company's policy for establishing VSOE of fair value of maintenance services is based on the price charged when the maintenance is renewed separately. Establishment of VSOE of fair value of professional services is based on the price charged when these services are sold separately.
Revenues from fixed price contracts that require significant customization, integration and installation are recognized based on ASC 605-35, "Construction-Type and Production-Type Contracts", using the percentage-of-completion method of accounting based on the ratio of costs related to contract performance incurred to date to the total estimated amount of such costs. The amount of revenue recognized is based on the total fees under the arrangement and the percentage of completion achieved. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are first determined, in the amount of the estimated loss on the entire contact.
The Company's SaaS offerings provide customers access to certain of its software within a cloud-based IT environment on a subscription basis, and may also include network connectivity services over Company's network or through third party network connectivity providers on a usage basis. Because such offerings do not grant customers the right to take possession of the software, the Company considers these arrangements to be service contracts which are not within the scope of ASC 985-605. In addition, the Company also derives revenue from professional services included in implementing or improving a customer's cloud software solutions experience.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (Cont.)
Revenues for SaaS offerings are recognized ratably over the contract term or based on actual usage, commencing with the date the service is made available to customers and all other revenue recognition criteria have been satisfied. Revenue from the network connectivity usage is derived based on customer specific rate plans and call usage and is recognized in the period the call is initiated. Upfront fees related to professional services that are not considered to have standalone value are deferred and recognized over the estimated life of the customer.
To assess the probability of collection for revenue recognition, the Company has a credit policy that determines the credit limit that reflects an amount that is deemed probably collectible for each customer. These credit limits are reviewed and revised periodically on the basis of new customer financial statements information, credit insurance data and payment performance.
The Company maintains a provision for product returns and other contractual rights which are estimated based on the Company's past experience and are deducted from revenues.
Deferred revenues and advances from customers include payments received from customers, for which revenue has not yet been recognized.
|
m. |
Research and development costs:
|
Research and development costs (net of grants and capitalized expenses) incurred in the process of software production are charged to expenses as incurred.
The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This topic prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. Deferred tax assets and deferred tax liabilities are presented under long-term assets and long-term liabilities, respectively.
The Company implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
The Company classifies interest and penalties on income taxes (which includes uncertain tax positions) as taxes on income.
Non-royalty bearing grants from the Government of Israel and the European Union for funding research and development projects are recognized at the time the Company is entitled to such grants on the basis of the related costs incurred and recorded as a deduction from research and development expenses.
|
p. |
Concentrations of credit risk:
|
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, trade receivables, marketable securities and foreign currency derivative contracts.
The Company's cash and cash equivalents are invested in deposits mainly in dollars with major international banks. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.
The Company's trade receivables are derived from sales to customers located primarily in North America, and in EMEA and APAC. The Company performs ongoing credit evaluations of its customers and insures certain of its receivables with a credit insurance company. A general allowance for doubtful accounts is provided, based on the length of time the receivables are past due.
The Company's marketable securities include investment in corporate debentures and U.S. Treasuries. The Company's investment policy limits the amount that the Company may invest in any one type of investment or issuer, thereby reducing credit risk concentrations.
The Company entered into foreign currency forward and option contracts intended to protect cash flows resulting from payroll and facilities related expenses against the volatility in value of forecasted non-dollar currency. The derivative instruments hedge a portion of the Company's non-dollar currency exposure. See Note 10.
Israeli Severance Pay Law-1963 generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain circumstances. The Company makes ongoing deposits into Israeli employees’ pension plans to fund their severance liabilities. According to Section 14 of the Severance Pay Law, the Company deposits for employees employed by the Company since May 1, 2009 are made in lieu of the Company’s severance liability; therefore no obligation is provided for in the financial statements. Severance pay liabilities for employees employed by the Company prior to May 1, 2009, as well as employees with special contractual arrangements, are provided for in the financial statements based upon the latest monthly salary multiplied by the number of years of employment.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
Severance pay expense for 2017, 2016 and 2015 amounted to $9,862, $9,970 and $8,936, respectively.
The Company also has other liabilities for severance pay in other jurisdictions.
The Company provides 401(K) defined contribution plan for the benefit of certain employees in the U.S. Under this plan, contributions are based on specified percentages of pay. In the years 2017, 2016 and 2015, the Company recorded an expense for matching contributions in the amount of $7,044, $3,930 and $4,310, respectively.
|
r. |
Basic and diluted net earnings per share:
|
Basic net earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted net earnings per share are computed based on the weighted average number of ordinary shares outstanding during each year plus dilutive potential equivalent ordinary shares considered outstanding during the year, in accordance with ASC 260, "Earnings per Share".
As the Company’s intention and ability is to settle the convertible debt in cash, the potential issuance of shares related to the convertible debt does not affect diluted shares.
As further described in Note 14, the Company entered into an exchangeable note hedge transaction and warrants transaction. The exchangeable note hedge transaction and the warrants transaction are anti-dilutive and as such are not included in the computation of diluted earnings per share. The number of shares related to outstanding exchangeable note hedge transaction and warrants transaction are 3,457,475 and 3,457,475, respectively.
The weighted average number of shares related to outstanding anti-dilutive options excluded from the calculations of diluted net earnings per share was 249,274, 398,544 and 561,621 for the years 2017, 2016 and 2015, respectively.
|
s. |
Accounting for stock-based compensation:
|
The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation - Stock Compensation" ("ASC 718"), which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to employees and directors. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model.
The Company recognizes compensation expenses for the value of its awards, which have graded vesting, based on the accelerated attribution method over the requisite service period of each of the awards.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model, which requires a number of assumptions: the expected volatility is based upon actual historical stock price movements; the expected term of options granted is based upon historical experience and represents the period of time that options granted are expected to be outstanding; the risk-free interest rate is based on the yield from U.S. Federal Reserve zero-coupon bonds with an equivalent term; and the expected dividend rate (an annualized dividend yield) is based on the per share dividend declared by the Company's Board of Directors. For information on the Company's dividend payments, see Note 13d.
The Company measures the fair value of restricted stock based on the market value of the underlying shares at the date of grant.
|
t. |
Fair value of financial instruments:
|
The Company applies ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"). Under this standard, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date. The Company measures its investments in money market funds classified as cash equivalents, marketable securities and its foreign currency derivative contracts at fair value.
In determining fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.
The hierarchy is broken down into three levels based on the inputs as follows:
|
· |
Level 1 - Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
|
|
· |
Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.
|
|
· |
Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
The availability of observable inputs can vary from investment to investment and is affected by a wide variety of factors, including, for example, the type of investment, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment and the investments are categorized as Level 3.
The Company's marketable securities and foreign currency derivative contracts are classified within Level 2 (see Notes 3 and 10).
The carrying amounts of cash and cash equivalents, short-term bank deposits, trade receivables and trade payables, approximate their fair value due to the immediate or short-term maturities of these financial instruments. The carrying amount of the long term loan approximates its fair value due to the fact the loan bears a variable interest rate.
The Company is currently involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss.
Advertising expenses are charged to expense as incurred. Advertising expenses for the years 2017, 2016 and 2015 were $13,543, $9,693 and $7,986, respectively.
The Company repurchases its ordinary shares from time to time on the open market or in other transactions and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a reduction of shareholders' equity. The Company reissues treasury shares under the stock purchase plan, upon exercise of options and upon vesting of RSUs. Reissuance of treasury shares is accounted for in accordance with ASC 505-30 whereby gains are credited to additional paid-in capital and losses are charged to additional paid-in capital to the extent that previous net gains are included therein; otherwise to retained earnings.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
The Company applies the provisions of ASC 805, "Business Combination" and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from customer relationships, acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.
The Company accounts for comprehensive income in accordance with ASC 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments and unrealized gains and losses on available for sale marketable securities and changes in foreign currency translation adjustments.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
The following tables show the components of accumulated other comprehensive income, net of taxes, as of December 31, 2017 and 2016:
|
|
Year ended December 31, 2017
|
|
|
|
Unrealized losses on marketable securities
|
|
|
Unrealized gains (losses) on cash flow hedges
|
|
|
Foreign currency translation adjustment
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance
|
|
$
|
(216
|
)
|
|
$
|
(101
|
)
|
|
$
|
(46,507
|
)
|
|
$
|
(46,824
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) before reclassifications
|
|
|
(854
|
)
|
|
|
6,821
|
|
|
|
13,529
|
|
|
|
19,496
|
|
Amounts reclassified from accumulated other comprehensive income
|
|
|
-
|
|
|
|
(5,586
|
)
|
|
|
-
|
|
|
|
(5,586
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net current-period other comprehensive income (loss)
|
|
|
(854
|
)
|
|
|
1,235
|
|
|
|
13,529
|
|
|
|
13,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
(1,070
|
)
|
|
$
|
1,134
|
|
|
$
|
(32,978
|
)
|
|
$
|
(32,914
|
)
|
|
|
Year ended December 31, 2016
|
|
|
|
Unrealized gains (losses) on marketable securities
|
|
|
Unrealized gains (losses) on cash flow hedges
|
|
|
Foreign currency translation adjustment
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance
|
|
$
|
(1,930
|
)
|
|
$
|
(569
|
)
|
|
$
|
(21,706
|
)
|
|
$
|
(24,205
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss) before reclassifications
|
|
|
5,102
|
|
|
|
600
|
|
|
|
(24,801
|
)
|
|
|
(19,099
|
)
|
Amounts reclassified from accumulated other comprehensive income
|
|
|
(3,388
|
)
|
|
|
(132
|
)
|
|
|
-
|
|
|
|
(3,520
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net current-period other comprehensive income (loss)
|
|
|
1,714
|
|
|
|
468
|
|
|
|
(24,801
|
)
|
|
|
(22,619
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance
|
|
$
|
(216
|
)
|
|
$
|
(101
|
)
|
|
$
|
(46,507
|
)
|
|
$
|
(46,824
|
)
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
|
z. |
Recently adopted accounting standards:
|
In March 2016, the FASB issued ASU 2016-09, "Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting" ("ASU 2016-09"), which simplified certain aspects of the accounting for share-based payment transactions, including income taxes, classification of awards and classification in the statement of cash flows. ASU 2016-09 became effective for the Company beginning the first quarter of 2017, at which time it changed its accounting policy to account for forfeitures as they occur. The change was applied on a modified retrospective basis with a cumulative effect adjustment to retained earnings of $6,208 as of January 1, 2017. In addition, historically, excess tax benefits or deficiencies from the Company’s equity awards were recorded as additional paid-in capital in its consolidated balance sheets and were classified as a financing activity in its consolidated statements of cash flows. As a result of the adoption, the Company will prospectively record any excess tax benefits or deficiencies from its equity awards as part of its provision for income taxes in its consolidated statements of operations in the reporting periods in which equity vesting occurs. Excess tax benefits for share-based payments are now presented as an operating activity in the statements of cash flows rather than financing activity. The Company elected to apply the cash flow classification requirements related to excess tax benefits retrospectively to all periods presented, which resulted in an increase to cash generated by operating activities and in a decrease to cash generated by financing activities in the consolidated statements of Cash Flows of $7,868 and $7,595 for the years ended December 31, 2016 and December 31, 2015, respectively.
|
aa. |
Recently issued accounting standards, not yet adopted:
|
In May 2014, the FASB issued Accounting Standards Update 2014-09 ("ASU 2014-09") "Revenue from Contracts with Customers (Topic 606)". ASU 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)", and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. Subsequently, the FASB issued several additional ASUs related to ASU. 2014-09, collectively they are referred to as the “new revenue standards,” which become effective for the Company beginning January 1, 2018. The Company has adopted the new revenue standards using the modified retrospective transition method.
The Company estimated its analysis of all potential impacts of the new revenue standards. The impacts mainly relate to arrangements that include term-based software licenses, allocation of transaction price to each performance obligation on a relative standalone selling price and capitalization of costs related to obtaining customer contracts. Based on work performed to date, on January 1, 2018 the Company expects to record a cumulative-effect of approximately $39 million attributed to Deferred Revenues and approximately $45 million attributed to costs related to obtaining customer contracts. These amounts will be recorded as adjustment to retained earnings. The impact derives from arrangements that based on "Revenue Recognition (Topic 605)" were to be recognized in future years during 2018 to 2022.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
In January 2016, the FASB issued ASU 2016-01, "Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities" ("ASU 2016-01"), which updates certain aspects of recognition, measurement, presentation and disclosure of financial instruments. ASU 2016-01 will be effective for the Company for interim and annual periods beginning on or after January 1, 2018. The Company expects no material impact on its consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, "Leases" ("ASU 2016-02"). The updated standard aims to increase transparency and comparability among organizations by requiring lessees to recognize lease assets and lease liabilities on the balance sheet and requiring disclosure of key information about leasing arrangements. This update is effective for annual periods beginning after December 15, 2018, and interim periods within those annual periods; early adoption is permitted and modified retrospective application is required. The Company is currently evaluating the impact of adopting ASU 2016-02 on its consolidated financial statements.
In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments." The guidance addresses the classification of cash flow related to (1) debt prepayment or extinguishment costs, (2) settlement of zero-coupon debt instruments or other debt instruments with coupon rates that are insignificant in relation to the effective interest rate of the borrowing, (3) contingent consideration payments made after a business combination, (4) proceeds from the settlement of insurance claims, (5) proceeds from the settlement of corporate-owned life insurance, including bank-owned life insurance, (6) distributions received from equity method investees and (7) beneficial interests in securitization transactions. The guidance also clarifies how the predominance principle should be applied when cash receipts and cash payments have aspects of more than one class of cash flows. The guidance will generally be applied retrospectively and is effective for financial statements issued for annual reporting periods beginning after December 15, 2017. The Company expects no material impact on its statement of cash flows upon adoption.
In October 2016, the FASB issued Accounting Standards Update 2016-16, "Income Taxes (Topic 740): Intra-Entity Transfers Other than Inventory" ("ASU 2016-16"), which requires companies to recognize the income-tax consequences of an intra-entity transfer of an asset other than inventory. ASU 2016-16 will be effective for the Company for interim and annual periods beginning after December 15, 2017. The Company expects no material impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 "Intangibles - Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment" ("ASU 2017-04"). ASU 2017-04 eliminates step 2 of the goodwill impairment test, which requires the calculation of the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Instead, an entity will compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The Company is currently evaluating the effect that this guidance will have on its consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 2:- |
SIGNIFICANT ACCOUNTING POLICIES (Cont.)
|
In January 2017, the FASB issued ASU 2017-01 "Business Combinations (Topic 805): Clarifying the Definition of a Business" ("ASU 2017-01"), which provides guidance to evaluate whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. If substantially all of the fair value of the gross assets acquired (or disposed of) is concentrated in a single asset or a group of similar assets, the assets acquired (or disposed of) are not considered a business. ASU 2017-01 is effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those periods. The Company expects no material impact on its consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, "Financial Instruments - Credit Losses (Topic 326)" ("ASU 2016-13"). The amendments in this update require a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The amendments broaden the information that an entity must consider in developing its expected credit loss estimate for assets measured either collectively or individually. The use of forecasted information incorporates more timely information in the estimate of expected credit loss, which will be of greater use to users of the financial statements. ASU 2016-13 is effective for the Company for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is allowed as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is still evaluating the effect that this guidance will have on the Company’s consolidated financial statements.
In August 2017, the FASB issued ASU 2017-12, "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities". The objectives of this ASU are to improve the financial reporting of hedging relationships to better portray the economic results of an entity's risk management activities in its financial statements and to make certain targeted improvements to simplify the application of the hedge accounting guidance in current GAAP. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. The Company is currently evaluating the effect that this guidance will have on its consolidated financial statements.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 3:- |
SHORT-TERM AND LONG-TERM INVESTMENTS
|
Short-term and long-term investments include marketable securities in the amount of $196,771 and $129,013 as of December 31, 2017 and 2016, respectively.
The following table summarizes amortized costs, gross unrealized gains and losses and estimated fair values of available-for-sale marketable securities as of December 31, 2017 and 2016:
|
|
Amortized cost
|
|
|
Gross unrealized gains
|
|
|
Gross unrealized losses
|
|
|
Estimated fair value (Level 2 within the fair value hierarchy)
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debentures
|
|
$
|
189,836
|
|
|
$
|
122,335
|
|
|
$
|
9
|
|
|
$
|
91
|
|
|
$
|
908
|
|
|
$
|
225
|
|
|
$
|
188,937
|
|
|
$
|
122,201
|
|
U.S. Treasuries
|
|
|
7,007
|
|
|
|
7,008
|
|
|
|
-
|
|
|
|
-
|
|
|
|
170
|
|
|
|
196
|
|
|
|
6,837
|
|
|
|
6,812
|
|
U.S. Government Agencies
|
|
|
998
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1
|
|
|
|
-
|
|
|
|
997
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
197,841
|
|
|
$
|
129,343
|
|
|
$
|
9
|
|
|
$
|
91
|
|
|
$
|
1,079
|
|
|
$
|
421
|
|
|
$
|
196,771
|
|
|
$
|
129,013
|
|
The scheduled maturities of available-for-sale marketable securities as of December 31, 2017 were as follows:
|
|
Amortized
|
|
|
Estimated
|
|
|
|
cost
|
|
|
fair value
|
|
|
|
|
|
|
|
|
Due within one year
|
|
$
|
64,055
|
|
|
$
|
63,951
|
|
Due after one year through five years
|
|
|
133,786
|
|
|
|
132,820
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
197,841
|
|
|
$
|
196,771
|
|
Investments with continuous unrealized losses for less than 12 months and 12 months or greater and their related fair values as of December 31, 2017 and 2016 were as indicated in the following tables:
|
|
December 31, 2017
|
|
|
|
Investments with continuous unrealized losses for less than 12 months
|
|
|
Investments with continuous unrealized losses for 12 months or greater
|
|
|
Total Investments with continuous unrealized losses
|
|
|
|
Fair
value
|
|
|
Unrealized losses
|
|
|
Fair
value
|
|
|
Unrealized losses
|
|
|
Fair
value
|
|
|
Unrealized losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debentures
|
|
$
|
135,252
|
|
|
$
|
(711
|
)
|
|
$
|
49,076
|
|
|
$
|
(198
|
)
|
|
$
|
184,328
|
|
|
$
|
(909
|
)
|
U.S. treasuries
|
|
|
-
|
|
|
|
-
|
|
|
|
6,837
|
|
|
|
(170
|
)
|
|
|
6,837
|
|
|
|
(170
|
)
|
U.S. Government agencies
|
|
|
997
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
997
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
136,249
|
|
|
$
|
(711
|
)
|
|
$
|
55,913
|
|
|
$
|
(368
|
)
|
|
$
|
192,162
|
|
|
$
|
(1,079
|
)
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 3:- |
SHORT-TERM AND LONG-TERM INVESTMENTS (Cont.)
|
|
|
December 31, 2016
|
|
|
|
Investments with continuous unrealized losses for less than 12 months
|
|
|
Investments with continuous unrealized losses for 12 months or greater
|
|
|
Total Investments with continuous unrealized losses
|
|
|
|
Fair
value
|
|
|
Unrealized losses
|
|
|
Fair
value
|
|
|
Unrealized losses
|
|
|
Fair
value
|
|
|
Unrealized losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debentures
|
|
$
|
19,444
|
|
|
$
|
(137
|
)
|
|
$
|
56,799
|
|
|
$
|
(88
|
)
|
|
$
|
76,243
|
|
|
$
|
(225
|
)
|
U.S. treasuries
|
|
|
-
|
|
|
|
-
|
|
|
|
6,812
|
|
|
|
(196
|
)
|
|
|
6,812
|
|
|
|
(196
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
19,444
|
|
|
$
|
(137
|
)
|
|
$
|
63,611
|
|
|
$
|
(284
|
)
|
|
$
|
83,055
|
|
|
$
|
(421
|
)
|
NOTE 4:- |
PREPAID EXPENSES AND OTHER CURRENT ASSETS
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Government authorities
|
|
$
|
26,275
|
|
|
$
|
23,312
|
|
Interest receivable
|
|
|
2,042
|
|
|
|
804
|
|
Prepaid expenses
|
|
|
26,688
|
|
|
|
24,863
|
|
Inventories
|
|
|
9,013
|
|
|
|
4,716
|
|
Prepaid expenses and other current assets of discontinued operations
|
|
|
2,042
|
|
|
|
3,734
|
|
Other
|
|
|
4,014
|
|
|
|
4,271
|
|
|
|
$
|
70,074
|
|
|
$
|
61,700
|
|
NOTE 5:- |
OTHER LONG-TERM ASSETS
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Severance pay fund
|
|
$
|
14,859
|
|
|
$
|
14,701
|
|
Long-term deposits
|
|
|
3,637
|
|
|
|
3,000
|
|
Investments in affiliate
|
|
|
1,000
|
|
|
|
1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
19,496
|
|
|
$
|
18,701
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 6:- |
PROPERTY AND EQUIPMENT, NET
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
Cost:
|
|
|
|
|
|
|
Computers and peripheral equipment
|
|
$
|
212,449
|
|
|
$
|
181,738
|
|
Internal use software
|
|
|
37,948
|
|
|
|
9,882
|
|
Office furniture and equipment
|
|
|
12,030
|
|
|
|
13,982
|
|
Leasehold improvements
|
|
|
53,266
|
|
|
|
48,573
|
|
|
|
|
|
|
|
|
|
|
|
|
|
315,693
|
|
|
|
254,175
|
|
Accumulated depreciation:
|
|
|
|
|
|
|
|
|
Computers and peripheral equipment
|
|
|
163,162
|
|
|
|
139,066
|
|
Internal use software
|
|
|
2,924
|
|
|
|
-
|
|
Office furniture and equipment
|
|
|
6,614
|
|
|
|
7,847
|
|
Leasehold improvements
|
|
|
24,718
|
|
|
|
19,584
|
|
|
|
|
|
|
|
|
|
|
|
|
|
197,418
|
|
|
|
166,497
|
|
|
|
|
|
|
|
|
|
|
Depreciated cost
|
|
$
|
118,275
|
|
|
$
|
87,678
|
|
Depreciation expense totaled $37,924, $18,422 and $15,575 for the years 2017, 2016 and 2015, respectively.
The Company recorded a reduction of $6,790 and $10,941 to the cost and accumulated depreciation of fully depreciated equipment and leasehold improvements no longer in use for the years ended December 31, 2017 and 2016, respectively.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 7:- |
OTHER INTANGIBLE ASSETS, NET
|
a. Definite-lived other intangible assets:
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
Original amounts:
|
|
|
|
|
|
|
Core technology
|
|
$
|
673,291
|
|
|
$
|
623,274
|
|
Customer relationships, backlog and distribution network
|
|
|
382,031
|
|
|
|
372,438
|
|
Trademarks
|
|
|
56,196
|
|
|
|
55,745
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,111,518
|
|
|
|
1,051,457
|
|
Accumulated amortization:
|
|
|
|
|
|
|
|
|
Core technology
|
|
|
315,665
|
|
|
|
238,898
|
|
Customer relationships and distribution network
|
|
|
225,951
|
|
|
|
181,123
|
|
Trademarks
|
|
|
18,555
|
|
|
|
12,701
|
|
|
|
|
|
|
|
|
|
|
|
|
|
560,171
|
|
|
|
432,722
|
|
|
|
|
|
|
|
|
|
|
Other intangible assets, net
|
|
$
|
551,347
|
|
|
$
|
618,735
|
|
|
b. |
Amortization expense amounted to $118,377, $58,968 and $40,055 for the years ended December 31, 2017, 2016 and 2015, respectively.
|
|
c. |
The Company recorded a reduction $9,677 amounts and accumulated amortization of fully amortized other intangible assets for the years ended December 31, 2016. In 2017 there was no such reduction.
|
|
d. |
Estimated amortization expense:
|
For the year ended December 31,
|
|
|
|
|
|
|
|
2018
|
|
$
|
102,561
|
|
2019
|
|
|
99,091
|
|
2020
|
|
|
93,837
|
|
2021
|
|
|
85,822
|
|
2022 and thereafter
|
|
|
170,036
|
|
|
|
|
|
|
|
|
$
|
551,347
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
Following the Company's acquisitions in 2017, as described in Note 1b, the changes in the carrying amount of goodwill allocated to reportable segments for the years ended December 31, 2017 and 2016 are as follows:
|
|
Year ended December 31, 2017
|
|
|
|
Customer Engagement
|
|
|
Financial Crime and Compliance
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
As of January 1, 2017
|
|
$
|
1,022,198
|
|
|
$
|
262,512
|
|
|
$
|
1,284,710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions (*)
|
|
|
24,346
|
|
|
|
-
|
|
|
|
24,346
|
|
Functional currency translation adjustments
|
|
|
7,378
|
|
|
|
1,808
|
|
|
|
9,186
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2017
|
|
$
|
1,053,922
|
|
|
$
|
264,320
|
|
|
$
|
1,318,242
|
|
|
|
Year ended December 31, 2016
|
|
|
|
Customer Engagement
|
|
|
Financial Crime and Compliance
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
As of January 1, 2016
|
|
$
|
384,808
|
|
|
$
|
266,304
|
|
|
$
|
651,112
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisitions (**)
|
|
|
651,892
|
|
|
|
-
|
|
|
|
651,892
|
|
Functional currency translation adjustments
|
|
|
(14,502
|
)
|
|
|
(3,792
|
)
|
|
|
(18,294
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2016
|
|
$
|
1,022,198
|
|
|
$
|
262,512
|
|
|
$
|
1,284,710
|
|
|
(*) |
Includes a reduction of $3,799 of goodwill in respect of 2016 acquisition resulted from a finalization of purchase price allocation.
|
|
(**) |
Including a goodwill balance of $559,372 related to the acquisition of inContact.
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 9:- |
ACCRUED EXPENSES AND OTHER LIABILITIES
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Employees and payroll accruals
|
|
$
|
142,182
|
|
|
$
|
118,599
|
|
Accrued expenses
|
|
|
80,893
|
|
|
|
86,236
|
|
Government authorities
|
|
|
79,515
|
|
|
|
67,218
|
|
Accrued expenses and other liabilities of discontinued operations
|
|
|
189
|
|
|
|
3,077
|
|
Other
|
|
|
6,571
|
|
|
|
1,081
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
309,350
|
|
|
$
|
276,211
|
|
NOTE 10:- |
DERIVATIVE INSTRUMENTS
|
The Company's risk management strategy includes the use of derivative financial instruments to reduce the volatility of earnings and cash flows associated with changes in foreign currency exchange rates.
ASC 815, "Derivatives and Hedging" ("ASC 815"), requires the Company to recognize all of its derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.
For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the line item associated with the hedged transaction in the period or periods during which the hedged transaction affects earnings. The remaining gain or loss on the derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item representing the ineffective portion of the derivative, if any, is recognized in financial income (expense) in the period of change.
The Company entered into option and forward contracts to hedge a portion of anticipated New Israeli Shekel ("NIS") and Indian Rupee (INR) payroll and benefit payments as well as facilities related payments. These derivative instruments are designated as cash flow hedges, as defined by ASC 815 and accordingly are measured in fair value. These transactions are effective and, as a result, gain or loss on the derivative instruments are reported as a component of accumulated other comprehensive income (loss) and reclassified as payroll expenses, facility expenses or finance expenses, respectively, at the time that the hedged income/expense is recorded.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 10:- |
DERIVATIVE INSTRUMENTS (Cont.)
|
|
|
Notional amount
|
|
|
Fair value
(Level 2 within the fair value hierarchy)
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option contracts to hedge payroll
|
|
|
|
|
|
|
|
|
|
|
|
|
expenses ILS
|
|
$
|
4,000
|
|
|
$
|
43,600
|
|
|
|
46
|
|
|
$
|
107
|
|
expenses INR
|
|
|
17,800
|
|
|
|
12,000
|
|
|
|
232
|
|
|
|
4
|
|
Option contracts to hedge facility expenses INR
|
|
|
1,846
|
|
|
|
-
|
|
|
|
19
|
|
|
|
-
|
|
Forward contracts to hedge payroll
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
expenses ILS
|
|
|
30,000
|
|
|
|
52,000
|
|
|
|
947
|
|
|
|
(212
|
)
|
expenses INR
|
|
|
400
|
|
|
|
-
|
|
|
|
6
|
|
|
|
-
|
|
Forward contracts to hedge facility expenses ILS
|
|
|
-
|
|
|
|
2,549
|
|
|
|
-
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
54,046
|
|
|
$
|
110,149
|
|
|
$
|
1,250
|
|
|
$
|
(91
|
)
|
The Company currently hedges its exposure to the variability in future cash flows for a maximum period of one year. As of December 31, 2017, the Company expects to reclassify all of its unrealized gains and losses from accumulated other comprehensive income to earnings during the next twelve months.
The fair value of the Company's outstanding derivative instruments at December 31, 2017 and 2016 is summarized below:
|
|
|
Fair value of derivative instruments
|
|
|
|
|
December 31,
|
|
|
Balance sheet line item
|
|
2017
|
|
|
2016
|
|
Derivative assets:
|
|
|
|
|
|
|
|
Foreign exchange option contracts
|
Prepaid expenses and other current assets
|
|
$
|
297
|
|
|
$
|
111
|
|
Foreign exchange forward contracts
|
Prepaid expenses and other current assets
|
|
$
|
953
|
|
|
$
|
10
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities:
|
|
|
|
|
|
|
|
|
|
Foreign exchange option contracts
|
Accrued expenses and other liabilities
|
|
$
|
-
|
|
|
$
|
-
|
|
Foreign exchange forward contracts
|
Accrued expenses and other liabilities
|
|
$
|
-
|
|
|
$
|
(212
|
)
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 10:- |
DERIVATIVE INSTRUMENTS (Cont.)
|
The effect of derivative instruments in cash flow hedging relationship on income and other comprehensive income for the years ended December 31, 2017, 2016 and 2015 is summarized below:
|
|
Amount of gain (loss) recognized in
other comprehensive income
on derivative (effective portion)
|
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
Derivatives in foreign exchange cash flow hedging relationships:
|
|
|
|
|
|
|
|
|
|
Forward contracts
|
|
$
|
160
|
|
|
$
|
202
|
|
|
$
|
-
|
|
Option contracts
|
|
|
1,075
|
|
|
|
(802
|
)
|
|
|
954
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,235
|
|
|
$
|
(600
|
)
|
|
$
|
954
|
|
Derivatives in foreign exchange cash flow hedging relationships:
|
|
|
Amount of gain (loss) reclassified from other comprehensive income into income (expenses)
(effective portion)
|
|
|
|
|
Year ended December 31,
|
|
|
Statements of income lime item
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
Option contracts
|
Cost of revenues, operating expenses and discontinued operations
|
|
$
|
(2,429
|
)
|
|
$
|
(132
|
)
|
|
$
|
4,010
|
|
Forward contracts to hedge payroll expenses
|
Cost of revenues and operating expenses
|
|
|
(3,157
|
)
|
|
|
|
|
|
|
-
|
|
|
|
|
$
|
(5,586
|
)
|
|
$
|
(132
|
)
|
|
$
|
4,010
|
|
NOTE 11:- |
COMMITMENTS AND CONTINGENT LIABILITIES
|
The Company leases office space, office equipment and various motor vehicles under operating leases.
|
1. |
The Company's office space and office equipment are rented under several operating leases.
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 11:- |
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
|
Future minimum lease commitments under non-cancelable operating leases for the years ended December 31, were as follows:
2018
|
|
$
|
18,150
|
|
2019
|
|
|
17,060
|
|
2020
|
|
|
14,879
|
|
2021
|
|
|
13,207
|
|
2022
|
|
|
14,379
|
|
2023 and thereafter
|
|
|
19,392
|
|
|
|
|
|
|
|
|
$
|
97,067
|
|
Rent expenses for the years 2017, 2016 and 2015 were approximately $14,103, $23,669 and $15,880, respectively.
On October 30, 2015, the Company entered into an agreement to rent new office space in Hoboken NJ, USA. Consequently, in November 2016, the Company ceased using its offices in Paramus, NJ and Manhattan, NY, USA prior to their original contractual termination date, and the Company set to sub-lease its two former facilities in New Jersey and New York for the remainder of their respective lease terms. As a result, the Company recorded an exit activity liability as of December 31, 2016 and recognized rent expenses in the amount of $6,457. In 2017, the Company managed to sub-lease additional space of its former facilities, and as a result, the Company recognized rent income in the amount of $3,067.
|
2. |
The Company leases its motor vehicles under cancelable operating lease agreements.
|
The minimum payment under these operating leases, upon cancellation of these lease agreements was $ 671 as of December 31, 2017.
Lease expenses for motor vehicles for the years 2017, 2016 and 2015 were $2,656, $2,747 and $5,103, respectively.
The Company is obligated under certain agreements with its suppliers to purchase licenses and hosting services. These non-cancelable obligations as of December 31, 2017 and 2016 were $30,831 and $22,207, respectively.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 11:- |
COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)
|
c. Legal proceedings:
1.
|
In May 2009, inContact was served a lawsuit titled California College, Inc., et al., v. UCN, Inc., et al. in connection with the sale of services with those Insidesales.com, Inc. California College originally sought damages in excess of $20,000. Insidesales.com and inContact filed cross-claims against one another, which they subsequently agreed to dismiss with prejudice. In October 2011, California College reached a settlement with Insidesales.com, the terms of which have not been disclosed and remain confidential. In June of 2013, California College amended its damages claim to $14,400, of which approximately $5,000 was alleged to be pre-judgment interest. On September 10, 2013, the court issued an order on inContact's Motion for Partial Summary Judgment. The court determined that factual disputes exist as to several of the claims, but dismissed California College's cause of action for intentional interference with prospective economic relations and the claim for prejudgment interest. Dismissing the claim for prejudgment interest effectively reduced the claim for damages to approximately $9,200. The trial court granted inContact’s motion to stay the trial without date pending an interlocutory appeal to the Utah Supreme Court of the trial court’s ruling with respect to allowing California College’s experts to testify at trial. The briefs were filed in the matter and oral arguments were made in August 2017. The Utah Court of Appeals has yet to rule on the matter. At this stage we are unable to evaluate the probability of a favorable or unfavorable outcome in this litigation.
|
|
2. |
From time to time the Company or its subsidiaries may be involved in legal proceedings and/or litigation arising in the ordinary course of business. While the outcome of these matters cannot be predicted with certainty, the Company does not believe it will have a material effect on its consolidated financial position, results of operations, or cash flows.
|
NOTE 12:- |
TAXES ON INCOME
|
Commencing 2012, NICE Ltd. and its Israeli subsidiary elected the Preferred Enterprise regime to apply under the Law for the Encouragement of Capital Investments (the “Investment Law”). The election is irrevocable. Under the Preferred Enterprise Regime, from 2015 through 2016, NICE Ltd. and its Israeli subsidiary's entire preferred income was subject to the tax rate of 16%.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
In December 2016, the Israeli Knesset passed a number of changes to the Investments Law regimes. These changes came into law in May 2017, retroactively effective beginning January 1, 2017, upon the passing into law of Regulations promulgated by the Finance Ministry to implement the “Nexus Principles” based on OECD guidelines published as part of the Base Erosion and Profit Shifting (BEPS) project. Such Regulations provide rules for implementation of the new beneficial Preferred Technology Enterprise tax regime.
The Company believes it qualifies in tax year 2017 as a Preferred Technology Enterprise and accordingly be eligible for a tax rate of 12% on its preferred technology income, as defined in such regulations, beginning from tax year 2017 and onwards. The Company expects that it will qualify as a Preferred Technology Enterprise in 2018 and subsequent tax years.
Income not eligible for Preferred Enterprise or Preferred Technology Enterprise benefits is taxed at the regular corporate tax rate, which is 24% in 2017, was 25% in 2016 and 26.5% in 2015. This rate is further scheduled to be reduced to 23% in 2018 and thereafter.
Prior to 2012, most of NICE Ltd. and its Israeli subsidiary's income was exempt from tax or subject to reduced tax rates under the Investment Law. Upon distribution of exempt income, the distributing company was subject to reduced corporate tax rates ordinarily applicable to such income under the Investment Law. Currently, income subjected to a reduced tax rate under the Preferred Enterprise and Preferred Technology Enterprise Regime will be freely distributable as dividends, subject to a 20% withholding tax (or lower, under an applicable tax treaty). However, upon the distribution of a dividend from such Preferred Income to an Israeli company, no withholding tax will be imposed.
Pursuant to a temporary tax relief initiated by the Israeli government, a company that elected by November 11, 2013 to pay a reduced corporate tax rate as set forth in the temporary tax relief with respect to undistributed exempt income generated under the Investment Law accumulated by the company until December 31, 2011 is entitled to distribute a dividend from such income without being required to pay additional corporate tax with respect to such dividend. A company that has so elected must make certain qualified investments in Israel over a five-year period. A company that has elected to apply the temporary tax relief cannot withdraw from its election. The election did not require the actual distribution of these previously tax-exempted earnings.
In September 2013, the Company made the election and duly released all of NICE and its Israeli subsidiary’s tax-exempted income through 2011 related to their various pre 2012 programs under the Investment Law. As a result of the election and the related settlement of a routine multi-year tax audit, the Company recorded an expense of $19,200 and paid an amount of approximately $32,000. The Company believes that it has fulfilled its commitment to make certain investments in "industrial projects" (as defined in the Law), as was required to be completed by December 31, 2017. Additionally, the Company believes that this commitment has already been fulfilled during 2013 as part of its existing investment plans. Further to the election, NICE no longer has a tax liability upon future distributions of its tax-exempted earnings, while the Israeli subsidiary may have a tax liability upon future distributions only with respect to its 2012 tax-exempted earnings.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
|
2. |
Foreign Exchange Regulations:
|
Under the Foreign Exchange Regulations, NICE and its Israeli subsidiary calculate their tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into New Israeli Shekels according to the exchange rate as of December 31st of each year.
|
3. |
Tax benefits under the Israeli Law for the Encouragement of Industry (Taxation), 1969:
|
NICE and its Israeli subsidiary believe they currently qualify as an "Industrial Company" as defined by the above law and, as such, is entitled to certain tax benefits including accelerated depreciation, deduction of public offering expenses in three equal annual installments and amortization of cost of purchased know-how and patents for tax purposes over 8 years.
|
b. |
Income taxes on non-Israeli subsidiaries:
|
Non-Israeli subsidiaries are taxed according to the tax laws in their respective country of residence. The Company's consolidated tax rate depends on the geographical mix of where its profits are earned. Primarily, in 2017, the Company's U.S. subsidiaries are subject to combined federal and state income taxes of approximately 39% and its subsidiaries in the U.K. are subject to corporation tax at a rate of approximately 19%. Neither Israeli income taxes, foreign withholding taxes nor deferred income taxes were provided in relation to undistributed earnings of the Company's foreign subsidiaries. This is because the Company has the intent and ability to reinvest these earnings indefinitely in the foreign subsidiaries and therefore those earnings are continually redeployed in those jurisdictions. As of December 31, 2017, the amount of undistributed earnings of non-Israeli subsidiaries, which is considered indefinitely reinvested, was $ 349,888 with a corresponding unrecognized deferred tax liability of $ 64,144. If these earnings were distributed to Israel in the form of dividends or otherwise, the Company would be subject to additional Israeli income taxes (subject to an adjustment for foreign tax credits) and foreign withholding taxes.
On December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (the “U.S. Tax Reform”); a comprehensive tax legislation that includes significant changes to the taxation of business entities. These changes include several key tax provisions that might impact the Company, among others: (i) a permanent reduction to the statutory federal corporate income tax rate from 35% to 21% effective for tax years beginning after December 31, 2017; (ii) a partial limitation on the tax deductibility of business interest expense; (iii) a shift of the U.S. taxation of multinational corporations from a tax on worldwide income to a territorial system (along with certain rules designed to prevent erosion of the U.S. income tax base) and (iv) a one-time deemed repatriation tax on accumulated offshore earnings held in cash and illiquid assets, with the latter taxed at a lower rate.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
Due to the timing of the enactment and the complexity involved in applying the provisions of the U.S. Tax Reform, the Company has made reasonable estimates of the effects and recorded provisional amounts in the financial statements as of December 31, 2017. As the Company collects and prepares necessary data, and interprets the U.S. Tax Reform and any additional guidance issued by the U.S. Treasury Department, the IRS, and other standard-setting bodies, the Company may make adjustments to the provisional amounts. Those adjustments may impact the Company's provision for income taxes and effective tax rate in the period in which the adjustments are made. The accounting for the tax effects of the U.S. Tax Reform will be completed in 2018 with accordance with SAB 118.
Provisional amounts for the following income tax effects of the U.S. Tax Reform have been recorded as of December 31, 2017 and are subject to change during 2018.
Deferred tax effects
As a result of the U.S. Tax Reform and the reduced U.S. corporate income tax rate, the Company has remeasured its deferred taxes as of December 31, 2017 to reflect the reduced rate that will apply in future periods, when these deferred taxes are settled or realized. The remeasurement resulted in the Company’s recognition of a deferred tax benefit of $31,000.
As the Company completes its analysis of the U.S. Tax Reform and incorporates additional guidance that may be issued by the U.S. Treasury Department, the IRS or other standard-setting bodies, the Company may identify additional effects not reflected as of December 31, 2017.
|
d. |
Net operating loss carryforward:
|
As of December 31, 2017, the Company and certain of its subsidiaries had tax loss carry-forwards totaling in aggregate approximately $335,360 which can be carried forward and offset against taxable income. Approximately $69,053 of these carry-forward tax losses have no expiration date, with the balance expiring between 2018 and 2037.
Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses increasing taxes before utilization.
|
e. |
Deferred tax assets and liabilities:
|
Deferred taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts recorded for tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
Deferred tax assets:
|
|
|
|
|
|
|
Net operating losses carryforward and tax credits
|
|
$
|
79,196
|
|
|
$
|
82,243
|
|
Share based payments
|
|
|
16,142
|
|
|
|
17,299
|
|
Research and development costs
|
|
|
3,606
|
|
|
|
4,246
|
|
Reserves, allowances and other
|
|
|
8,915
|
|
|
|
8,507
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets before valuation allowance
|
|
|
107,859
|
|
|
|
112,295
|
|
Valuation allowance
|
|
|
(8,853
|
)
|
|
|
(8,839
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
99,006
|
|
|
|
103,456
|
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Acquired intangibles
|
|
|
(142,352
|
)
|
|
|
(231,645
|
)
|
Acquired deferred revenue
|
|
|
(2,600
|
)
|
|
|
(4,670
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities
|
|
|
(144,952
|
)
|
|
|
(236,315
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities, net
|
|
$
|
(45,946
|
)
|
|
$
|
(132,859
|
)
|
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
$
|
11,850
|
|
|
$
|
14,093
|
|
Deferred tax liabilities
|
|
|
(57,796
|
)
|
|
|
(146,952
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities, net
|
|
$
|
(45,946
|
)
|
|
$
|
(132,859
|
)
|
The Company has provided valuation allowances in respect of certain deferred tax assets resulting from tax loss carry forwards and other reserves and allowances due to uncertainty concerning their realization.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
|
f. |
A reconciliation of the Company's effective tax rate to the statutory tax rate in Israel is as follows:
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes on income, as reported in the consolidated statements of income
|
|
$
|
129,660
|
|
|
$
|
144,481
|
|
|
$
|
171,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statutory tax rate in Israel
|
|
|
24.0
|
%
|
|
|
25.0
|
%
|
|
|
26.5
|
%
|
Preferred Enterprise benefits (*)
|
|
|
(16.8
|
%)
|
|
|
(8.9
|
%)
|
|
|
(6.1
|
%)
|
Changes in valuation allowance
|
|
|
0.0
|
%
|
|
|
1.0
|
%
|
|
|
(0.4
|
%)
|
Earnings taxed under foreign law
|
|
|
(4.6
|
%)
|
|
|
(7.7
|
%)
|
|
|
(4.0
|
%)
|
Tax settlements and other adjustments
|
|
|
14.3
|
%
|
|
|
5.8
|
%
|
|
|
1.1
|
%
|
U.S. Tax Reform one-time adjustment
|
|
|
(23.9
|
%)
|
|
|
-
|
|
|
|
-
|
|
Other
|
|
|
(3.5
|
%)
|
|
|
(0.4
|
%)
|
|
|
0.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective tax rate
|
|
|
(10.5
|
%)
|
|
|
14.8
|
%
|
|
|
18.0
|
%
|
|
(*) |
The effect of the benefit resulting from the "Preferred Enterprise" status on net earnings per ordinary share is as follows:
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.36
|
|
|
$
|
0.22
|
|
|
$
|
0.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.35
|
|
|
$
|
0.21
|
|
|
$
|
0.17
|
|
|
g. |
Income before taxes on income is comprised as follows:
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Domestic
|
|
$
|
188,070
|
|
|
$
|
131,111
|
|
|
$
|
122,952
|
|
Foreign
|
|
|
(58,410
|
)
|
|
|
13,370
|
|
|
|
48,458
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
129,660
|
|
|
$
|
144,481
|
|
|
$
|
171,410
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
h. Taxes on income (tax benefit) are comprised as follows:
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Current
|
|
$
|
57,174
|
|
|
$
|
47,318
|
|
|
$
|
23,978
|
|
Deferred
|
|
|
(70,805
|
)
|
|
|
(25,906
|
)
|
|
|
6,854
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(13,631
|
)
|
|
$
|
21,412
|
|
|
$
|
30,832
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic
|
|
$
|
27,673
|
|
|
$
|
28,097
|
|
|
$
|
24,812
|
|
Foreign
|
|
|
(41,304
|
)
|
|
|
(6,685
|
)
|
|
|
6,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(13,631
|
)
|
|
$
|
21,412
|
|
|
$
|
30,832
|
|
Of which:
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Domestic taxes:
|
|
|
|
|
|
|
|
|
|
Current
|
|
$
|
22,808
|
|
|
$
|
27,932
|
|
|
$
|
14,860
|
|
Deferred
|
|
|
4,865
|
|
|
|
165
|
|
|
|
9,952
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27,673
|
|
|
|
28,097
|
|
|
|
24,812
|
|
Foreign taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
|
|
|
34,366
|
|
|
|
19,386
|
|
|
|
9,118
|
|
Deferred
|
|
|
(75,670
|
)
|
|
|
(26,071
|
)
|
|
|
(3,098
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(41,304
|
)
|
|
|
(6,685
|
)
|
|
|
6,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxes on income (tax benefit)
|
|
$
|
(13,631
|
)
|
|
$
|
21,412
|
|
|
$
|
30,832
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
TAXES ON INCOME (Cont.)
|
i. Uncertain tax positions:
A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Uncertain tax positions, beginning of year
|
|
$
|
26,659
|
|
|
$
|
18,236
|
|
Increases in tax positions for prior years
|
|
|
5,105
|
|
|
|
2,147
|
|
Increases in tax positions for current year
|
|
|
15,140
|
|
|
|
9,926
|
|
Settlements
|
|
|
-
|
|
|
|
(1,331
|
)
|
Expiry of the statute of limitations
|
|
|
(2,920
|
)
|
|
|
(2,319
|
)
|
|
|
|
|
|
|
|
|
|
Uncertain tax positions, end of year
|
|
$
|
43,984
|
|
|
$
|
26,659
|
|
All the Company's unrecognized tax benefits would, if recognized, reduce the Company's annual effective tax rate. The Company has further accrued $1,262 and $206 due to interest and penalties related to uncertain tax positions as of December 31, 2017 and 2016 respectively.
During 2017, prior tax years in the US and the United Kingdom were closed by way of the expiration of the statute of limitations. The Company is currently in the process of routine Israeli income tax audits for the tax years 2013 through 2015. The U.S. subsidiaries are currently in the process of a routine Internal Revenue Service audit of the tax year 2014 consolidated U.S. Federal tax return. As of December 31, 2017, the Company or its subsidiaries are still subject to U.S. federal income tax audits for the tax years of 2014 through 2016 and to other income tax audits for the tax years of 2012 through 2016.
NOTE 13:- |
SHAREHOLDERS' EQUITY
|
|
a. |
The Ordinary shares of the Company are traded on the Tel-Aviv Stock Exchange and its American Depositary Shares (“ADSs”), each representing one fully paid ordinary share, par value NIS 1.00 per share of the Company are traded on NASDAQ.
|
b. Share option plans:
2008 and 2016 Share Incentive Plan
In June 2008 the Company adopted the 2008 Share Incentive Plan (the “2008 Plan”) and in February 2016, the Company adopted the 2016 Share Incentive Plan (the “2016 Plan” and together with the 2008 Plan the “Plans”). The Company adopted the Plans to provide incentives to employees, directors, consultants and/or contractors by rewarding performance and encouraging behavior that will improve the Company’s profitability.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 13:- |
SHAREHOLDERS' EQUITY (Cont.)
|
Under each of the Plans, the Company's employees, directors, consultants and/or contractors may be granted any equity-related award, including any type of an option to acquire the Company ordinary shares; share appreciation right; share and/or restricted share award (“RSA”); restricted stock unit (“RSU”) and/or other share unit; and/or other share-based award and/or other right or benefit under the Plans, including any such equity-related award that is a performance based award (each an "Award").
Generally, under the terms of the 2016 Plan, and unless determined otherwise by the Board of Directors, 25% of the restricted share units and par value options granted become vested on each of the four consecutive annual anniversaries following the date of grant. Specifically with respect to options (other than options granted at an exercise price equal to their nominal value), unless determined otherwise by the administrator of the 2016 Plan, 25% of an Award granted becomes exercisable on the first anniversary of the date of grant and 6.25% becomes exercisable once every quarter during the subsequent three years. Certain executive officers are entitled to acceleration of vesting of awards in the event of a change of control, subject to certain conditions. Awards with a vesting period expire six years after the date of grant. Options that are performance-based shall expire seven years following the date of grant. The 2016 Plan provides that the number of shares that may be subject to Awards granted under the 2016 Plan shall be an amount per calendar year, equal to 3.5% of the Company issued and outstanding share capital as of December 31 of the preceding calendar year. Such amount is reset for each calendar year. Awards are non-transferable except by will or the laws of descent and distribution.
Options would be granted at an exercise price equal to the average of the closing prices of one ADR, as quoted on the NASDAQ market, during the 30 consecutive calendar days preceding the date of grant, unless determined otherwise by the administrator of the 2016 Plan (including in some cases options granted with an exercise price equal to the nominal value of an ordinary share).
The Company Board of Directors also adopted an addendum to the 2016 Plan for Awards granted to grantees who are residents of Israel (the "Addendum") and resolved to elect the "Capital Gains Route" (as defined in Section 102(b)(2)) of the Tax Ordinance for the grant of Awards to Israeli grantees. The U.S. addendum of the 2016 Plan provides only for non-qualified stock options for purposes of U.S. tax laws. The 2016 Plan is generally administered by our Board of Directors and compensation committee.
During 2017, we granted 1,099,141 options and restricted share units under the 2016 Plan (which constituted 1.83% of the Company issued and outstanding share capital as of December 31, 2016).
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 13:- |
SHAREHOLDERS' EQUITY (Cont.)
|
Pursuant to the terms of the acquisitions of Actimize Ltd., e-Glue Software Technologies Inc., Fizzback, Merced Causata, Nexidia and inContact, the Company assumed or replaced unvested options, RSAs and RSUs and converted them or replaced them with NICE options, RSAs and RSUs, as applicable, based on an agreed exchange ratio. Each assumed or replaced option, RSA and RSU is subject to the same terms and conditions, including vesting, exercisability and expiration, as originally applied to any such option, RSA and RSU immediately prior to the acquisition.
The fair value of the Company's stock options granted to employees and directors for the years ended December 31, 2017, 2016 and 2015 was estimated using the following assumptions:
|
|
2017
|
|
2016
|
|
2015
|
|
|
|
|
|
|
|
Expected volatility
|
|
21.69%-22.90%
|
|
21.05%-25.92%
|
|
23.02%-27.55%
|
Risk free interest rate
|
|
1.53%-2.00%
|
|
0.58%-2.04%
|
|
0.76%-1.18%
|
Expected dividend
|
|
0%
|
|
0%-1.00%
|
|
0%-1.29%
|
Expected term (in years)
|
|
3.5
|
|
3.5
|
|
3.5
|
A summary of the Company's stock options activity and related information for the year ended December 31, 2017, is as follows:
|
|
Number of options
|
|
|
Weighted-average exercise price
|
|
|
Weighted- average remaining contractual term
(in years)
|
|
|
Aggregate intrinsic
value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at January 1, 2017
|
|
|
2,273,664
|
|
|
|
23.61
|
|
|
|
4.46
|
|
|
|
102,652
|
|
Granted
|
|
|
444,826
|
|
|
|
20.75
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(813,787
|
)
|
|
|
23.35
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(224,289
|
)
|
|
|
22.85
|
|
|
|
|
|
|
|
|
|
Cancelled
|
|
|
(4,284
|
)
|
|
|
15.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at December 31, 2017
|
|
|
1,676,130
|
|
|
|
23.07
|
|
|
|
4.45
|
|
|
|
115,390
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at December 31, 2017
|
|
|
598,843
|
|
|
|
33.38
|
|
|
|
3.45
|
|
|
|
35,049
|
|
The weighted-average grant-date fair value of options granted during the years 2017, 2016 and 2015 was $61.54, $46.24 and $32.58, respectively.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 13:- |
SHAREHOLDERS' EQUITY (Cont.)
|
The total intrinsic value of options exercised during the years 2017, 2016 and 2015 was $42,592, $35,664 and $40,519, respectively.
The options outstanding under the Company's stock option plans as of December 31, 2017 have been separated into ranges of exercise price as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
Options
|
|
|
Weighted
|
|
|
|
|
|
Options
|
|
|
average
|
|
|
|
|
outstanding
|
|
|
average
|
|
|
Weighted
|
|
|
exercisable
|
|
|
exercise
|
|
|
|
|
as of
|
|
|
remaining
|
|
|
average
|
|
|
as of
|
|
|
price of
|
|
Ranges of
|
|
|
December 31,
|
|
|
contractual
|
|
|
exercise
|
|
|
December 31,
|
|
|
options
|
|
exercise price
|
|
|
2017
|
|
|
term
|
|
|
price
|
|
|
2017
|
|
|
exercisable
|
|
|
|
|
|
|
|
(Years)
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.29
|
|
|
|
922,427
|
|
|
|
4.46
|
|
|
|
0.29
|
|
|
|
197,933
|
|
|
|
0.29
|
|
$
|
0.69
|
|
|
|
1,888
|
|
|
|
1.90
|
|
|
|
0.69
|
|
|
|
1,888
|
|
|
|
0.69
|
|
$
|
6.72-9.89
|
|
|
|
8,861
|
|
|
|
6.66
|
|
|
|
7.03
|
|
|
|
6,655
|
|
|
|
7.12
|
|
$
|
11.40-15.16
|
|
|
|
3,301
|
|
|
|
2.73
|
|
|
|
14.09
|
|
|
|
3,301
|
|
|
|
14.09
|
|
$
|
17.72
|
|
|
|
934
|
|
|
|
3.20
|
|
|
|
17.72
|
|
|
|
934
|
|
|
|
17.72
|
|
$
|
28.64-42.92
|
|
|
|
339,873
|
|
|
|
4.12
|
|
|
|
39.15
|
|
|
|
200,777
|
|
|
|
38.61
|
|
$
|
43.01-64.06
|
|
|
|
211,186
|
|
|
|
4.52
|
|
|
|
52.79
|
|
|
|
90,409
|
|
|
|
59.11
|
|
$
|
64.61-85.14
|
|
|
|
187,660
|
|
|
|
4.83
|
|
|
|
73.63
|
|
|
|
96,946
|
|
|
|
69.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,676,130
|
|
|
|
4.45
|
|
|
|
23.07
|
|
|
|
598,843
|
|
|
|
33.38
|
|
A summary of the Company's RSU and the Company's RSA activities and related information for the year ended December 31, 2017, is as follows:
|
|
Number of RSU and
RSA (*)
|
|
|
|
|
|
Outstanding at January 1, 2017
|
|
|
1,498,643
|
|
Granted
|
|
|
654,315
|
|
Vested
|
|
|
(456,807
|
)
|
Cancelled
|
|
|
(250
|
)
|
Forfeited
|
|
|
(170,889
|
)
|
|
|
|
|
|
Outstanding at December 31, 2017
|
|
|
1,525,012
|
|
|
(*) |
NIS 1 par value which represents approximately $0.29
|
As of December 31, 2017, there was approximately $92,650 of unrecognized compensation expense related to non-vested stock options, RSUs and RSAs, expected to be recognized over a period of up to four years.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 13:- |
SHAREHOLDERS' EQUITY (Cont.)
|
The total equity-based compensation expense related to all of the Company's equity-based awards, recognized for the years ended December 31, 2017, 2016 and 2015, was comprised as follows:
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
$
|
11,337
|
|
|
$
|
7,878
|
|
|
$
|
3,712
|
|
Research and development, net
|
|
|
9,038
|
|
|
|
5,676
|
|
|
|
2,161
|
|
Selling and marketing
|
|
|
23,107
|
|
|
|
16,403
|
|
|
|
11,266
|
|
General and administrative
|
|
|
13,498
|
|
|
|
10,590
|
|
|
|
10,521
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expenses
|
|
$
|
56,980
|
|
|
$
|
40,547
|
|
|
$
|
27,660
|
|
On May 6, 2015 the Company's Board of Directors authorized a program to repurchase up to $100,000 of the Company's issued and outstanding Ordinary shares and ADRs. On January 10, 2017 the Company announced that the Board of Directors authorized a program to repurchase up to an additional $150,000 of the Company's issued and outstanding ordinary shares and ADRs. This share repurchase program commenced on April 7, 2017 following completion of the prior program. Repurchases may be made from time to time in the open market or in privately negotiated transactions and will be in accordance with applicable securities laws and regulations. The timing and amount of the repurchase transactions will be determined by management and may depend on a variety of factors, including market conditions, alternative investment opportunities and other considerations. The programs do not obligate the Company to acquire any particular amount of ordinary shares and ADRs and the program may be modified or discontinued at any time without prior notice.
d. Dividends:
On February 13, 2013, the Company announced that the Board of Directors had approved a dividend policy under which the Company intended to pay quarterly cash dividends to holders of its ordinary shares and ADRs subject to declaration by the Board from non-taxable approved enterprise earning. Under Israeli law, dividends may be paid only out of total accumulated retained profits and other surplus (as defined in the law) as of the most recent financial statements or as accrued over a period of the last two years, whichever is higher, provided that there is no reasonable concern that the dividend distribution will prevent the Company from meeting its existing and foreseeable obligations as they come due. Dividends are generally declared and paid in U.S. dollars, although the Company may pay such dividends in Israeli currency.
On January 10, 2017 the Company announced its capital return strategy to optimize the Company’s long term growth profile. In connection with adopting this strategy, the Board of Directors eliminated the dividend policy effective in the first quarter of 2017.
The total amount of annual dividend declared and paid in 2017 and 2016 was $0.16, $0.64 per share.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
In connection with financing the acquisition of inContact (refer to Note 1b) which closed on November 14, 2016, the Company entered into a Credit Agreement with certain lenders, according to which the following credit facilities were issued: 1) a long term loan of $475,000, and 2) a revolving credit loan of up to $75,000.
The Credit Agreement contains a number of covenants and restrictions that among other things, and subject to certain agreed upon exceptions, require the Company and its subsidiaries to satisfy certain financial covenants and restricts the ability of the Company and its subsidiaries to incur liens, incur additional indebtedness, make loans and investments, engage in mergers and acquisitions, engage in asset sales, declare dividends or redeem or repurchase capital stock, prepay, redeem or purchase subordinated debt and amend or otherwise alter debt agreements, in each case, subject to certain agreed upon exceptions. A failure to comply with these covenants could permit the lenders under the Credit Agreement to declare all amounts borrowed under the Credit Agreement, together with accrued interest and fees, to be immediately due and payable. As of December 31, 2017, the Company was in compliance with all covenants and requirements outlined in the Credit Agreement.
Long term loan
In January 2017, the Company prepaid a principal amount of $260,000 of the amount outstanding under the long term loan. As a result, the remaining principal of $215,000 are due on the final maturity date of the term loan facility.
As of December 31, 2017, the contractual principal payments for the long term loan are $215,000 which are due at December 31, 2021.
The long term loan bears interest through maturity at a variable rate based upon, at the Company's option every interest period, either (a) the LIBOR rate for Eurocurrency borrowing or (b) an Alternate Base Rate ("ABR"), which is the highest of (i) the administrative agent's prime rate, (ii) one-half of 1.00% in excess of the overnight U.S. Federal Funds rate, and (iii) 1.00% in excess of the one-month LIBOR), plus in each case, an applicable margin. The applicable margin for Eurocurrency loans ranges, based on the applicable total net leverage ratio, from 1.25% to 2.00% per annum and the applicable margin for ABR loans ranges, based on the applicable total net leverage ratio, from 0.25% to 1.00% per annum.
Debt issuance costs of $10,158 attributable to the long term loan are amortized as interest expense over the contractual term of the loan using the effective interest rate. Upon pre-payment of the principal $260,000 as mentioned above, the Company amortized $5,300 of debt issuance costs in addition to $1,034 amortization expenses related to debt issuance costs recorded in 2017.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 14:- |
LONG TERM DEBT (Cont.)
|
The carrying values of the liability's components are reflected in the Company's accompanying consolidated balance sheets as follows:
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Principal
|
|
$
|
215,000
|
|
|
$
|
475,000
|
|
Less: Debt issuance costs, net of amortization
|
|
|
(3,486
|
)
|
|
|
(9,820
|
)
|
|
|
|
|
|
|
|
|
|
Net liability carrying amount
|
|
$
|
211,514
|
|
|
$
|
465,180
|
|
Interest expense related to the liability is reflected on the accompanying consolidated statements of operations for the years ended December 31:
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Amortization of debt issuance costs
|
|
$
|
6,334
|
|
|
$
|
338
|
|
Interest expense
|
|
|
5,558
|
|
|
|
1,266
|
|
|
|
|
|
|
|
|
|
|
Total interest expense recognized
|
|
$
|
11,892
|
|
|
$
|
1,604
|
|
|
|
|
|
|
|
|
|
|
Effective interest rate |
|
|
3.30%
|
|
|
|
2.84%
|
|
Revolving credit loan
Pursuant to the Credit Agreement, the Company has also been granted a revolving credit facility that entitles the Company to borrow up to $75,000 through December 2021 with interest payable on the borrowed amount set at the same terms as the term loan, as well as a quarterly commitment fee on unfunded amounts ranging from 0.25% to 0.5%, subject to the achievement of certain leverage levels. As of December 31, 2017, no amounts had been funded.
Debt issuance costs of $1,667 attributable to the revolving credit loan are capitalized and amortized as interest expense over the contractual term of the agreement on a straight line basis.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 14:- |
LONG TERM DEBT (Cont.)
|
Exchangeable Senior Notes and Hedging Transactions
Exchangeable Senior Notes
In January 2017, the Company issued $287,500 aggregate principal amount of Exchangeable Senior Notes (the “Notes”) due 2024. The following table summarizes some key facts and terms regarding the outstanding exchangeable senior notes:
|
|
Due 2024
|
|
Issuance date
|
|
January 18, 2017
|
|
Maturity date
|
|
January 15, 2024
|
|
Principal amount
|
|
$
|
287,500
|
|
Cash coupon rate (per annum)
|
|
|
1.25
|
%
|
Conversion rate effective September 15, 2023 (per $1000 principal amount)
|
|
|
12.026
|
|
Effective conversion price effective September 15, 2023 (per ADS)
|
|
$
|
83.15
|
|
Subject to satisfaction of certain conditions and during certain periods, as defined in the indenture governing the notes, the holders will have the option to exchange the notes for (i) cash, (ii) ADSs or (iii) a combination thereof, at the Company’s election.
NICE may provide additional ADSs upon conversion if there is a "Make-Whole Fundamental Change" in the business as defined in the indenture governing the notes.
The Notes are not redeemable by the Company prior to the maturity date apart from certain cases as defined in the indenture governing the Notes.
Debt issuance costs of $5,791 attributable to the long term loan are amortized as interest expense over the contractual term of the loan using the effective interest rate.
The carrying values of the liability and equity components of the exchangeable senior notes are reflected in the Company's accompanying consolidated balance sheets as follows:
|
|
December 31,
|
|
|
|
2017
|
|
|
|
|
|
Principal
|
|
$
|
287,500
|
|
Less:
|
|
|
|
|
Debt issuance costs, net of amortization
|
|
|
(5,182
|
)
|
Unamortized discount
|
|
|
(46,190
|
)
|
Net liability carrying amount
|
|
$
|
236,128
|
|
Equity component - net carrying value
|
|
$
|
51,176
|
|
Interest is payable on the debentures semi-annually at the cash coupon rate; however, the remaining debt discount is being amortized as additional non-cash interest expense using an effective annual interest rate equal to the Company's estimated nonconvertible debt borrowing rate at the time of issuance.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 14:- |
LONG TERM DEBT (Cont.)
|
Interest expense related to the notes is reflected on the accompanying consolidated statements of operations for the year ended December 31:
|
|
Year Ended
December 31,
|
|
|
|
2017
|
|
|
|
|
|
Amortization of debt issuance costs
|
|
$
|
609
|
|
Non-cash amortization of debt discount
|
|
|
6,278
|
|
Interest expense
|
|
|
3,414
|
|
Net liability carrying amount
|
|
$
|
10,301
|
|
|
|
|
|
|
Equity component - net carrying value |
|
|
4.68%
|
|
Exchangeable notes hedge transactions
In connection with the pricing of the Notes, the Company has entered into privately negotiated exchangeable note hedge transactions with some of the initial purchasers and/or their respective affiliates (the “option counterparties”).
Subject to customary anti-dilution adjustments substantially similar to those applicable to the Notes, the exchangeable note hedge transactions cover the same number of ADSs that initially underlined the Notes.
The note hedge transactions are expected generally to reduce potential dilution to the ADSs and/or offset potential cash payments the Company is required to make in excess of the principal amount, in each case, upon any exchange of the Exchangeable Notes.
A portion of the call-options can be settled upon a surrender of the same amount of Exchangeable Senior Notes by a Holder. Settlement can be done in cash, ADSs or a combination of both, at NICE’s election.
Concurrently with the Company’s entry into the exchangeable note hedge transactions, the Company has entered into warrant transactions with the option counterparties relating to the same number of ADSs (3,457,475), with a strike price of $101.82 per ADS, subject to customary anti‑dilution adjustments.
The warrants are exercisable for a period of 3 months as of the notes maturity date.
The Company has recorded a net decrease of $20,281 in additional paid in capital, due to its equity components.
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 15:- |
REPORTABLE SEGMENTS AND GEOGRAPHICAL INFORMATION
|
ASC 280, Segment Reporting, establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company's chief operating decision maker is its Chief Executive Officer.
During 2015, the Company divested its Physical Security as well as its Cyber and Intelligence operations, which were a major part of the Security Solutions segment, to allow it to focus on its core markets as part of the execution of its long-term strategy. Following this divestiture, the Company operates in the following operation-based segments: Customer Engagement provide data driven insights that enable businesses to deliver consistent and personalized experience to customers, and Financial Crime and Compliance provide real time and cross-channel fraud prevention, anti-money laundering, brokerage compliance and enterprise-wide case management.
|
|
Year ended December 31, 2017
|
|
|
|
Customer Engagement
(1) (2)
|
|
|
Financial Crime and Compliance
|
|
|
Not
allocated
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
1,051,350
|
|
|
$
|
280,802
|
|
|
$
|
-
|
|
|
$
|
1,332,152
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
175,247
|
|
|
$
|
101,774
|
|
|
$
|
(126,951
|
)
|
|
$
|
150,071
|
|
|
|
Year ended December 31, 2016
|
|
|
|
Customer Engagement
(1) (2)
|
|
|
Financial Crime and Compliance
|
|
|
Not
allocated
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
754,398
|
|
|
$
|
261,144
|
|
|
$
|
-
|
|
|
$
|
1,015,542
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
202,893
|
|
|
$
|
89,990
|
|
|
$
|
(158,707
|
)
|
|
$
|
134,176
|
|
|
|
Year ended December 31, 2015
|
|
|
|
Customer Engagement
(1) (2)
|
|
|
Financial Crime and Compliance
|
|
|
Not
allocated
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
688,060
|
|
|
$
|
238,807
|
|
|
$
|
-
|
|
|
$
|
926,867
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
206,994
|
|
|
$
|
73,131
|
|
|
$
|
(114,019
|
)
|
|
$
|
166,106
|
|
|
(1) |
Includes the results of a certain operation (formerly part of the Security Solutions segment), which was retained following the above mentioned divestiture and integrated within the Customer Engagement operating segment.
|
|
(2) |
Includes the results of companies which were acquired in 2017 and 2016 and are being integrated within the Customer Engagement segment.
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 15:- REPORTABLE SEGMENTS AND GEOGRAPHICAL INFORMATION (Cont.)
The following presents property and equipment as of December 31, 2017 and 2016, based on operational segments:
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Customer Engagement
|
|
$
|
104,981
|
|
|
$
|
68,935
|
|
Financial Crime and Compliance
|
|
|
9,636
|
|
|
|
13,192
|
|
Non-allocated
|
|
|
3,658
|
|
|
|
5,551
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
118,275
|
|
|
$
|
87,678
|
|
|
b. |
Geographical information:
|
Total revenues from external customers on the basis of the Company's geographical areas are as follows:
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Americas, principally the US
|
|
$
|
1,035,871
|
|
|
$
|
720,520
|
|
|
$
|
630,096
|
|
EMEA (*)
|
|
|
186,268
|
|
|
|
189,223
|
|
|
|
192,640
|
|
Israel
|
|
|
3,693
|
|
|
|
4,295
|
|
|
|
4,231
|
|
Asia Pacific
|
|
|
106,320
|
|
|
|
101,504
|
|
|
|
99,900
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1,332,152
|
|
|
$
|
1,015,542
|
|
|
$
|
926,867
|
|
The following presents property and equipment as of December 31, 2017 and 2016, based on geographical areas:
|
|
December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
Americas, principally the US
|
|
$
|
70,404
|
|
|
$
|
49,175
|
|
EMEA (*)
|
|
|
3,557
|
|
|
|
3,398
|
|
Israel
|
|
|
37,571
|
|
|
|
28,237
|
|
Asia Pacific
|
|
|
6,743
|
|
|
|
6,868
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
118,275
|
|
|
$
|
87,678
|
|
|
(*) |
Includes Europe, the Middle East (excluding Israel) and Africa.
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 16:- |
SELECTED STATEMENTS OF INCOME DATA
|
|
a. |
Research and development, net:
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Total costs
|
|
$
|
211,406
|
|
|
$
|
151,698
|
|
|
$
|
132,039
|
|
Less - grants and participations
|
|
|
(2,363
|
)
|
|
|
(1,668
|
)
|
|
|
(2,174
|
)
|
Less - capitalization of software development costs
|
|
|
(27,936
|
)
|
|
|
(8,502
|
)
|
|
|
(1,380
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
181,107
|
|
|
$
|
141,528
|
|
|
$
|
128,485
|
|
|
b. |
Financial income (expenses) and other, net:
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
Financial income:
|
|
|
|
|
|
|
|
|
|
Interest and amortization/accretion of premium/discount on marketable securities, net
|
|
$
|
2,537
|
|
|
$
|
5,607
|
|
|
$
|
6,844
|
|
Exchange rates differences
|
|
|
241
|
|
|
|
3,961
|
|
|
|
-
|
|
Realized gain on marketable securities
|
|
|
-
|
|
|
|
3,388
|
|
|
|
32
|
|
Interest
|
|
|
1,149
|
|
|
|
953
|
|
|
|
430
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,927
|
|
|
|
13,909
|
|
|
|
7,306
|
|
Financial expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
|
|
)
|
|
|
(1,861
|
)
|
|
|
(66
|
)
|
Debt issuance costs amortization
|
|
|
|
)
|
|
|
(338
|
)
|
|
|
-
|
|
Exchangeable Senior Notes amortization of discount
|
|
|
(6,278
|
)
|
|
|
-
|
|
|
|
-
|
|
Exchange rates differences
|
|
|
-
|
|
|
|
-
|
|
|
|
(731
|
)
|
Other
|
|
|
(1,518
|
)
|
|
|
(925
|
)
|
|
|
(780
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(24,319
|
)
|
|
|
(3,124
|
)
|
|
|
(1,577
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expenses, net
|
|
|
(19
|
)
|
|
|
(480
|
)
|
|
|
(425
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(20,411
|
)
|
|
$
|
10,305
|
|
|
$
|
5,304
|
|
NICE LTD. AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
NOTE 16:- |
SELECTED STATEMENTS OF INCOME DATA (Cont.)
|
|
c. |
Net earnings per share:
|
The following table sets forth the computation of basic and diluted net earnings per share:
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations available to ordinary shareholders
|
|
$
|
143,291
|
|
|
$
|
123,069
|
|
|
$
|
140,578
|
|
Net income from discontinued operations available to ordinary shareholders
|
|
|
-
|
|
|
|
(6,149
|
)
|
|
|
118,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income to Ordinary shareholders
|
|
$
|
143,291
|
|
|
$
|
116,920
|
|
|
$
|
258,831
|
|
|
2. |
Denominator (in thousands):
|
|
|
Year ended December 31,
|
|
|
|
2017
|
|
|
2016
|
|
|
2015
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for basic net earnings per share:
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares
|
|
|
60,444
|
|
|
|
59,667
|
|
|
|
59,552
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Add - employee stock options and RSU
|
|
|
1,675
|
|
|
|
1,368
|
|
|
|
1,729
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator for diluted net earnings per share - adjusted weighted average shares
|
|
|
62,119
|
|
|
|
61,035
|
|
|
|
61,281
|
|
SIGNATURES
The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.
|
NICE LTD. |
|
|
|
|
|
|
By:
|
/s/ Barak Eilam |
|
|
|
Barak Eilam |
|
|
|
Chief Executive Officer |
|
|
|
|
|